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1020-265 Common Human SCN5A Polymorphisms Have Altered 
Electrophysiology When Expressed in the Q1077 Splice 
Variants
Bi-Hua Tan, Carmen R. Valdivia, Benjamin A. Rok, Bin Ye, Karen M. Ruwaldt, David J. 
Tester, Michael J. Ackerman, Jonathan C. Makielski, University of Wisconsin, Madison, 
WI, Mayo Clinic College of Medicine, Rochester, MN
Background: The current through the Na channel encoded by SCN5A underlies cardiac 
excitability, and abnormalities in this current underlie various heritable arrhythmia 
syndromes. Recently, we reported the minor allelic frequencies of eight common (> 0.5%) 
polymorphisms in SCN5A detected in 4 major ethnic groups: R34C, R481W, S524Y, 
H558R, P1090L, S1103Y, R1193Q, and V1951L. Two splice variants of human SCN5A, 
one lacking a glutamine at position 1077 (Q1077del) and one containing Q1077, exist in 
every human. We engineered the eight polymorphisms in the two SCN5A splice variants 
to study their function. 
Methods: We generated the point mutation by site directed mutagenesis in both variants 
and expressed them into HEK-293 cells for voltage clamp studies. 
Results: 24 hr after transfection, only R34C and V1951L showed no functional differences 
in the two splice variants. First, we conﬁrmed our earlier observation that current density 
for H558R is dramatically reduced when expressed in the Q1077 variant (-14±5 pA/pF 
n=8); similarly, S524Y in the Q1077 variant had signiﬁcantly reduced current (-75±11 
pA/pF n=28) compared to WT-Q1077 (-326±44 pA/pF n=21) p<0.0001. However, S524Y 
expressed in the Q1077del variant had current density similar to WT-Q1077 (-284±59 
pA/pF n=20 for S524Y and -338±68 n=14 for WT-Q1077). Second, we found that the two 
variants have subtle but signiﬁcantly kinetic changes for some of the polymorphisms. 
The Q1077del variant changed the mid-point of activation (SSA) in P1090L by -5 mV, in 
S1103Y by -3 mV. The Q1077 variant changed the SSA in S524Y by +3 mV, in H558R 
by +14 mV, in S1103Y by +5, and in R1193Q by -6 mV. The steady state of inactivation 
(SSI) was signiﬁcantly left shifted for R481W (-6 mV) in Q1077del, and for R1193Q (-5 
mV) in Q1077. Q1077 also shifted the SSI to the positive direction for S524Y, H558R, and 
S1103Y (by +3 mV, +10 mV, and +6 mV, respectively). 
Conclusions: We conclude that many common SCN5A polymorphisms affect function to 
the same extent as that described for arrhythmia mutations such as Brugada syndrome 
and that the splice variant background used to study mutations is important. These 
ﬁndings have implications for the signiﬁcance of clinical arrhythmia phenotypes.
1020-267A The Inﬂuence of Extracellular Acidosis on the Effect 
of Type III Antiarrhythmic Agents on the Cardiac 
Potassium Channel (IKr)
Lin Congrong, Xiaogang Ke, Vasant Ranade, John C. Somberg, Rush University, Chicago, IL
Ischemia may cause major changes in pH. The change in pH could inﬂuence the effect 
of type III agents on the rapid delayed rectiﬁer potassium channel (IKr). We evaluated the 
effects of acidosis on IKr inhibition caused by amiodarone (AM), azimilide (AZ), dofetilide 
(D) and quinidine (Q). IKr was studied at room temperature by using HERG gene 
expressed in Xenopus oocytes and two electrodes voltage clamp technique was applied. 
The recording bath solution contained in mmol/L: 96 NaCl, 5.0 KCl, 2.0 CaCl2, 1.0 MgCl2, 
5 HEPES; and pH adjusted with NaOH to 6.2 or 7.4. AZ, AM, Q at 1, 3, 10, 30, 100 µM 
and D at 0.03, 0.1, 0.3, 1, 3 µM caused dose dependent block in HERG current. The IC50 
was 5.8 ± 0.3 µM for AZ, 9.9 ±1.01 µM for Q and 0.5 ± 0.02 µM for D. When extracellular 
pH was decreased from 7.4 to 6.2, the IC50 increased to 96 ± 11 µM for AZ, 203 ± 16 µM 
for Q and 13 ± 1 µM for D. The block effect was decreased 32% for AZ, 42% for D, 29% for 
Q when pH was decreased from 7.4 to 6.2. For AM, the IC50 was 38 ± 9 µM at pH 7.4 and 
27 ± 2 µM at and pH 6.2. There was no signiﬁcant difference in the percentage of current 
block by AM between pH 6.2 and 7.4. Our data shows that the Ikr blocking effect of AZ, D 
and Q was attenuated at acidic pH while this was not the case for AM. The effect of AZ, 
D and Q at low pH creates heterogeneity of repolarization between ischemic and normal 
regions, but no change in current block would be expected with AM with regional acidosis. 
These observations may explain the reduced proarrhythmic effect of AM.
1020-267 Reentry Mediated by Ca2+ Transient: Roles of 
Intracellular Ca2+ on Graded Propagation and 
Conduction Block
Hideki Hayashi, Norihiko Ono, Ayaka Kawase, Chung-Chuan Chou, Peng-Sheng Chen, 
Shien-Fong Lin, Cedars-Sinai Medical Center and David Geffen School of Medicine at 
UCLA, Los Angeles, CA
Background: When given during the vulnerable period, a single premature stimulus (S2) 
of appropriate strength can induce reentry. A reentry pathway has been considered to be 
determined by the dispersion of refractoriness. Due to the complex interaction between 
transmembrane potential (Vm) and intracellular Ca2+ handling, we hypothesized that the 
intracellular Ca2+ transient (CaT) is associated with the formation of reentry.
Methods: A unipolar premature stimulation (S2) with strong current (40-100 mA) 
was applied after 8 beats of baseline pacing (S1) on the left ventricular epicardium in 
Langendorff-perfused rabbit heart. The line connecting S1 to S2 was parallel to the ﬁber 
orientation. The isolated hearts (n=8) were simultaneously stained with voltage- and 
Ca2+-sensitive dyes. Then the epiﬂuorescences (128×128 pixels over 2×2 cm2) were 
acquired with 4-ms/frame temporal resolution, using 2 charge-coupled device cameras. 
The ﬂuorescence level was calibrated by S1 induced AP, which we assumed to have a 
Vm varying between -90 mV to 10 mV and a CaT amplitude varying between 100 nM 
and 1000 nM.
Results: Cathodal and anodal S2s initiated reentry. After reentering the S2 site, Vm 
exhibited graded propagation. During the propagation in the reentrant pathway, the takeoff 
potential of Vm was signiﬁcantly more depolarized at the entry site (cathodal S2, -37±2 mV; 
anodal S2, -38±5 mV) than at the exit site (cathodal S2, -46±4 mV; anodal S2, -49±7 mV). 
As activation propagated along the reentrant pathway, the amplitude of CaT signiﬁcantly 
increased (cathodal S2, 33±16 %; anodal S2, 35±28 %). At the exit, the initial rise of CaT 
preceded that of Vm. When Vm was high enough to block the conduction near the S2 site 
(cathodal S2, -21±7 mV; anodal S2, -22±2 mV), CaT near the S2 site (cathodal S2, 520±37 
nM; anodal S2, 542±48 nM) was greater as compared to when reentrant activation passed 
through (cathodal S2, 412±51 nM; anodal S2, 397±71 nM).
Conclusion: Reentrant propagation is mediated through the mechanism regarding 
elevated CaT increases intracellular cations. The propagation with elevated CaT at the 
exit suggests triggered activity. Further increase of CaT induces conduction block.
1020-268 Ranolazine Reverses the Changes in Cardiac 
Depolarization-Repolarization Patterns Caused by 
E-4031 and ATX-II. An Optical Mapping Study Using 
Experimental Models of LQT-2 and LQT-3 Syndromes
Dmitry O. Kozhevnikov, Arvinder K. Dhalla, John Shryock, Luiz Belardinelli, CV 
Therapeutics, Inc., Palo Alto, CA
Background: Ranolazine has clinical anti-anginal activity and is reported to suppress the 
arrhythmogenic effects of a number of QT-prolonging drugs in pre-clinical models.
Objectives: The purpose of this study was to determine the effects of ranolazine on dispersion 
of ventricular electrical activity in the absence and presence of either the late INa-enhancer 
ATX-II (LQT-3 syndrome model) or the IKr-blocker E-4031 (LQT-2 syndrome model).
Methods: Langendorff-perfused guinea pig isolated hearts were treated with ATX-II (3 to 
20 nM), E-4031 (0.1 to 3 µM) or ranolazine (5 to 30 µM) alone and ranolazine combined 
with either ATX-II or E-4031. Action potentials were simultaneously recorded from 256 
anterior right and left ventricular epicardial sites using a high-resolution photodiode-
array-based optical mapping system. Action potential duration (APD) and ventricular 
transepicardial APD gradient (APD dispersion) were determined.
Results: Under control conditions, APD and transepicardial APD gradient were 179 ± 6 
msec and 2.3 ± 0.3 msec/mm, respectively. ATX-II (20 nM; n=4) and E-4031 (3 µM; n=3) 
signiﬁcantly increased the mean APD above control by 128% and by 58% respectively, and 
the APD gradient by 494% and 206%, respectively. Ranolazine alone (n=4) caused a 20% 
prolongation of APD (p<0.001) at the highest concentration (30 µM), but did not cause 
a signiﬁcant change in the transepicardial APD gradient. Ranolazine, in a concentration-
dependent manner, signiﬁcantly (p<0.001 at 30 µM ranolazine) reduced the increases 
in APD caused by 10 nM ATX-II and by 1 µM E-4031 from 302 ± 18 to 224 ± 4 msec 
(n=8) from 261 ± 5 to 234 ± 4 msec (n=6), respectively. Ranolazine (30 µM) reversed 
the increase in the APD gradient caused by ATX-II from 6.1 ± 1.0 to 2.3 ± 0.2 msec/mm 
(p<0.01) and that caused by E-4032 from 3.9 ± 0.2 to 2.0 ± 0.1 msec/mm (p<0.001).
Conclusions: Ranolazine (30 µM) caused a moderate prolongation of the APD. However, 
ranolazine did not increase dispersion of APD as measured by the transepicardial APD 
gradient. On the contrary, ranolazine (30 µM) reversed the actions of ATX-II and E-4031 
both to prolong APD and to increase the transepicardial APD gradient.
1020-269 Enhanced Cardiac L-Type Calcium Current Response to 
Urotensin II in Heart Failure
Qing-Hua Han, Heng-Jie Cheng, Atsushi Morimoto, Che-Ping Cheng, Wake Forest 
University School of Medicine, Winston-Salem, NC
Background. Urotensin II (U-II) is a somatostatin-like peptide recently identiﬁed as a 
potent vasoconstrictor with negative inotropic actions. In heart failure (HF) patients, 
circulating and myocardial U-II levels are increased, which suggest a pathophysiological 
role of this peptide. However, the cellular mechanism of U-II-induced cardiac depression 
is unclear. Virtually no previous studies have speciﬁcally examined U-II-induced changes 
in L-type Ca2+ current (ICa,L).
Methods. We assessed the effect of U-II on ICa,L response in isolated left ventricular (LV) 
myocytes obtained from 16 rats with isoproterenol (ISO)-induced HF (4 months after 
340 mg/kg, sq, for 2 days) and from 10 age-matched normal control rats. To examine 
the mechanism of U-II-induced changes in ICa,L, the U-II functional responses were also 
evaluated in 3 subgroups after the myocytes were pretreated with U-II receptor antagonist, 
Urantide (10-5 M), pertussis toxin (PTX, 2µg/ml, 36°C, 6h), and dibutyryl-cAMP (Db-cAMP, 
10-4 M). ICa,L was measured using whole-cell voltage clamp technique. 
Results. Superfusion of U-II (10-8-10-5 M) caused a dose-dependent decrease in ICa,L in 
both normal and HF myocytes with maximal inhibition at 10-5 M. In normal myocytes, U-II 
(10-5 M) decreased ICa,L by 14.3% (5.0±0.29 vs 5.9±0.3 pA/pF, p<0.01). In HF myocytes, 
the baseline ICa,L was signiﬁcantly lower (3.0±0.1 vs 5.9±0.3 pA/pF, p<0.01) and was 
further reduced by 31.3% with U-II 10-5 M (2.1±0.1 vs 3.0±0.1 pA/pF) that was signiﬁcantly 
greater than U-II-induced changes in normal myocytes. U-II-induced reductions in ICa,L 
were signiﬁcantly attenuated by U-II-antagonist and were reversed after washout of U-II. 
In both groups of rats, U-II-induced decreases of ICa,L were prevented with pretreatment 
myocytes with PTX (normal: 5.3±0.3 vs 5.3±0.2; HF: 3.0±0.3 vs 3.0±0.4 pA/pF) or Db-
cAMP (normal: 5.2±0.2 vs 5.3±0.1; HF: 2.9±0.1 vs 2.9±0.3 pA/pF).
Conclusion. U-II inhibits L-type Ca2+ channel and decreases ICa,L in both normal and HF 
myocytes. In HF, U-II-induced inhibition of ICa,L was enhanced. These effects are likely 
to be mediated through cAMP-dependent mechanism and coupled with PTX-sensitive 
G-protein.
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1021-250 Angiotensin II Receptor Blocker Reduces Plasma B-
type Natriuretic Peptide Level in Patients With Atrial 
Fibrillation: A Randomized, Open-Label, Controlled 
Study
Akihiro Nakamura, Atushi Goto, Sunichi Ito, Nobuo Hoshi, Kunio Shirato, Iwate 
Prefectural Miyako Hospital, Miyako, Japan, Tohoku University Graduate School of 
Medicine, Sendai, Japan
Background: Plasma B-type natriuretic peptide (BNP) is elevated in medically stable 
outpatients with chronic atrial ﬁbrillation (AF). The purpose of this study was to assess 
plasma BNP level as a result of administration with angiotensin II receptor blocker (ARB), 
that has beneﬁcial effects on AF, in pts with chronic nonvalvular AF. 
Methods: This study was a single-center randomized, controlled, open-label study during 
two years (from April 2001 through December 2003), and seventy-six pts initially enrolled. 
Fifty-eight subjects (37 men, age 68±10 yrs) were included in the analysis. Of these, 28 
were allocated to ARB group (losartan 50mg per day), and 30 to control group. 
Results: In terms of base-line characteristics, ARB group and control group were well 
matched. 1) At baseline, BNP level was signiﬁcantly greater in pts with chronic AF (n=58) 
than in normal subjects (n=89) (131.9±111.4 vs 25.2±31.1 pg/ml, p < 0.0001), however, 
did not differ between pts with ARB administration (ARB group, n=28) and pts without 
ARB (control group, n=30) (140.1±104.3 vs 124.3±118.9 pg/ml, p=0.5923). 2) During a 
mean follow-up period of 24±4 months, in ARB group, plasma BNP level was signiﬁcantly 
decreased (140.1±104.3 to 114.7±92.6 pg/ml, p=0.0163; a 50.1 percent decrease), 
however, there was no signiﬁcant change in control group (124.3±118.9 to 114.1±135.5 
pg/ml, p=0.9294). In both group, there were no signiﬁcant differences in hemodynamic 
performance including blood pressure or heart rate. 
Conclusion: This is ﬁrst report to show that angiotensin II receptor blocker reduces 
plasma BNP in pts with AF. This study suggests that the association of renin-angiotensin 
system with nonvalvular AF and may provide the rationale for clinical trials to investigate 
the use of ARB in the management of chronic AF.
1021-251 Propafenone-Sotalol: Which Is Preferred in Atrial 
Fibrillation, for the Maintenance of Normal Sinus 
Rhythm
Nick E. Igoumenidis, George E. Kochiadakis, Michael E. Hamilos, Panagiotis G. 
Tzerakis, Nick C. Klapsinos, Panos E. Vardas, Heraklion University Hospital, Heraklion, 
Greece
Background. In this prospective, randomized, single-blinded, placebo-controlled trial, 
we assessed and compared the efﬁcacy and safety of sotalol and propafenone when 
used long-term for the prevention of atrial ﬁbrillation. Previous studies with both agents 
have reported favorable clinical results but limited data are available on the long-term 
effectiveness of such drugs.
Methods. We studied 254 consecutive patients (128 men, mean age 63 ± 9 years) with 
recurrent, symptomatic atrial ﬁbrillation. After restoration of sinus rhythm, patients were 
randomized to propafenone (450 mg/day), to sotalol (160-480 mg/day as tolerated) and to 
placebo. Follow up clinical evaluations were conducted at the 1st, 2nd, 4th and 6th month 
and at 3-month intervals thereafter. The proportion of pts remaining in sinus rhythm was 
calculated for the two groups using the Kaplan-Meier method. End point of the study was 
recurrence of atrial ﬁbrillation or occurrence of side effects necessitating discontinuation 
of medication.
Results. Of the 254 patients, 86 were assigned to propafenone, 85 to sotalol and 83 to 
placebo. Of the 86 patients receiving propafenone 45 relapsed to atrial ﬁbrillation and/or 
experienced intolerable side effects after a mean time of 26 months, compared to 69 
of the 85 sotalol patients after a mean time of 18 months and 73 of 83 controls after a 
mean time of 11 months (p<0.001 for propafenone and sotalol vs. placebo; p<0.001 for 
propafenone vs. sotalol).
Conclusion. Both propafenone and sotalol can be used for the maintenance of sinus 
rhythm in patients with recurrent symptomatic atrial ﬁbrillation. However, for long-term 
maintenance propafenone seems to be more effective than sotalol.
1021-252 Long-Term Outcome in Patients With Atrial Fibrillation 
Treated According to the Guidelines for Antithrombotic 
Therapy in Comparison to Patients in Whom Guidelines 
Were Not Implemented
Karlheinz Seidl, Klaus Dönges, Elke Fromm, Thomas Kleemann, Thorsten Becker, Ömer 
Yildiz, Jochen Senges, Heart Center Ludwigshafen, Ludwigshafen, Germany
Aim of this single center observational study was to compare the outcome in patients (pts) 
with atrial ﬁbrillation (AF) implementing antithrombotic treatment(ATT) according to the 
guidelines with pts not treated as recommended by the guidelines.
Method: In this prospective AF registry 750 pts were included with AF. Pts were deﬁned 
according their individuell risk for thromboembolic complications (TEC) in high risk pts 
(deﬁned if one of the following risk indicators (RI) was positive: age > 75 yrs, org. heart 
disease, prior embolism, > 1 intermediate RI); intermediate risk pts (deﬁned as age 
65 - 75 yrs, diabetes or hypertension) and low risk pts (age < 65 yrs, no RI). ATT was 
recommended according to the guidelines: high risk pts received oral anticoagulation 
(OAC), intermediate risk pts OAC or ASA, low risk pts no OAC.
At the end of follow-up with a median of 65 months (50-84 months) pts were classiﬁed 
as follows: group 1 ATT according to the guidelines vs group 2 ATT not implemented as 
recommended. Follow up was complete in 93 % of pts.
Conclusion: 1) Pts with atrial ﬂutter were less often treated with OAC compared to pts with 
AF. 2) Pts treated as recommended by the guidelines had a better prognosis in respect 
of mortality/stroke/severe bleeding compared to pts without implementing the guidelines 
for ATT as recommended.
pts characteristics 
(*p<0.05)
Group 1 as recommended by 
guidelines (576 pts)
Group 2 ATT not implemented 
as recommended (174 pts)
atrial ﬁbrillation 76% 49%*
atrial ﬂutter 41% 73%*
org. heart disease 84% 74%
hypertension 63% 42%*
prior stroke 14% 8%*
long-term follow-up:
death 26.4% 32.3%*
stroke 5.6% 8.3%*
bleeding 1.0% 1.8%
1021-253 Amiodarone or Carvedilol Pretreatment Improves 
Conversion Rates in Persistent Atrial Fibrillation 
Patients - Clinical and Electrophysiological Outcomes
Emmanuel M. Kanoupakis, Emmanuel G. Manios, Hercules E. Mavrakis, Dimitris A. 
Arfanakis, Panagiotis Kafarakis, Eleftherios M. Kallergis, Panos E. Vardas, Heraklion 
University Hospital, Heraklion, Greece
Background: Pre-treatment with antiarrhythmic agents could improve cardioversion and 
atrial ﬁbrillation (AF) recurrence rates in patients with persistent AF. In this prospective 
trial we examined the conversion and recurrence rates of persistent AF patients pre-
treated with the b-blocker carvedilol and amiodarone.
Methods: One hundred forty-ﬁve patients were randomly assigned to treatment with 
carvedilol, amiodarone or placebo for four weeks prior to electrical cardioversion for 
persistent AF. The mean ﬁbrillatory cycle length interval (FF) was evaluated before 
cardioversion and effective refractory period (ERP) was measured ﬁve minutes after 
restoration of sinus rhythm. Holter recordings were obtained from all patients on the day 
after cardioversion and the density of supraventricular ectopic beats was calculated.
Results: Cardioversion rates were 43/47 (91.5%) for carvedilol, 42/45 (93.3%) for 
amiodarone and 33/45 (73%) for placebo, making both drugs statistically superior to 
placebo (p=0.017). Both drugs prolonged FF and ERP in the setting of atrial remodeling 
due to AF and this could be related to their beneﬁcial effect on conversion rate. Total AF 
recurrence rates during the ﬁrst month after conversion were 27.9%, 16.6% and 39.4%, 
for the three groups respectively. The superiority to placebo was statistically signiﬁcant 
only for amiodarone. Amiodarone patients also had a signiﬁcantly lower density of 
supraventricular ectopic beats post-conversion.
Conclusions: The combination of electrical cardioversion with amiodarone or carvedilol is 
more effective than cardioversion alone in persistent AF patients. Amiodarone is superior 
in terms of sinus rhythm maintenance post-conversion. This could be related to the lower 
density of supraventricular ectopic beats.
1021-254 Comparison of a Na+ and K+ Channel Blocker on 
Electrophysiological Properties of the Pulmonary Veins 
in Patients With Atrial Fibrillation
Tomoo Yasuda, Koichiro Kumagai, Masahiro Ogawa, Hiroo Noguchi, Hideo Takashima, 
Souichi Muraoka, Chiharu Mitsutake, Keijiro Saku, Fukuoka University Hospital, 
Fukuoka, Japan
Antiarrhythmic agents are used for the treatment of atrial ﬁbrillation (AF). However, the 
effects of antiarrhythmic drugs on the electrophysiological properties of the pulmonary 
veins (PVs) have not been well characterized. Therefore, we assessed the effects of 
pilsicainide (PLS), a pure Na+ channel blocker (class Ic drug), and nifekalant (NFK), a 
pure IKr blocker (class III drug), on the electrophysiological characteristics within the PV 
and at the PV-left atrial (LA) junction using multielectrode basket catheter.
Methods and Results: PV mapping using a basket catheter was performed in 22 
patients (19 men; mean age 58 ± 12 years old) with paroxysmal AF. Thirty-two bipolar 
electrograms were recorded simultaneously from a basket catheter. Thirty-four PVs, 
including 12 left superior, 6 right superior and 4 left inferior PVs, were studied at 58 
pacing sites. The proximal electrode of the basket catheter was located at the PV-LA 
junction. The programmed stimulation was performed in the distal PV and PV-LA junction 
before and after infusion of PLS (1 mg/kg) in 12 patients or NFK (0.3 mg/kg) in 10 patients. 
Both drugs signiﬁcantly prolonged the effective refractory period (ERP) of both the distal 
PV (PLS; from 165±34 to 186±45 ms, P<0.02, NFK; from 197±43 to 211±50 ms, P<0.05) 
and the PV-LA junction (PLS; from 203±56 to 213±60 ms, P<0.05, NFK; from 232±36 
to 264±39 ms, P<0.0001). The degree of ERP prolongation by PLS in the distal PV was 
signiﬁcantly higher than that in the PV-LA junction (15±17 vs. 4±18 %, P<0.05), whereas 
that by NFK in the PV-LA junction was signiﬁcantly higher than that in the distal PV (15±7 
vs. 6±9 %, P<0.05). PLS signiﬁcantly prolonged the conduction time (S1-A1) from the distal 
PV to PV-LA junction (from 45±16 to 60±19 ms, P<0.05), and in a patient with induced 
sustained AF, PLS blocked the conduction from the LA to PV at the PV-LA junction, and 
then terminated AF. In contrast, NFK did not change the conduction time in PVs.
Conclusions: In patients with AF, PLS has antiarrhythmic effects mainly on the distal PV 
by modifying the ERP and the conduction properties. In contrast, NFK has antiarrhyrhmic 
effects mainly on the PV-LA junction by modifying the ERP.
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1022-255 Clinical Value of Repeating Indeterminate Microvolt T-
Wave Alternans Tests
Theodore Chow, Sinan Gursoy, John R. Onufer, Karin M. Brinkman, Wenji Pu, Richard 
J. Cohen, The MASTER Trial Investigators, The Lindner Center for Research and 
Education, Cincinnati, OH
Background: Microvolt T-Wave Alternans (MTWA), a non-invasive test for assessing 
ventricular tachyarrhythmic risk, has had reported rates of indeterminate test results 
typically in the 20% to 30% range. The effect of repeating indeterminate MTWA tests on 
the overall indeterminacy rate is unknown.
Methods: The MASTER Trial is a 1500 patient prospective study evaluating MTWA as a 
predictor of future spontaneous ventricular tachyarrhythmic events in patients with prior 
myocardial infarction and LVEF ≤ 0.40. This trial uses the HeartwaveTM (Cambridge Heart, 
Inc.) for measuring MTWA. The protocol requires that all tests classiﬁed by the automated 
report classiﬁer as indeterminate be repeated at the same testing session as the initial 
test. Final classiﬁcation of MTWA tests was determined by an expert reader blinded to the 
clinical data. An interim analysis of the effect of repeating indeterminate MTWA tests on 
the overall indeterminacy rate was performed.
Results: Of 606 initial MTWA tests, 113 (18.6%) were classiﬁed as indeterminate. The 
causes of indeterminacy were: non-sustained alternans (32.7%), bad beats (32.7%), 
inadequate heart rate (23.0%), noise (10.6%), and heart rate rise too rapid (0.9%). 
Repeat testing was performed on 65 of these patients and resulted in a determinate result 
in 60%of the repeated tests (MTWA positive in 35.4%, negative in 24.6%, indeterminate 
in 38.5%, and technically inadequate in 1.5%). The initial cause for indeterminacy was not 
signiﬁcantly associated with whether repeating the test would yield a determinate result. 
Final classiﬁcations for 606 patients included 280 (46.2%) as Positive, 240 (39.6%) as 
Negative, 59 (9.7%) as Indeterminate, and 27 (4.5%) as Technically Inadequate.
Conclusion: Repeating MTWA tests initially classiﬁed by the automatic report classiﬁer 
as indeterminate results in a determinate result in 60% of repeated tests and reduces 
the overall indeterminacy rate to 9.7% (margin of error 2.4%) which is substantially lower 
than previously reported.
1022-256 The Prognostic Value of Consecutive Abnormal Signal-
Averaged Electrocardiograms in Patients after Acute 
Myocardial Infarction
George Kazianis, Angelos Economou, 7th Hospital of Social Insurance Institution, 
Athens, Greece
Objective: To assess the prognostic ability of consecutive abnormal signal-averaged 
electrocardiograms (SAECGs) during hospitalization after an acute myocaridal infarction (AMI).
Methods: Seven hundred and ﬁve pts (525 men), aged 63+0.4 (SE) years in sinus 
rhythm were studied prospectively post-AMI. All pts underwent 1) Estimation of functional 
Killip class on admission, 2) SAECG obtained at the 1st, 3rd and 7th days after admission. 
Abnormal SAECG was deﬁned if fQRS>114 ms plus either LAS>38 ms or RMS<20 µV 
for a standard QRS duration <120 msec or fQRS>155 ms, LAS>55ms or RMS<17 µV 
for a QRS>120 msec. 3) Measurement of ejection fraction (EF) by 2D-echo on 1st day. 4) 
24-hour Holter ECG recording with arrhythmias analysis based on Lown’s classiﬁcations. 
5) 12-lead ECG estimation of infarct size by QRS score based on Q and R wave duration 
and R/S and R/Q ratio at hospital discharge. Thrombolysis was given in 58% of pts. A 
cohort of 60 pts had consecutive abnormal SAECGs.
Results: During a follow-up period of 39+0.9 months 178 (25%) pts died of cardiac 
causes (including sudden cardiac death). The presence of the 3 consecutive abnormal 
SAECGs was correlated with age (p=0.00), EF (p=0.00), old MI (p=0.05), anterior AMI 
(0.00), QRS score (0.00) and Killip class>II (p=0.00). In multivariate analysis (logistic 
regression) only age (p=0.001), EF (p=0.002) and abnormal consecutive SAECGs 
(p=0.00) were independent predictors of cardiac mortality. The presence of 3 consecutive 
abnormal SAECG had higher speciﬁcity and higher positive predictive value (96% and 
65%) than the separate abnormal SAECG (89% and 52% for the 1st, 90% and 42% for the 
3rd or 87% and 32% for the 7th day respectively).
Conclusion: The presence of consecutive abnormal SAECGs improved the independent 
prognostic value of the SAECG for cardial mortality.
1022-257 The Shortage of Short QTs
Michael G. Reinig, Simon Topalian, Joseph E. Parrillo, Toby R. Engel, Cooper University 
Hospital/UMDNJ-RWJ, Camden, NJ
Background: Ventricular tachyarrhythmias and syncope or sudden death has recently 
been associated with a short QT interval (QTc <300 msec, the so-called Short QT 
interval Syndrome, SQTS). We investigated the prevelance of short QT intervals and the 
frequency of SQTS when the QTc is <300 msec.
Methods and Results: QTc was measured by a Marquette MAC 5000 and veriﬁed by 
a cardiologist at 25 mm/sec paper speed. From 1988 to July 2004, 479,120 consecutive 
electrocardiograms (ECGs) were analyzed by the MAC 5000, which reported 215 tracings 
with QTc <300ms. Each of these 215 ECGs were then measured manually but no QTc 
<300 msec was validated: 67% were found to be in error because of a pacemaker spike, 
17% had supraventricular tachycardia with inaccurate detection of T wave offset, as from 
ﬂutter waves, and 16% were found to have an error in cycle length calculation. Therefore, 
not one of the 479,120 ECGs were found to have a QTc <300ms.
We surveyed QT intervals in 80 subjects (40 men) after exclusion of tracings with bundle 
branch block, heart rates >100 beats per minute (bpm), ST depression or T inversion 
consistent with ischemia, or left ventricular hypertrophy with QRS widening. Patients were 
excluded if taking drugs that might cause QT prolongation. Average QTc for men was 
425 msec ± 20 SD and for women: 436 ± 19. Combining sexes, 95% conﬁdence interval 
for QTc = 392-468 msec. QTc<300 msec then would be >5 SD less than mean QTc, 
presumably reﬂecting 1 of 100,000 of our hospitalized subjects.
There were 50 patients in sinus rhythm <100 bpm with a relatively short QTc (350-360 
msec per the Marquette MAC 5000) were validated by manual measurement to insure 
that the device did not systematically overestimate QT interval measurements and 
thereby fail to detect some patients with a true QTc <300 msec. Indeed, the physician 
measurement tended to be longer (average 373 msec ±39) than the computer average 
(362±33, r = 0.83).
Conclusions: SQTS has received considerable attention over the past few years, but 
only cases from seven families have been reported. A review of our hospital database 
failed to reveal new cases of QTc <300msec, suggesting that SQTS is quite rare.
1022-258 Localization of Idiopathic Ventricular Tachycardia 
Originating in Basal Left Ventricle: Utility of Distinct 
Electrocardiographic Features
Sanjay Dixit, Edward Gerstenfeld, David Callans, David Lin, Henry Hsia, Hemal Nayak, 
Ralph Verdino, Joshua Cooper, Andrea Russo, Vickas Patel, Erica Zado, Francis 
Marchlinski, University of Pennsylvania Health System, Philadelphia, PA, Philadelphia 
VAMC, Philadelphia, PA
Background: Pace maps (PM) from various basal left ventricle (BLV) locations manifest 
unique ECG morphologies. In this study we test the accuracy of PM derived ECG criteria in 
predicting site of origin (SOO) of idiopathic ventricular tachycardia (IVT) arising from BLV. 
Methods: From 1/99 to 12/03, 122 patients (pts) underwent IVT ablation at our center 
of which 14 had fascicular VT. In remaining 108 pts, successful ablation site on 3-D 
electroanatomic map was from: right ventricular outﬂow tract in 88, aortic cusps / LV 
epicardium in 9 and basal LV endocardium in 11. The latter group manifested 12 VTs, 
which were reviewed by a blinded investigator (BI) who predicted SOO using criteria 
outlined in table below. At least 3 of 4 criteria had to be met for predicting SOO. 
Results: Average age of study population was 58±20 years (8 males; LV Ejection Fraction 
0.54±0.8). Successful ablation site was as follows: septal-parahisian (S-P) - 2, aorto-mitral 
continuity (AMC) - 4, superior mitral annulus (MA) - 3 and supero-lateral MA - 3. BI was able 
to accurately localize SOO of IVT in 10 of 12 cases (83%). In 2 cases SOO was incorrectly 
identiﬁed as superior MA and S-P region (successful ablation site was AMC in both). 
Conclusion: PM derived speciﬁc ECG features can be used to accurately localize IVT 
originating from BLV. This may facilitate intracardiac mapping and ablation of these 
arrhythmias.
* Reversal of Q to R and vice  
versa < V3 = Early and > V5 = Late 
S-P AMC Superior MA Supero-Lateral MA Lateral MA
Lead I R or Rs Rs or rs rs or rS rS or QS rS or rs
Lead V1 QS or Qr qR R or Rs R or Rs R or Rs
Precordial Transition* Early None None None None or Late
Ratio of QRS in leads 
II and III >1 ≤1 ≤1 ≤1 >1
1022-259 Transesophageal Deﬁbrillation: A Therapeutic Option 
For Refractory Ventricular Fibrillation?
Karl Mischke, Thomas Schimpf, Christian Knackstedt, Markus Zarse, Jurgita Plisiene, 
Patrick Schauerte, Technical University Aachen, Aachen, Germany
Objektive: Shock-resistant or recurrent ventricular ﬁbrillation occurs in about 10-25% 
of out-of-hospital resuscitations. Because of the proximity of the electrodes to the heart 
transesophageal deﬁbrillation might increase deﬁbrillation success. The study evaluated 
the comparative efﬁcacy of a device for transesophageal deﬁbrillation to transthoracic 
deﬁbrillation.
Methods: After induction of VF monophasic and biphasic shocks were delivered between 2 
cutaneous electrodes or between transesophageal and cutaneous electrodes. To evaluate 
the optimum transesophageal electrode conﬁguration deﬁbrillation thresholds (DFTs) 
were measured in 12 pigs (68±4kg) for 4 different electrode conﬁgurations. Choosing 
the optimum conﬁguration DFTs were determined for external and transesophageal 
deﬁbrillation in 10 additional pigs with lower body weight (39±1kg).
Results: Lowest DFTs were achieved with 1 large esophageal electrode vs. 2 external 
electrode patches. In 5 of 12 pigs with high body weight external deﬁbrillation failed with 
maximum energy (200 J biphasic, 360 J monophasic shocks) whereas transesophageal 
deﬁbrillation was still successful. In the remaining 7 pigs, DFTs were signiﬁcantly lower 
for transesophageal deﬁbrillation than for transthoracic deﬁbrillation (biphasic: 67±27 vs. 
164±23 J, monophasic: 171±45 vs. 320±56, p<0.001). In 10 pigs with lower body weight 
DFTs for transesophageal deﬁbrillation were also signiﬁcantly lower than for transthoracic 
deﬁbrillation. Biphasic shocks yielded signﬁcantly lower DFTs than monophasic ones. 
Long-term esophageal damage was ruled out by macro- and microscopic examinations 
in 6 mongrel dogs.
Conclusions: In this animal model, non-responders to external biphasic deﬁbrillation 
could successfully be deﬁbrillated with a transesophageal electrode conﬁguration. Overall, 
a 35-50% DFT reduction was obtained by transesophageal deﬁbrillation. Transesophageal 
deﬁbrillation might increase primary deﬁbrillation success rate and provide an additional 
tool for terminating VF which is refractory to external deﬁbrillation.
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1022-260 Effects of n-3 Polyunsaturated Fatty Acids on 
Arrhythmic Pattern in Chronic Heart Failure Patients
Chiara Vaccarini, Diego Domenighini, Giuseppe Furgi, Filippo Mastropasqua, Giorgio 
Mazzuero, Maria Rosa Perotti, Simona Sarzi-Braga, Maria Teresa La Rovere, 
Fondazione “S. Maugeri”, IRCCS, Istituto Scientiﬁco di Montescano, Montescano 
(Pavia), Italy
Background: N-3 polyunsaturated fatty acids (n-3 PUFA) found in ﬁsh or their dietary 
supplementation are associated with a reduced risk of sudden cardiac death, and 
experimental data suggest antiarrhythmic properties. Premature Ventricular Contractions 
(PVCs) have been regarded as a marker of increased arrhythmic risk. Preliminary data 
suggest that n-3 PUFA intake reduces the number of PVCs.
We evaluated the effects of n-3 PUFA in patients with chronic heart failure, a group at 
high prevalence of PVCs.
Methods and Results: One-hundred sixty-seven patients with ischemic (71%) or 
idiopathic cardiomyopathy (age 60±10 yrs, NYHA cl II 88%, Ejection Fraction 32±6%, 
stable therapy within the previous 3 months) were randomised to a standard dose of 1 
gr/day of n-3 PUFA (SEACOR, SPA, Italy) or placebo for 6 months. Patients underwent 
24h-ECG monitoring and plasma determination of eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA). At entry the two groups did not differ in terms of systolic 
arterial pressure (SAP, 114±14 vs 114±15 mmHg), heart rate (HR, 67±9 vs 66±10 b/min), 
PVCs /24h (1555±3937 vs 1153±2910), EPA (0.72±0.37 vs 0.74±0.44) and DHA plasma 
levels (2.1±0.6 vs 2.1±0.8 %fatty acids). One-hundred forty-two patients concluded the 
study, with the same drop-out rate in the two groups. At 6 months, no differences were 
found in SAP (116±16 vs 115±15 mmHg) and HR (67±10 vs 66±10 b/min), while there 
was a signiﬁcant reduction of 55% in the total number of PVCs in the treatment group 
and an increase in the placebo group (705±1147 vs 1953±5064, p = 0.036); the same 
happened for the number of couplets and non sustained ventricular tachycardia events. 
Plasma levels of EPA and DHA were increased in the treatment group, with no change 
occurring in the placebo group (EPA 1.72±0.66 vs 0.78±0.38 DHA 2.9±0.8 vs 2.1±0.9 
%fatty acids, p < 0.001). During the study 3 deaths were recorded: one stroke in the 
treatment and two sudden deaths in the placebo group.
Conclusions: These data suggest that the antiarrhythmic effect of n-3 PUFA can 
determine a reduction of PVCs in a population at high risk of sudden death. The 
increase in cardiac electrical stability observed in these patients does not correlate with 
a bradycardic effect.
1022-261 Elevation of Aortic and Coronary Artery Nerve Growth 
Factor Following Acute Myocardial Infarction in Humans
Saibal Kar, Simon Kangavari, Shengmei Zhou, Hongmei Li, Su-Chao Ding, Yii-Der Ida 
Chen, Lan S. Chen, Peng-Sheng Chen, Division of Cardiology, Cedars Sinai Medical 
Center and David Geffen School of Medicine of UCLA, Los Angeles, CA, Children’s 
Hospital and Keck School of Medicine, USC, Los Angeles, CA
Background. We recently reported in a canine model that acute myocardial infarction 
(AMI) results in an upregulation of nerve growth factor (NGF) expression in the 
myocardium with peak activity at 1 week after MI. The total blood NGF rapidly increased 
after AMI, and stayed high for at least one month. The increased NGF was associated with 
cardiac nerve sprouting, which contributes to arrhythmogenesis after MI. We hypothesize 
that human patients with AMI might show similar increases in NGF levels with its resulting 
consequences.
Methods. Blood was drawn simultaneously from aorta and culprit coronary artery in 
ten AMI patients undergoing urgent cardiac catheterization. Serum NGF concentrations 
was quantiﬁed by using enzyme-linked immunosorbant assay. In each patient the time 
between blood sampling and the onset of chest discomfort was recorded
Results. There were 9 males and 1 female. The mean age was 63 yrs (range 42 to 82). 
There was no signiﬁcant difference between the aortic and coronary arterial NGF levels in 
each patient. Patients with AMI > 6 hours had signiﬁcantly higher aortic (235±131 ng/ml) 
and coronary artery (225±128 ng/ml) NGF levels than patients with AMI < 6 hours (58±71 
ng/ml and 53±131 ng/ml, respectively, p=0.036 for both comparisons). The large standard 
deviation indicates a large individual variation of the NGF concentration. There is a good 
linear correlation between the time since the onset of chest pain and the NGF levels in the 
aorta (r=0.80, p=0.0057) and in the coronary artery (r=0.81, p=0.0048). One patient with 
a highly elevated NGF level (447 ng/ml) developed ventricular tachycardia nine months 
later, documented by an implantable cardioverter-deﬁbrillator.
Conclusion. There is a time-dependent increase in systemic NGF concentrations in 
AMI patients. Increased NGF concentrations following AMI may cause increased cardiac 
nerve sprouting, resulting in an increases risk for serious ventricular arrhythmias.
1022-262 Use of Three Dimensional Image Rendering From 
Fluoroscopy to Determine Catheter Location in Excised 
Porcine Hearts
Amin Al-Ahmad, Michael Homer, Teri Moore, Paul J. Wang, Stanford University Medical 
Center, Stanford, CA
Background: Fluoroscopy has long been the standard for imaging of the heart during 
cardiac electrophysiological procedures. Catheter orientation within the cardiac chambers 
can often be difﬁcult to precisely determine. New technology that renders a three 
dimensional (3-D) image from ﬂuoroscopic imaging has become available.
Objectives: To validate the utility of 3-D image rendering from ﬂuoroscopy in determining 
catheter position in excised hearts.
Methods: We placed a steerable catheter in 8 locations within 6 excised pig hearts. The 
heart was then placed under the ﬂuoroscopy C-arm ﬂat detector on a standard cath lab 
table. Using the AXIOM Artist dTA system (Siemens, Germany) a ﬂuoroscopic scan was 
performed. A 3-D image was then rendered that could be manipulated on a computer 
screen and rotated in 360 degrees. The image contrast could be changed to see within 
the chamber to visualize the catheter, and see some surface landmarks. Using the scan, a 
blinded investigator was asked to precisely locate the catheter within the heart.
Results: The 3-D scan was successfully performed on all hearts in less than 30 sec. All 
images could be rotated to see all aspect of the heart. The catheter orientation, course 
and contact point with the wall could be seen. Catheter location could be accuratly 
determined in 40 of 46 images (87%).
Conclusion: The 3-D ﬂuoroscopic scan technology shows great future promise for use in 
real time to aid in catheter position for mapping and ablation. 
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1023-247 Can Oral Magnesium Reduce the QTc Interval of 
Patients Receiving Class III Antiarrhythmics?
Brian F. McBride, Jeffrey Kluger, Bokyung Min, Danette Guertin, Craig I. Coleman, Burton 
Silver, Michael White, Hartford Hospital, Hartford, CT, University of Connecticut, Storrs, CT
Background: Intravenous magnesium (Mg++) reduces the QTc interval of patients 
receiving ibutilide. This study was undertaken to evaluate the impact of oral Mg++ on the 
QTc interval of patients taking sotalol and dofetile and whether an inherent intracellular 
magnesium deﬁciency exists among patients with arrhythmias. 
Methods: Patients (n=30) receiving sotalol or dofetilide for atrial or ventricular arrhythmias 
were randomized to receive twice daily Mg++ L-lactate (Niche Pharmaceuticals, 504mg 
elemental Mg++ daily) or placebo for 48 hours. A 12-lead ECG was taken at baseline, 3 
hours, and 51 hours after dosing initiation to correspond to the Tmax after oral ingestion. 
The QTc interval was measured from the ECGs and compared between groups. 
Intracellular Mg++ concentrations were determined by energy-dispersive X-ray Analysis at 
baseline and 51 hours after dosing (Intracellular Diagnostics, Inc.; Foster City, CA).
Results: QTc interval reductions from baseline were greater in the Mg++ group than 
placebo (Table). Overall 63.2% of patients had baseline intracellular Mg++ concentrations 
below the normal reference range of 33.9-41.9mEq/IU with an average level of 32.6±2.2 
mEq/IU. After Mg++ supplementation the intracellular concentrations rose signiﬁcantly 
(36.2±2.4 mEq/IU, p=0.002) with all patients achieving normal concentrations. 
Conclusion: Oral magnesium L-lactate raises intracellular magnesium concentrations 
and lowers the QTc interval of patients receiving sotalol or dofetilide.
QTc Interval Magnesium(n=14)
Placebo
(n=16) P-value
Baseline 472.5+54 459.6+44 0.667
3 hours 435.9+64 450.4+48 0.015
51 hours 449.4+52 463.1+48 <0.001
1023-248 Clinical and ECG Covariates of QT/RR Slope in 
Congestive Heart Failure Patients
Iwona Cygankiewicz, Wojciech Zareba, Juan Manuel Cino, Jose Ramon Juanatey, 
Vicente Nieto, Alfredo Bardaji, Carlos Macaya, Jordi Fabregat, Antoni Bayes de Luna, 
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, Red Tematica Muerte Subita en 
el Adulto, Spain
Background: The aim of this study was to evaluate the relationship between QT/RR 
slope and clinical covariates and other ECG measures of risk in congestive heart failure 
(CHF) patients. 
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Methods. In the population of 454 CHF patients (NYHA class II or III), we evaluated the 
slope of the QTa/RR (QT apex) and QTe/RR (QTend) during 24-hour Holter recording 
(ELA Medical) and separately during day and night periods. The results of this analysis 
were correlated with clinical covariates (age, EF, etiology of disease, NYHA class), 
ECG variables (QRS, QTc) and heart rate variability parameters from Holter recording. 
Results.1) The mean± sd for QTe/RR was 0.19 ± 0.07 and for QTa/RR was 0.17± 0.06 
and since they showed similar behavior we report results for QTe. 
2) Association of QT/RR with clinical data: QT/RR slope showed signiﬁcant negative 
association with ejection fraction (r=-0.18; p<0.01), i.e. lower ejection fraction was 
associated with steeper slope. Patients with idiopathic cardiomyopathy had steeper QT/
RR slope than those with ischemic cardiomyopathy (0.20 vs. 0.18; p=0.03). There was no 
signiﬁcant association between QT/RR slope and age and NYHA class. 
3) Association of QT/RR with ECG data There was no correlation between QT/RR 
slope and QRS duration. QT-RR slope correlated signiﬁcantly with QTc duration; i.e. 
patients with longer QTc had steeper slope (r=0.36; p<0.001). The QT/RR slope showed 
signiﬁcant positive association with heart rate (r=0.40; p<0.001). There was signiﬁcant 
negative association with several HRV parameters: SDNN (r=-0.31; p<0.001), SDNNI 
(-0.27; p<0.001), low frequency power (r=-0.32; p<0.001). The multivariate analysis 
adjusting for age and EF showed that increased QT-RR slope (above fourth quartile) is 
associated with increased heart rate and decreased heart rate variability. 3) Circadian 
variation of QT/RR: The slope of QT/RR was signiﬁcantly steeper during day vs. night 
hours (0.18 vs 0.17; p=0.001) 
Conclusions: The QT-RR slope is dependent on ejection fraction, heart rate, and heart 
rate variability in CHF patients. This association indicates that prognostic value of QT-RR 
slope need to be evaluated while adjusting for these factors in respective subgroups.
1023-249 The Relationship Between Left Ventricular Geometry 
and Transmural Dispersion of Repolarization
Magdi M. Saba, Salman A. Arain, Salma S. Ibrahim, Jason A. Mitchell, Carl J. Lavie, 
Richard V. Milani, Ochsner Clinic Foundation, New Orleans, LA, University of Maryland, 
College Park, MD
Background: Previously shown, ventricular ectopic activity (VEA) is increased in patients 
(pts) with LVH but diminished in pts with concentric remodeling (CR), compared to normal 
cardiac structure. Increased transmural dispersion of repolarization (TDR), which correlates 
to the interval from the peak to the end of the T-wave (Tpe) on ECG, is linked to ventricular 
tachyarrhythmias. We describe the relationship between LV geometry and TDR.
Methods: Tpe was assessed by ECG in 400 pts (59% male) with normal LV systolic 
function, QRS < 120 ms, in sinus rhythm, divided into 4 equal, age- and sex-matched 
groups by echocardiographically determined LV geometry. LVH was deﬁned as LV mass 
index (LVMI) ≥ 125 gm/m2 , and relative wall thickness (RWT) was deﬁned as 2 x posterior 
wall thickness/LV end-diastolic dimension, and was increased if > 0.43. Pts were divided 
into normal structure (no LVH, normal RWT), CR (no LVH, increased RWT), eccentric LVH 
(LVH, normal RWT) and concentric hypertrophy (LVH, increased RWT). Tpe interval was 
deﬁned as the mean of 3 cycles from the precordial leads V1-V3.
Results: See table.
Normal
Structure
(n = 100)
Concentric 
Remodeling
(n = 100)
Eccentric 
Hypertrophy
(n = 100)
Concentric 
Hypertrophy
(n = 100)
ANOVA
p-value
Age, yrs. 54.5 ± 3.0 54.8 ± 3.0 55.2 ± 3.6 54.9 ± 3.0 NS
BMI, kg/m2 29.0 ± 7.9 32.8 ± 7.31 31.7 ± 7.11 31.9 ± 7.21 0.0028
EF, % 61 ± 5 63 ± 3 62 ± 3 62 ± 6 NS
LVMI, gm/m2 76.1 ± 17 76.8 ± 20 156.7 ± 141,2 158.5 ± 381,2 <0.0001
RWT 0.37 ± 0.04 0.51 ± 0.081 0.39 ± 0.04 0.69 ± 0.81,2,3 <0.0001
QRS, ms 89.3 ± 9.4 87.1 ± 11.2 94.1 ± 8.41,2 98.6 ± 17.91,2,3 <0.0001
QTc, ms 418.7 ± 20.7 416.1 ±19.5 425.9 ± 22.31,2 441.3 ± 30.01,2,3 <0.0001
Tpe, ms 88.6 ± 15.9 79.1 ± 13.61,3,4 98.5 ± 10.21,2 103.9 ± 25.81,2 <0.0001
Tpe/QTc 0.20 ± 0.06 0.19 ± 0.03 0.23 ± 0.031,2 0.24 ± 0.061,2 <0.0001
 
1,2,3,4 signiﬁcantly different compared to respective column
Conclusion: Concordant with our previous observations of VEA and cardiac structure, 
TDR was increased in LVH but reduced in CR compared to normal structure. While LVH 
represents a maladaptive process resulting in an unfavorable electrical substrate, CR may 
represent a positive structural adaptation rendering a more favorable electrical milieu.
1023-270 Changes in QRS Amplitudes During Transient Right 
Bundle Branch Block: Effect on Voltage Criteria Used 
for the Detection of Left Ventricular Hypertrophy
Peter G. Chan, Michael A. Logue, Paul Kligﬁeld, Weill Medical College of Cornell 
University, New York, NY
Background: Although right bundle branch block (RBBB) delays right ventricular 
depolarization, its theoretical “unmasking” of left ventricular forces by reduced cancellation 
in the early and mid-QRS might be offset or altered by directional changes in septal 
and right ventricular depolarization. Systematic changes in QRS amplitude during 
transient RBBB bear directly on performance of standard ECG criteria for left ventricular 
hypertrophy (LVH), and these changes require quantiﬁcation during constant temporal 
and physiological conditions.
Methods: We examined the instantaneous effect of RBBB on QRS amplitudes and 
LVH voltages in 40 patients who had intermittent complete RBBB during a single 10 
sec standard 12-lead ECG recording, comprising 0.01% of approximately 400,000 
consecutive ECGs in a university teaching hospital setting. Amplitudes were measured 
by magnifying graticule to the nearest 25 microvolts, averaged for up to 3 normal and 3 
RBBB complexes, and compared by paired t-test.
Results: RBBB was associated with an increase in mean initial rightward and inferior QRS 
forces (RV1, QV6, QIII) but signiﬁcant decreases in mean leftward and posterior mid-QRS 
amplitudes that result from left ventricular depolarization (RaVL [-75 microvolts], SV1 [-
389 microvolts], SV3 [-617 microvolts], RV5 [-100 microvolts], RV6 [-123 microvolts]). 
Mean late rightward and anterior QRS forces were increased with RBBB (R’V1, SV5, SI). 
As a result, combined voltages used for LVH criteria were signiﬁcantly reduced by RBBB: 
Sokolow-Lyon voltage decreased from 1520 ± 739 to 1014 ± 512 microvolts (p<0.001), 
and Cornell voltage decreased from 1438 ± 683 to 746 ± 399 microvolts (p<0.001).
Conclusion: RBBB is associated with signiﬁcant reduction in “left ventricular” QRS 
amplitudes of the standard ECG, suggesting cancellation, rather than unmasking, of 
mid-QRS forces by altered septal and delayed right ventricular depolarization. Because 
QRS voltages that are routinely combined for the detection of LVH are reduced in RBBB, 
standard LVH criteria will perform with lower sensitivity in patients with RBBB.
1023-271 A Novel Diagnostic Technique in Identifying Patients at 
Risk in Brugada Syndrome
Takanori Ikeda, Satoru Yusu, Kentaro Nakamura, Masayuki Yotsukura, Hideaki Yoshino, 
Kyorin University School of Medicine, Tokyo, Japan
Background: The autonomic modulation, particularly high vagal tone plays an important 
role in the occurrence of ventricular tachyarrhythmias in Brugada syndrome. The full 
food intake is one of the factors of the modulation of vagal activity. We assessed clinical 
usefulness of a novel diagnostic technique, namely, a full stomach test in identifying high-
risk group in Brugada syndrome.
Methods: We investigated changes of 12-lead electrocardiograms (ECGs) between 
before and within 30 minutes after a full meal in 37 patients (34 men; age 51 ± 15 years) 
with an ECG diagnostic of Brugada syndrome. We also analyzed several noninvasive 
markers such as late potentials by signal-averaged ECG, microvolt T-wave alternans, a 
mean QRS duration >120 msec, maximal QT interval >440 msec, and QT dispersion >50 
msec. These values were compared to those of 30 control subjects who were matched 
for age and gender. A full stomach test was deﬁned as positive when the augmentation of 
characteristic ECG abnormalities (i.e., a prominent coved-type ST-segment elevation >0.2 
mV in leads V1-V2 at its peak) was seen after the meal.
Results: Life-threatening arrhythmic events deﬁned as aborted sudden death or 
ventricular ﬁbrillation were present in 12 (32%) of the 37 patients with Brugada-type ECG. 
The full stomach test was positive in 18 patients (49%) with Brugada-type ECG and none 
of the control subjects. The positive outcomes of the test were characterized by a higher 
incidence (56%) of life-threatening events than that (11%) in the negative outcomes 
(P=0.008), whereas there was no difference in signal-averaged ECG, microvolt T-wave 
alternans, a mean QRS duration, maximal QT interval, and QT dispersion. Multivariate 
logistic regression analysis revealed that the full stomach test had the most signiﬁcant 
correlation to life-threatening events (P=0.015).
Conclusions: Characteristic ECG abnormalities augmented by a full meal is associated 
with the arrhythmogenesis of Brugada syndrome. The full stomach test could be a useful 
diagnostic technique for risk stratiﬁcation in patients with Brugada-type ECG.
1023-272 Absence of Direct Effects of the If Current Blocker 
Ivabradine on Ventricular Repolarization: Analysis 
Based on a Population Heart Rate Correction Formula
Irina Savelieva, John Camm, St George’s Hospital Medical School, London, United Kingdom
A selective If inhibitor ivabradine (IVA) has previously demonstrated anti-ischemic 
efﬁcacy in a placebo-controlled trial and in a direct parallel comparison with atenolol. 
Prolongation of the uncorrected QT interval was observed with IVA as a result of its 
speciﬁc bradycardic action. Because of the inverse and non-linear relationship between 
the heart rate (HR) and the QT interval, conventional Bazett (QTcB) and Fridericia 
(QTcF) formulae for rate correction tend to under- or overestimate, respectively, the 
QTc interval. The aim of the study was to assess whether QT prolongation observed 
with IVA relates to bradycardia or a direct effect of IVA on ventricular repolarization. A 
population correction formula (QTcP) was developed and validated in a total of 23997 
paired QT/RR values from the ECG recordings in 1216 matched drug-free participants 
in the Ivabradine Programme in coronary artery disease. (Figure, left). As determined 
by the analysis of the drug-free QT/RR values, the QTcP formula fell between the 
QTcB and QTcF formulae and was found to be truly independent of HR. The QTcP 
correction formula was then applied to 995 pts treated with IVA 10 mg bid for 3 months. 
Prolongation of the uncorrected QT interval was consistent with a decrease in HR but 
there were no changes in the corrected QTcP interval throughout the follow-up period 
(Figure, right). The QTcP correction formula provides evidence of the absence of any 
signiﬁcant direct effects of IVA on the duration of ventricular repolarization. 
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1023-272A Validation of RR-Irregularity Algorithm for Automatic 
Detection of Atrial Fibrillation on the Surface ECG
Trang Dinh, Richard PM Houben, Vincent CMH Larik, Tim DJ Jongen, Michel HG 
Janssen, Harry JGM Crijns, Robert G. Tieleman, University Hospital Maastricht, 
Maastricht, The Netherlands, Medtronic Bakken Research Center BV, Maastricht, The 
Netherlands
Background: In atrial ﬁbrillation (AF) it has been shown that more than half of the AF 
episodes are asymptomatic. Symptoms have a low discriminative power concerning 
presence of AF. Holter monitoring is labour-intensive, and has a low diagnostic yield. 
New automatic diagnostic tools are required for improvement of AF detection and 
determination of AF burden.
Methods: In cooperation with Medtronic Bakken Research Center BV an external loop-
recorder with built-in analysis for AF detection was developed (AF alarm). Detection of AF 
was based on an algorithm evaluating RR-irregularity during 2-minute intervals. An exact 
copy of the AF alarm R-wave detection and rhythm analysis was implemented in Matlab® 
(The Math Works Inc.). This was used to analyze ﬁles from 2 datasets. Dataset 1 consisted 
of 24 ECG rhythm ﬁles from the Massachusetts Institute of Technology AF database. The 
2nd dataset consisted of annotated 24-hour 3-lead Holter recordings (Marquette® MARS 
system) from 47 patients referred for evaluation of presence of AF.
Results: In dataset 1, 7,022 2-minute rhythm episodes were analysed. The AF alarm 
correctly identiﬁed 2,535 AF episodes (true positive, TP), and 3,865 non-AF episodes 
(true negative, TN). The AF-alarm wrongfully detected 359 false positive (FP) episodes. 
273 AF episodes were not identiﬁed by the AF alarm (false negative, FN). In dataset 1, 
the sensitivity and speciﬁcity of the AF-alarm RR-detection and AF-analysis were 90.3% 
and 91.5%, respectively. The Holter recordings from dataset 2 were divided in 33,216 
episodes of 2 minutes. 10,888 Episodes were annotated AF (TP). AF was absent in 
21,269 rhythm episodes (TN). The AF-alarm wrongfully detected 383 FP episodes. In 
total 560 AF episodes were FN. In dataset 2, the sensitivity and speciﬁcity of the AF-alarm 
RR-detection and AF-analysis were 95.1% and 98.2%, respectively.
Conclusion: Using a custom-made algorithm based on RR-irregularity, AF can be 
reliably identiﬁed. Incorporation of this algorithm in an external ambulatory loop recorder 
with storage capacity for electrograms can improve diagnostic yield of AF detection, and 
especially the determination of AF burden.
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1050-247 The Inﬂuence Of Ace Inhibitors On The Expression 
Of Bfgf And Vegf And The Microcapillary Density 
In Patients Whith Paroxysmal And Chronic Atrial 
Fibrillation
Michaela E. Resetar, Heart Center Leipzig, Leipzig, Germany
Background: AF has been suggested to be associated with ischemic processes in a 
recent study. Therefore, we investigated the expression of angiogenic growth factors 
and microcapillary density in the atrium in patients with paroxysmal AF, chronic AF, non-
ischemic patients in sinus rhythm (NISR) and ischemic patients in SR (ISR), additionally 
classifying groups with or without ACE inhibtor (ACE-I) treatment.
Methods: Atrial tissue samples were obtained from patients with lone AF (n=44) or sinus 
rhythm (n=17). Vascular endothelial growth factor (VEGF) and basic ﬁbroblast growth 
factor (bFGF) protein levels were measured by quantitative Western Blotting techniques. 
Histological tissue samples were used for calculating microvessel density. 
Results: The expression of bFGF in ISR, lone paroxysmal AF and lone chronic AF was 
signiﬁcantly elevated versus NISR (p<0,001; p<0,05, p<0,01). The expression of VEGF 
exhibited similar results. The bFGF protein expression was systematically increased 
in patients in ISR versus lone chronic AF (p<0,05) and lone chronic AF versus lone 
paroxysmal AF (p<0,05).The microcapillary density was signiﬁcantly decreased in 
paroxysmal AF (4,7cap./ 0,4mm2) and chronic AF (3,7cap.) versus ISR (6,3cap.) or NISR 
(7,7cap.). Lone chronic AF with ACE-I exhibited a signiﬁcantly lower bFGF and VEGF 
protein expression compared to chronic AF without ACE-I (p<0,05). Interestingly, the 
microcapillary density was signiﬁcantly higher in paroxysmal AF with ACE-I (p<0,01) and 
SR versus paroxysmal AF without ACE-I and chronic AF with or without ACE-I. 
Conclusion: We speculate that lone AF is associated with a condition of ischaemia in 
humans, which might be positively inﬂuenced by ACE-I treatment.
1050-248 Electrophysiological Mechanism of Atrial Fibrillation in 
a Novel Experimental Model of Left Atrial Volume Load
Hiroya Ohmori, Takashi Nitta, Masami Ochi, Kazuo Shimizu, Nippon Medical School, 
Tokyo, Japan
Permanent AF is frequently associated with an LA volume loaded heart such as in mitral 
valve disease. However, the electrophysiological mechanism in this subset of AF has not 
been examined in an appropriate animal model. A novel experimental model that was 
highly relevant to human AF, consisting of an LA volume load achieved by a subclavian 
artery to pulmonary artery shunt and electrical remodeling induced by rapid LA pacing, 
was established and the electrophysiological consequences were examined in 10 
canines. Rapid LA pacing was initiated at a paced cycle length of 100ms one week after 
the shunt surgery. Three animals died of severe heart failure in the early postoperative 
period. In the remaining animals, the LA diameter increased progressively from 27±4 mm 
preoperatively to 42±4 mm 5 weeks after the shunt surgery (p<0.05). The duration of the 
induced AF during a temporal suspension of the pacing prolonged progressively from 
136±88 sec at the beginning of the pacing to a sustained AF (>10 min) within 4 weeks. 
The AF intervals measured at the LA appendages progressively shortened from 121±39 
ms at the beginning of the pacing to 103±10 ms 3 weeks after pacing (p<0.05). The 
entire atrial epicardium was mapped with form ﬁtted electrode patches with 246 bipolar 
electrodes and a three-dimensional dynamic mapping system during sustained AF 5 
weeks postoperatively. The activation maps revealed repetitive activations arising from the 
pulmonary veins with ﬁbrillatory conduction toward the RA in all animals and coexisting 
RA macroreentry in 3. Concurrent repetitive activations originated from the right and left 
superior pulmonary veins in 4 animals and a repetitive activation originated from the right 
superior pulmonary vein in 5, while no animals exhibited activations arising from the 
inferior pulmonary veins. The average cycle length of the repetitive activations originating 
from the pulmonary veins was signiﬁcantly shorter than that from the RA. In conclusion, 
a volume load of the LA may provoke repetitive activations in the pulmonary veins, and 
electrical remodeling of the atrial myocardium further facilitates the perpetuation of AF.
1050-249 Electrophysiologic Characteristics of Spontaneous 
Atrial Tachyarrhythmias in Patients with Refractory 
Atrial Fibrillation Deﬁned by Combined Biatrial Catheter 
and Three Dimensional Noncontact Mapping
Sanjeev Saksena, Hygriv B. Rao, Nicholas D. Scadsberg, PBI Regional Medical Center, 
Passaic, NJ, Robert Wood Johnson University Hospital, New Brunswick, NJ
The electrophysiology of human atrial ﬁbrillation (AF) in patients(pts) with heart disease, 
remains undeﬁned.
Methods: We evaluated 59 pts with refractory AF, mean age 63 yrs, using combined 
biatrial catheter & 3 dimensional noncontact mapping (NCM). 47 pts had heart disease 
(Gp. 1) & 12 pts had no disease (Gp. 2).
Results: Sinus rhythm (SR, n=59), 104 atrial premature beats (APBs) in 51 pts (Gp. 1=40 
pts {85%} & Gp. 2=11 pts {92%}) & 65 AF episodes in 41 pts were mapped. Mean P-wave 
duration in SR was 143 ms. Terminal atrial diastolic electrical activity was seen by NCM in 
selected pts in SR. APBs often arose in disparate RA & LA regions in the same pt. At AF 
onset, NCM demonstrated macroreentrant ATs in 46 pts (Gp.1 = 36, Gp.2 = 10) in RA or 
LA with a head to tail wavefront i.e.continuous electrical activation.Simultaneous ATs in 
RA & LA were observed only in Gp.1. Focal ATs were seen in 11 pts (Gp.1 = 8, Gp.2 = 3) & 
had centrifugal propagation with intermittent transatrial conduction. Focal ATs were more 
common in LA (9 pts) than RA (2 pts). LA ﬂutter, focal LA AT & non-isthmus RA ﬂutter had 
comparable rates (Figure) but were faster than RA ATs (p<0.04). Isthmus dependent RA 
ﬂutter was slower than LA ﬂutter (p<0.04) but faster than RA ATs (p<0.04).
Conclusions: 1. During human AF, macroreentrant ATs are more common than focal 
AT in pts with and without heart disease & occur with a biatrial distribution. 2. AT cycle 
lengths of LA focal ATs overlap with other ATs, & biatrial mapping with NCM is essential 
for accurate AT diagnosis. 
1050-250 Three-Dimensional Analysis of Left Atrial and 
Pulmonary Vein Anatomy: Implications for Balloon 
Catheter-based Circumferential Ostial Ablation
Jameel Ahmed, Sandeep Sohal, Zachary J. Malchano, Jeremy N. Ruskin, Vivek Y. Reddy, 
Massachusetts General Hospital, Boston, MA, Boston Medical Center, Boston, MA
Background: Balloon catheters using various ablative energy sources are being 
developed to perform pulmonary vein (PV) isolation, but these must accommodate the 
variability in PV anatomy. Prior studies have examined PV anatomy using multi-planar 
2D CT/MR images (long- and short-axis measurements). However, these studies may 
be limited by the frequent elliptical shape of the PV ostia, the non-orthogonal orientation 
of the PVs to the LA chamber, and difﬁculty in appreciating the frequency of common 
left PVs. To provide PV anatomical data relevant to the use of balloon ablation catheters, 
3D surface reconstructions of LA-PVs were generated and analyzed to deﬁne ostial 
architecture and circumferential size.
Methods: Using MRI datasets obtained from 51 paroxysmal AF pts, the LA-PVs were 
segmented, and 3D surface reconstructions of the LA-PVs were generated and analyzed 
for ostial architecture using both external and endoluminal projections. The distance 
between the ostial border of the common left PV and the branching saddle-region 
separating the LSPV and LIPV was measured. PV circumferential measurements were 
made for each ostium.
Results: Left PVs: A common left-sided ostium was identiﬁed in all patients, with an ostial 
circumference of 95±14mm (range 70-129). Branching of the left PVs occurred 0-5 mm 
from the common left ostium in 23 pts (45%), 5-15 mm from the common os in 19 pts 
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(37%), and >15 mm from the common os in 9 pts (18%). In pts with a common os <15 mm 
(42 pts), the individual LSPV/LIPV ostial circumferences were 66±11mm (range 38-87) 
and 59±9mm (range 39-80), respectively. In pts with a common os >15 mm (9 pts), the 
ostial circumference was 88±9mm (range 73-99). Right PVs: The ostial circumferences of 
the RSPV/RIPV were 67±12mm (range 42-91) and 65±11mm (range 40-91), respectively. 
A distinct right-middle PV was observed in only 4 pts (8%), measuring 29±6mm (range 
21-34). Based upon PV circumferences, the minimal diameter of a balloon ablation 
catheter required to isolate 95% of the RSPV, RIPV, LSPV, LIPV and LCPV are 29mm, 
28mm, 28mm, 25mm, and 34mm.
Conclusion: Analysis of 3D surface reconstructions of LA-PV anatomy is invaluable to 
the design of balloon ablation catheters for PV isolation.
1050-251 Atypical and Typical Atrial Flutter Can Be Separated 
From the ECG Using Preferred Planes of Activation
Andrew M. Kahn, Bobbi L. Hoppe, Alborz Hassankhani, Valmik Bhargava, David E. 
Krummen, Gregory K. Feld, Sanjiv M. Narayan, University of California and VAMC, San 
Diego, CA
Background: Separating typical from atypical atrial ﬂutter (AFL) from the ECG can be 
challenging, yet is central to guiding ablation. We hypothesized that typical AFL would 
show greater consistency in wavefront orientation than atypical AFL which is located less 
stereotypically.
Methods and Results: We studied 61 patients (51M, age 59.2+13.0), 39 with typical and 
22 with atypical AFL (from location of concealed entrainment and successful ablation). For 
each, we generated a ﬁltered atrial ECG from leads V5 (X-axis), aVF (Y) and V1 (Z) by 
correlating a 120 ms f-wave sample to successive ECG points. We generated loops of 
atrial cycles in the XY, YZ and XZ planes, and correlated successive loops as a measure 
of spatial coherence (range: 0-1). Three-dimensional spatial coherence (vector length) 
was greater for typical than atypical AFL (0.69+0.15 vs. 0.57+0.19; p<0.01). XY was the 
plane of greatest coherence for typical (p<10-5 vs XZ or YZ) and atypical (p<0.015 vs XZ 
or YZ) AFL. However, the degree of coherence was greater for typical than atypical AFL 
in both XY (0.82+0.14 vs 0.66+0.24; p=0.002) and XZ (0.56+0.32 vs 0.35+0.39; p=0.03) 
planes. Notably, coherence in atypical right AFL was more evident in the XY plane, while 
coherence in atypical left AFL was more evident in other planes (atypicals: left vs right 
AFL: p<0.05).
Conclusions: Atypical AFL shows different preferred planes of activation than typical 
AFL on the ECG, likely reﬂecting anatomic and functional substrates. This ECG method 
may guide the approach to ablation, and provide mechanistic insights into AFL.
1050-252 The Degree of Diastolic Dysfunction Is Independently 
Associated With Atrial Fibrillation After Cardiac Surgery
Martin Osranek, Kaniz Fatema, Fatema Kaddoura, Ahmed Al-Saileek, Walter P. Abhayaratna, 
Marion Barnes, Kenton J. Zehr, James B. Seward, Mayo Clinic, Rochester, MN
Background: Postoperative atrial ﬁbrillation (PO-AF) is associated with increased 
morbidity and mortality. The relationship of preoperative diastolic function grade (DFG) 
with the risk for PO-AF has not been investigated.
Methods: 130 patients (mean age 61 ± 16 years; 33.1% women) in sinus rhythm 
undergoing any cardiac surgery other than mitral valve or for congenital abnormalities 
were prospectively enrolled. Preoperative DFG was categorized using Doppler 
echocardiography as normal (N), abnormal relaxation (AR), pseudonormal (PN), and 
restrictive (R). PO-AF was documented by continuous postoperative telemetry during the 
hospital stay.
Results: 50 (38.5%) patients developed AF after a mean of 2.7±2.4 days. Patients who 
developed PO-AF had a longer mean hospital stay (8.1 days, range 4-46) compared 
to those who did not (5.8 days, range 2-16; p<0.0001). Any diastolic dysfunction was 
associated with a higher risk for PO-AF [hazard ratio (HR)=4.52; 95% CI: 1.40 to 14.53; 
p=0.01]. A multivariate Cox model including DFG, age, history of atrial ﬁbrillation, NYHA 
class and use of betablockers was built. Apart from age [HR=1.04; 95%CI: 1.02 to 1.06; 
p=0.001], DFG was the only independent predictor of PO-AF [HR=1.29; 95% CI: 1.05 to 
1.59; p=0.01]. As shown in the ﬁgure, there was a graded positive association between 
DFG and the incidence of PO-AF.
Conclusion: DFG is strongly associated with the occurrence of PO-AF. Preoperative DFG 
is a superior means of stratifying the risk for PO-AF. 
1050-267 Diabetes Mellitus Is a Strong Independent Risk for Atrial 
Fibrillation, Flutter, and Major Cardiovascular Disease
Mohammad Reza Movahed, Mehrtash Hashemzadeh, M. Mazen Jamal, University 
of California, Irvine, Medical Center, Orange, CA, Long Beach Veteran Administration 
Medical Center, Long Beach, CA
Background: Diabetes mellitus (DM) is a major risk factor for coronary artery disease 
(CAD) and atherosclerosis. There is a controversy about correlation between DM and 
atrial ﬁbrillation .The goal of this study was to evaluate DM as a risk factor for atrial 
ﬁbrillation or ﬂutter using a very large data base.
Method: We used PTF documents of inpatient treatment from all Veterans Health 
Administration (VHA) hospitals, extended care discharges and non-VHA hospital 
discharges at the Veterans Administration (VA) expense. The PTF contains demographic 
characteristics of patients and discharge diagnoses using ICD-9 codes. A total of 845,748 
patients from this database were studied for the occurrence of atrial ﬁbrillation and ﬂutter. 
The cohort was stratiﬁed using DM (293,124) and a control group with hypertension 
(HTN) but no DM (552,624). Continuous variables were analyzed by unpaired t tests. 
Binary variables were analyzed using X2 tests and Fisher’s Exact tests.
Results: Using univariant analysis, atrial ﬁbrillations occurred in 43,674 (14.9% ) DM 
patients vs. 57,077 (10.3 %) in control group (p<0.0001). Atrial ﬂutter occurred in 11,852 
(4%) DM patients vs. 13,554 (2.5%) of the control group (p< 0.0001). Using multi-variant 
analysis, DM remained a strong independed cause of atrial ﬁbrillation with an odds ratio 
(OR) of 2.13, ( 95% Conﬁdence interval (CI): 2.10 to 2.16; p<0. 0001) and ﬂutter (OR 2.20 
, CI: 2.15 to 2.26; p< 0.0001). Furthermore, congestive heart failure (CHF) (OR 3.12, CI: 
3.09 to 3.16; p<0. 0001), LVH (OR 1.85, CI: 1.77 to 1.92; p<0. 0001) and CAD (OR 2.39 
CI: 2.34 to 2.44; p<0. 0001) were also independently associated with DM.
Conclusion: This is the ﬁrst large scale study ﬁnding DM as a strong, independent risk 
for the occurrence of atrial ﬁbrillation and ﬂutter. Furthermore, we conﬁrmed the previous 
ﬁndings that DM is a strong predictor of LVH, CAD and CHF
1050-268 Gender Differences in Familial Atrial Fibrillation
Lin Y. Chen, Kathleen J. Herron, Curtis L. Olswold, Timothy M. Olson, Mayo Clinic, 
Rochester, MN
Introduction: Idiopathic or lone atrial ﬁbrillation (LAF) may be familial in at least 15% 
of cases. We have observed a male predominance in patients with both sporadic and 
familial forms of LAF recruited for our genetic research studies. This may reﬂect referral 
or ascertainment biases, yet epidemiological studies also show LAF is 4-fold higher in 
males. To determine whether or not there is an intrinsic, gender-speciﬁc difference in 
disease susceptibility, we conducted a systematic study of familial LAF pedigrees.
Methods: Since November 2000, 135 unrelated patients referred to our Arrhythmia Clinic with 
LAF were enrolled into the study. LAF was deﬁned as AF in patients < 60 years of age without 
hypertension or structural heart disease. Documentation of LAF was sought in relatives of 
patients with a positive family history for LAF. To eliminate potential gender-related referral 
bias, we excluded probands and compared males and females among affected relatives. 
Differences in proportions were tested using the Pearson Proportion Test. Differences in mean 
age at diagnosis were tested using the GENMOD (SAS version 8), a conservative test which 
accounts for potential biases introduced by analysis of unrelated pedigrees.
Results: A total of 65 probands with a family history of LAF (male=50, female=15) were 
identiﬁed. Of these, 24 probands had > 2 relatives with documented LAF and inheritance 
consistent with autosomal dominant disease. When relatives only were analyzed (n=56), 
there was no difference between the proportion of males (52.5%) and females (47.5%) 
[p=ns]. However, there was a trend toward earlier age at diagnosis in males compared to 
females (mean age 45.2 vs. 52.4 yrs, p=0.07). 
Conclusions: Both earlier age at onset and referral bias may account for the predominance 
of males with LAF observed in population and family based studies. Pedigree analyses 
suggest that male gender increases susceptibility to early-onset LAF.
1050-269 Atrial Fibrillation is an Independent Predictor for All-
Cause Mortality in Ischemic Cardiomyopathy but not in 
Dilated Cardiomyopathy
Thomas Kleemann, Andreas Kilkowski, Herbert Lorenz, Andreas Jost, Karl-Heinz Seidl, 
Karl Siegler, Bernhard Rauch, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Aim of the study was to evaluate the prognostic impact of atrial ﬁbrillation (AF) in 
ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM). Patients and 
methods: 1,119 unselected patients (P) with an ejection fraction (EF) < 45% were 
prospectively and consecutively included into the LVD-registry Ludwigshafen (mean age: 
67 years, 78% male, mean EF: 29%). Mean follow-up time was 27 months. All P received 
an optimized medical treatment for heart failure (93% ACE-inhibitor, 57% ß-blocker). AF 
or sinus rhythm (SR) was determined by standard ECG.
Results: P with ICM and AF (n = 112) were 5 years older (70 vs. 65 years, p<0.05) and 
had more often a reduced EF<30% (59 vs. 47%, p<0.05) than P with ICM and SR (n = 
645). However, P with DCM showed no differences of age or EF when comparing the AF 
(n = 91) and SR group (n = 271). In a multiple logistic regression for all-cause mortality 
adjusted for 12 parameters (age, gender, diabetes, hypertension, COPD, prior stroke, EF, 
ACE-inhibitor, beta blocker, sotalol, amiodaron and oral anticoagulant), AF represented 
an independent prognostic factor in P with ICM, but not in P with DCM.
Multiple logistic regression for all-cause mortality 
ICM, OR (95% CI) DCM, OR (95% CI)
AF 1.7 (1.2-2.6) 0.6 (0.3-1.0)
Diabetes 1.9 (1.4-2.8) 1.7 (0.9-3.0)
age >70 years 1.9 (1.4-2.7) 1.3 (0.6-3.0)
COPD 2.1 (1.4-3.2) 3.1 (1.8-5.6)
EF < 30% 2.7 (1.9-3.8) 3.4 (1.8-6.5)
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Conclusion: 1. P with ICM and AF were 5 years older and had a lower EF than P with 
ICM and SR. In P with ICM AF represented an independent prognostic factor for all-cause 
mortality. 2. In P with DCM, however, there were no differences with respect to age or EF 
between the AF and SR group, and AF was not associated with a worse prognosis.
1050-270 5 Year Follow-up of Patients Presenting With First 
Episode of Atrial Arrhythmia: Comparison to Patients 
With Already Recurrent Episodes. A Single Center 
Experience
Torsten Becker, Klaus Dönges, Thomas Kleemann, Margit Vater, Ömer Yildiz, Karlheinz 
Seidl, Heartcenter Ludwigshafen, Ludwigshafen, Germany
Objective: Comparison of the long-term prognosis of patients (pts) presenting with the 
ﬁrst episode of atrial arrhythmia versus those with recurrent episodes.
Methods: 1053 pts with atrial ﬁbrillation or ﬂutter were included in this single center 
registry and thereafter followed-up for 5 years regarding their long-term outcome and 
antithrombotic treatment (ATT) during this period. 
Results: 618 pts (59%) presented with ﬁrst episode of atrial arrhythmia vs. 435 pts (41%) 
with recurrent episodes. Baseline characteristics at index admission were as follows (ﬁrst 
vs. recurrent): male 71% vs. 74% , median age 65 vs. 64 years, structural heart disease 
58% vs. 59%, EF < 40% and NYHA II+ 13% vs. 8%. In 27% of pts with a ﬁrst episode 
compared to 13% of pts with recurrent episodes (Odds ratio (OR) 2.4, CI 1.7-3.3) the 
arrhythmia triggered new diagnosis of structural heart disease. Long-term outcome and 
ATT during 5 year follow-up are shown in the table below:
death embolic events severe bleeding
oral 
anticoagulation 
(OAC)
ASA
ﬁrst episode 27% 5% 1.2% 58% 26%
recurrent episodes 16% 4% 0.9% 70% 15%
OR (CI) 2.0 (1.4-2.7) 1.4 (0.6-3.4) 1.4 (0.3-5.7) 0.5 (0.4-0.7) 1.4 (1.0-2.2)
Conclusions: 1. Mortality rate over a 5 year period was higher in pts with ﬁrst episode 
of atrial arrhythmia than in those with recurrent episodes 2. This may be due to a higher 
proportion of pts receiving OAC in the group with recurrent episodes 3. Furthermore, 
compared to pts with recurrent episodes, a larger proportion of pts with ﬁrst episode 
of atrial arrhythmia had previously undiagnosed and therefore untreated structural heart 
disease, suggesting atrial arrhythmias as a sentinel for structural heart disease and 
indicating poor prognosis.
1050-271 Rate And Prognostic Signiﬁcance Of Atrial Fibrillation 
In Patients With Idiopathic Dilated Cardiomyopathy
Massimo Zecchin, Aneta Aleksova, Andrea Di Lenarda, Marco Merlo, Michele Moretti, 
Laura Massa, Gianfranco Sinagra, Struttura Complessa di Cardiologia, Trieste, Italy
Background: Atrial ﬁbrillation (AF) is the most common sustained arrhythmia in patients 
(pts) with heart failure. Its incidence increases with aging and progression of heart failure. 
The prevalence of AF in pts with idiopathic dilated cardiomyopathy (IDC) is not known. 
Also its inﬂuence on the outcome of pts with IDC has never been extensively evaluated.
The scopes of our study were to analyse the prevalence of AF and clinical characteristics 
of pts with AF at the baseline as well as the rate and prognostic signiﬁcance of AF during 
long term follow-up in pts with IDC.
Methods: Data were obtained from 544 pts with IDC enrolled in the Heart Muscle Disease 
Registry of Trieste from 1978 to 2002.
Results: At baseline 512 pts (94%) had sinus rhythm, and 32 pts (6%) had AF (14 pts 
(2.6%) chronic and 18 pts (3.4%) paroxysmal AF). During the follow up of 81±58 months 
new onset of AF was observed in 50 pts (9.8%, 1.2/100 patient-years), 21 pts chronic 
(4.1%) and 29 pts paroxysmal (5.7%). Two, ﬁve and 10 years rate of chronic versus 
paroxysmal AF were 2.1% v 0.8%, 5.3% v 2.8% and 11.2% v 4.5% respectively. Pts with 
AF had more severe symptoms (NYHA III-IV 40% v 25%, p=0.02), lower end diastolic left 
ventricular diameter (35.62±5.2 v 37.91±7.28, p=0.03), were less frequently treated with 
beta blockers (38% v 56%, p=0.01) and were more on treatment with amiodarone (30% 
v 17%, p=0.03).
Two, ﬁve and 10 years rate of pts died or underwent heart transplantation (D/HTx) in 
sinus rhythm versus pts in AF were 11.5% v 20.4 %, 23.5 % v 39.3 % and 34.6% v 44.4% 
respectively, p=0.02. At Cox proportional model predictors for D/HTx were NYHA III-IV 
class (p<0.001), LV ejection fraction ≤0.30 + LV end diastolic diameter >70 mm (p<0.001), 
lower systolic blood pressure (p=0.014), presence of left bundle branch block (p=0.04). AF 
was not signiﬁcantly related to the long term outcome (p=0.08).
Conclusion: The rate of AF in our group of pts with IDC was 15%. AF was more frequent 
among pts with more advanced disease, and also among those that were not receiving 
beta blockers. Its presence was not independent predictor of subsequent outcome.
1050-272 Lone Atrial Fibrillation in Olmsted County, Minnesota 
(1980-2000)
Yoko Miyasaka, Marion E. Barnes, Stephen S. Cha, Kent R. Bailey, James B. Seward, Walter 
P. Abhayaratna, Bernard J. Gersh, Teresa S.M Tsang, Mayo Clinic, Rochester, MN
Background: Lone atrial ﬁbrillation (AF) is clinically deﬁned as AF in the absence of 
structural heart disease. Using this deﬁnition, there are conﬂicting data with respect to 
prognosis and survival.
Methods: The complete medical records for residents of Olmsted County, MN, who had 
an ECG-conﬁrmed diagnosis of ﬁrst AF between 1980 and 2000 were comprehensively 
reviewed. We recorded every cardiovascular event and death in these patients without 
underlying structural heart disease, hypertension, diabetes mellitus, and had no reversible 
causes for AF. Survival of “lone AF” patients was compared with expected based on life 
tables for the Minnesota white population.
Results: A total of 4,618 residents were conﬁrmed to have developed ﬁrst AF between 
1980-2000. Of these, 413 subjects (mean age 73.1± 14.4 years, 66% men) at the time of 
the ﬁrst diagnosis of AF could be classiﬁed as lone AF, 120 (29%) of them died during a 
mean follow-up time of 8.3 ± 6.2 years. This represented a slight excess mortality (hazard 
ratio=1.2, p=0.051) compared to the general population of the same age, which was 
however conﬁned to the patients who were 70 years or older (n=119, hazard ratio=1.25, 
p=0.04). Of 413 patients, 56 (13.6%) patients developed at least one documented 
cardiovascular event; including 6 (1.5%) with a transient ischemic attack, 5 (1.2%) with 
a stroke, 27 (6.5%) with congestive heart failure, 10 with ischemic heart disease (2.4%), 
and 16 (3.9%) with cardiovascular death.
Conclusions: Patients who developed ﬁrst AF without any structural abnormality or 
additional cardiovascular risks represented a highly select minority of incident AF cases. 
As a group, they had a low cardiovascular event rate, and their survival appeared similar 
to that of the general population.
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1051-253 Effects of Pacing Site on Left Ventricular Activation 
Sequences Using a Non-Contact Mapping System: 
Implications for Heart Failure Pacing
Dezhi Xing, Fausto G. Devecchi, Thomas R. Staley, David S. Glassman, James B. 
Martins, University of Iowa College of Medicine and VA Medical Center, Iowa City, IA
Background: Left ventricular pacing is effective in alleviating heart failure symptoms. 
The mechanisms of beneﬁt and the optimal site of stimulation remain unclear. Methods: 
To address these issues, bipolar pacing was undertaken in ten �-chloralose open-chest 
dogs at ten sites, eight in the LV epicardium (EPI) and two in the RV including the 
interventricular septum. The cardiac activation of the entire LV was recorded with the 
EnSite 3000 (non-contact mapping) system and at twenty different endocardial (ENDO) 
locations using a steerable ablation catheter. Activation through the ventricular wall was 
also assessed transmurally with 23 multipolar plunge needles and ENDO pacing was 
performed using the endocardial-most electrodes. Virtual unipolar waveforms (non-
contact mapping) generated from the array were compared with contact unipolars during 
sinus, EPI and ENDO pacing. 
Results: Regardless of pacing site there was an excellent correlation between contact 
and virtual unipolars (non-contact). There was no signiﬁcant difference in occurrence of a 
QS pattern (90-98% of the ENDO surface) between reconstructed electrograms during left 
ventricular EPI or ENDO pacing, irrespective of the pacing site. These ﬁndings correlated 
with the activation sequences recorded during sinus rhythm, in which endocardial to 
epicardial activation always occurs. RV (and septal) pacing showed an initial R wave in 
90% to 100% of the reconstructed LV ENDO surface indicating that the Purkinje system 
was not at all involved with this activation. 
Conclusions: Our data conﬁrm that a more physiologic activation of the LV is achieved 
with any LV pacing site. This may reﬂect earlier engagement of the Purkinje network, 
which in turn more uniformly activates the rest of the ENDO surface compared with 
RV pacing activating predominantly via muscle. In our model, this activation pattern is 
irrespective from the LV pacing site chosen.
1051-254 Disparities Between Longitudinal and Circumferential 
Motion-Derived Analysis of Cardiac Dyssynchrony: 
Implications for Cardiac Resynchronization 
Assessment
Robert H. Helm, Christophe Leclerq, Owen Faris, Richard Tunin, Albert Lardo, David 
Kass, Johns Hopkins Medical Institution, Baltimore, MD
Background: QRS duration is widely used to identify cardiac resynchronization 
(CRT) patients, yet growing data supports the value of direct analysis of mechanical 
dyssynchrony. This is now commonly based on tissue-Doppler to measure longitudinal 
motion (εll). However, contraction is principally circumferential (e.g. ﬁber direction, εcc), 
and whether dyssynchrony indexed by both orientations yields similar results is unknown. 
Methods: εll and εcc strain maps were generated from failing canine hearts with LBBB 
using tagged MRI. Dyssynchrony was assessed with two indexes: temporal uniformity 
(Leclercq, Circ, 2002;106:1760) and regional variance (Wyman, AJP 2002;282:372).
Results: εcc analysis showed that biventricular (BiV) and left ventricular (LVP) pacing 
improved synchrony in systole and diastole. In contrast, εll analysis showed LVP improved 
synchrony during diastole only and BiV during both phases. It also had less sensitivity to 
synchrony overall (dynamic range of εll indexes were ~50% of εcc). Despite differences 
in BiV and LVP with εll -based analysis, both similarly improved global function (dP/dtmax 
and EF). (Table) 
Conclusion: Dyssynchrony indexes derived from εll have less sensitivity, follow different 
time courses, and may only manifest CRT beneﬁts in speciﬁc cardiac phases depending 
on pacing mode. These data stress potential limitations to εll -based dyssynchrony metrics, 
and support efforts to develop methods based on εcc to improve index performance and 
speciﬁcity.
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LBBB LVP BiV
dP/dtmax, mm Hg/s 1048 ±242 1309±339* 1392±413*
Ejection Fraction 23.0±12.7 28.0±16.1* 27.5±16.2*
Ecc-based DI in Systole -18.0±4.2 7.0±3.0* 11.0±1.9*
Ecc-based DI in Diastole -16.0±3.6 3.5±3.0* 12.3±1.9*
Ell-based DI in Systole -3.1±1.5 -3.3±2.4 6.4±3.2*
Ell-based DI in Diastole -6.9±1.4 0.1±1.3* 6.8±2.5*
* p< 0.05 verses LBBB baseline, DI = Temporal Uniformity Dyssynchrony Index (the 
more positive the index, the greater the synchrony)
1051-255 Deterioration of Left Ventricular Function Augments 
Regional Mechanical Dyssynchrony in a Model of 
Left Bundle Branch Block: Quantiﬁcation by Angle-
Corrected Radial Strain Imaging
Kaoru Dohi, Michael R. Pinsky, Hideaki Kanzaki, Donald A. Severyn, John Gorcsan, III, 
University of Pittsburgh, Pittsburgh, PA
Background: The relationship of acute changes in contractility to mechanical left 
ventricular (LV) dyssynchrony is unknown. We tested the hypothesis that acute 
deterioration of LV function augments mechanical dyssynchrony, which can be quantiﬁed 
by strain imaging.
Methods: Ten open-chest dogs had angle-corrected subendocardial strain images from 
mid-LV short axis views (Aplio 80, Toshiba Corp). Pressure-volume loops were also 
recorded. Data were collected at baseline, right ventricular pacing to simulate left bundle 
branch block (LBBB), and during high-dose esmolol to induce heart failure. Dyssynchrony 
was deﬁned as the time difference from earliest to latest peak strain among 6 radial sites. 
Heart rates were normalized.
Results: LBBB resulted in a large degree of dyssynchrony 346±64 ms* with early peak 
strain in the anterior wall 227±94 ms* and delays in the posterior wall 503±49 ms*, along 
with decreases in dp/dt -26±7 %*, and stroke work (SW) -59±18 %* (*p<0.05 vs. control). 
With esmolol, Ees decreased from 5.4±2.5 to 3.5±1.1* mmHg/ml (*p<0.05 vs. baseline). 
Esmolol-induced heart failure augmented dyssynchrony to 380±44 ms† with delays of 
posterior wall peak strain 563±61 ms† and further decreases in dp/dt -33±9 %† and SW 
-38±15 %† (†p<0.05 vs. baseline LBBB).
Conclusion: Angle-corrected subendocardial radial strain imaging demonstrated that LV 
dyssynchrony was augmented by acute deterioration in LV function in this model of LBBB 
and acute heart failure
. 
1051-256 Cardiac Resynchronization Improves Microcirculation
Ayten Erol-Yilmaz, Bektas Atasever, Keshen Mathura, Jerome Lindeboom, Arthur Wilde, 
Can Ince, Raymond Tukkie, Academic Medical Center, Amsterdam, The Netherlands
Background: Although it is known that cardiac resynchronisation therapy (CRT) in 
heart failure patients improves systemic circulation, its acute effects on microcirculation 
are as yet unknown. To investigate this issue, we measured sub-lingual microcirculation 
changes in heart failure patients to CRT and right ventricular pacing by use of orthogonal 
polarization spectral (OPS) imaging.
Methods and Results: Twelve heart failure patients and 10 healthy controls 
were included. Six months of CRT resulted in decrease of NYHA classiﬁcation and 
echocardiographic reverse remodeling. In these responders to CRT, acute microcirculatory 
changes were assessed by functional capillary density (FCD) and capillary velocity (CV). 
FCD and CV were measured sub-lingually after 15 minutes of programming in one of the 
pacing modalities (no pacing, right ventricular pacing, and biventricular pacing). FCD was 
signiﬁcantly higher in healthy controls (10.9 ± 1.9, cm/cm2) compared to right ventricular 
pacing (8.9 ± 1.9, cm/cm2 , p=0.025) and no pacing (8.3 ± 2.4, cm/cm2, p=0.008). 
Biventricular pacing (12.1 ± 2.2, cm/cm2) signiﬁcantly increased FCD compared to 
right ventricular pacing (8.9 ± 1.9 cm/cm2, p=0.03) and no pacing (8.3 ± 2.4, cm/cm2, 
p=0.018). CV was normal in all patients with or without pacing.
Conclusion: These study results showed for the ﬁrst time that CRT directly improves 
microcirculatory function in CRT responders. Application of sublingual OPS imaging could 
be used to evaluate non-invasively the hemodynamic response of CRT therapy in heart 
failure patients.
1051-257 Patients with Ischemic Cardiomyopathy Have Variable 
Regions of Latest Activation: Implications for 
Resynchronization Therapy
Stuart Beldner, William H. Sauer, Melissa L. McKernan, David Lin, Ralph J. Verdino, 
Joshua M. Cooper, Henry H. Hsia, David J. Callans, Francis E. Marchlinski, University of 
Pennsylvania Health System, Philadelphia, PA
Background: Patients with ischemic cardiomyopathy, increased QRS duration, and 
congestive heart failure beneﬁt from biventricular pacing. The optimal site for placement 
of the left ventricular (LV) lead is unclear. It has been suggested that the basal lateral 
wall should be targeted for LV pacing, but the optimal pacing site likely varies, depending 
on the impact of myocardial scar. We sought to identify the region of latest activation in 
patients with ischemic cardiomyopathy and prolonged QRS to characterize the variability 
of electrical dysynchrony.
Methods: Fifteen consecutive patients with ischemic cardiomyopathy and QRS duration > 
120 ms, undergoing electrophysiology testing and ablation of ventricular tachycardia were 
included in the study. All patients had LV activation and voltage mapping in sinus rhythm. 
Myocardial scar was deﬁned as voltage < 1.5mV and all activation times were recorded 
using electroanatomical mapping with a 4 mm catheter (Carto, Biosense-Webster; mean 
number of points 293 +/- 120). One-way analysis of variance and bivariable correlation 
were used to compare assigned regions of latest activation and clinical characteristics 
of the cohort.
Results: The mean LV ejection fraction was 22.7 +/- 7.8% and the mean QRS duration 
for all patients was 142.7 +/- 18.3 ms (10 LBBB: 144.9 +/- 19.2 ms; 5 RBBB: 138.2 +/- 
17.3 ms). There were 9 different regions of latest activation with the apex and basal lateral 
wall most common (4 patients each; 26.7%). There were no electrophysiologic or clinical 
characteristics that predicted the region of latest activation (P>0.05).
Conclusions: Patients with ischemic cardiomyopathy have variable regions of late left 
ventricular activation. These results may have implications for cardiac resynchronization 
therapy.
1051-258 Continuous Non-Invasive Hemodynamic Monitoring 
to Optimize Atrioventricular Delay in Cardiac 
Resychronization Therapy
Zachary I. Whinnett, Justin E.R Davies, Keith Willson, Anthony W. Chow, Rodney A. 
Foale, D. Wyn Davies, Alun D. Hughes, Darrel P. Francis, Jamil Mayet, Imperial College, 
London, United Kingdom, St May’s Hospital, London, United Kingdom
Background: The atrioventricular (AV) delay of cardiac resynchronization devices should 
be optimized after implantation. Use of echocardiography for this purpose is technically 
demanding and time-consuming. We studied the use of continuous measurement of 
instantaneous changes in systolic blood pressure (SBP) as an alternative.
Methods: The effect of differing AV delays (40 - 240ms) on beat-to-beat SBP was 
examined using a validated non-invasive ﬁnger photoplethysmograph device (Finapres). 
12 patients (median age 70; 8 male) with biventricular pacemakers were studied. Multiple 
alternations were performed and averaged to allow a precise measurement of SBP for 
each AV delay setting. The SBP at each AV delay was normalized to values at an AV 
delay of 120ms and the optimum AV delay was deﬁned as that yielding the maximum 
normalized increase in BP (�SBP). Data are means ±SEM.
Results: The optimal AV delay varied between individual patients (median 160 range 
120 - 200 ms). An AV delay 40ms less than the individual’s optimum reduced SBP 
by 4.9±1.1 mmHg (p<0.003); and a delay of 40ms above optimal decreased SBP by 
4.4±0.73 mmHg (p<0.0005). Changes in AV delay exceeding 40ms caused SBP to fall 
even further (Figure).
Conclusions: Small changes in AV delay produce signiﬁcant hemodynamic effects 
detectable by noninvasive blood pressure measurements. The ease and acceptability of 
this non-invasive approach makes it potentially useful as a clinical tool.
1051-259 AV Delay Programming and Cardiac Resynchronization 
Therapy: Left Ventricular Diastolic Filling Indices and 
Relation to Stroke Volume
Alan D. Waggoner, Mitchell N. Faddis, Judy Osborn, Joann Reagan, Sharon Heuerman, 
Victor G. Davila-Roman, Washington University, St. Louis, MO
Background: Pulsed Doppler mitral inﬂow velocities are used to optimize AV delay (AVD) 
during cardiac resynchronization therapy (CRT). Whether optimizing AVD to improve left 
ventricular (LV) diastolic ﬁlling is related to optimizing the AVD that increases LV stroke 
volume (ie, aortic time velocity integral, AoTVI), has not been characterized.
Methods: 31 patients (age 57 ± 11 years, 21 male, LV ejection fraction: 25 ± 5%) 
were evaluated by Doppler measurements of AoTVI, mitral early (E) and late ﬁlling (A) 
velocities, E and A duration (dur), and diastolic ﬁlling time (DFT) pre-CRT, and at AVD of 
60-160 ms (20 ms increments) after 10 cardiac cycles of pacing (acute-CRT). The AVD 
that maximally increased AoTVI, mitral E-wave duration, mitral A-wave duration, or DFT 
was considered “optimal.”
Results (see table): The optimal AVD by the AoTVI method was longer compared to 
optimal AVD that increases E wave duration or DFT (both p = .001) but was similar to 
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the AVD that increased mitral A-wave duration. Optimal AVD by the AoTVI method was 
shorter in patients with pre-CRT mitral E/A velocity ratio < 1 (n = 13) compared to those 
with E/A ≥ 1 (n=18, 97±37 vs.127±24 ms, respectively, p = .01); relative increase of AoTVI 
was lower in patients with E/A < 1 compared to E/A ≥ 1 (11 ± 12 vs. 22 ± 12%, p = .02).
Conclusions: In CRT patients the AVD that increases LV diastolic ﬁlling time differs 
signiﬁcantly from that which improves stroke volume. The LV diastolic ﬁlling pattern pre 
CRT inﬂuences the optimal AVD in heart failure patients.
AoTVI (cm) E dur (ms) A dur (ms) DFT (ms)
Pre-CRT 19.7±5.9 181±48 129±37 353±94
Acute-CRT 22.7±5.7 268±65 146±29 441±92
p value
(pre- vs acute-CRT) <.001 <.001 <.001 <.001
Optimal AVD 114±33 83±29* 123±36 84±32*
mean ± SD; * p < .001 vs. optimal AVD by AoTVI
1051-260 Beneﬁcial Chronic Effects Of AV-Delay Optimization In 
Patiens With Cardiac Resynchronisation Therapy
Stefan E. Hardt, Said Hashem Fani Yazdi, Alexander Bauer, Arthur Filusch, Philipp 
Ehlermann, Peter Staritz, Grigorios Korosoglou, Alexander Hansen, Andrew Remppis, 
Wolfgang Schoels, Hugo A. Katus, Helmut F. Kuecherer, University of Heidelberg, 
Heidelberg, Germany
Background: Cardiac resynchronisation therapy (CRT) has become a valuable treatment 
option in selected patients with heart failure. Acute changes of the AV-Delay in CRT 
patients have a signiﬁcant impact on hemodynamics. However, the more important 
chronic functional effects of AV-Delay optimization have not been systematically examined 
despite of its potential role for chronic functional improvement. Furthermore, there is no 
chronically validated standard procedure for optimizing AV-Delay. 
Aims: Therefore, in this study we investigated whether optimization of AV-Delay in CRT 
patients as assessed by echocardiographic measurement of the velocity time integral of 
the left ventricular outﬂow (LVOT-VTI) chronically changes 1. walking distance in the 6 min 
walk test, 2. levels of NT-proBNP as a marker of heart failure and 3. echocardiographic 
parameters of left ventricular function. 16 patients were enrolled in this study (15 male) 
aged 63±2 years, who had dilated (n=10) or ischemic cardiomyopathy (n=6). Optimization 
was performed 43±13 weeks after initiation of CRT. Follow up (FU) was conducted 39±2 
days after optimization. 
Results: LVOT-VTI increased from 188±11 mm (baseline) to 207±13 mm (optimized 
conditions, p<0.05). Compared to initial values AV-Delay was reduced by 43±8 ms in 
9 patients and prolonged by 29±3 ms in 7 patients using this method of optimization. 6 
min walk test improved from 442±17 m (baseline) to 479±18 m at FU (p<0.05). During 
this period NT-proBNP signiﬁcantly decreased from 3016±990 ng/l to 1862±545 ng/l by 
25 %. There was a slight but signiﬁcant increase of LV-ejection fraction as assessed by 
echocardiography acutely after optimization (baseline: 27±2%, optimized: 30±2%, p<0.05), 
while LV-ejection fraction at FU (28±3%) did not differ from baseline. Furthermore, the 
peak systolic velocity of tissue doppler imaging of the septal and the lateral mitral anulus 
did not differ signiﬁcantly between baseline, post-optimization and at FU. 
Conclusion: This study demonstrates for the ﬁrst time chronic functional improvement 
due to AV-Delay optimization guided by echocardiographic measurement of LVOT-VTI in 
patients with CRT.
1051-261 Comparison of Single-Site and Regional Pacing: 
Implications for Resynchronization Therapy
Robert H. Helm, Amir Schricker, Samantapudi Daya, James Chen, Richard Tunin, 
Menekhem Zviman, Ronald Berger, Henry Halperin, David Kass, Albert Lardo, Johns 
Hopkins Medical Institution, Baltimore, MD
Background: Ventricular stimulation during both single and dual chamber cardiac 
resynchronization therapy (CRT) is achieved using single-site electrodes that produce 
point source stimulation. It remains unknown, however, whether single-site stimulation 
(SS) or multi-site regional stimulation (RS) produces a greater chamber function 
response. The purpose of this study was to systematically compare acute chamber 
hemodynamics during SS and RS pacing using a novel electroanatomic mapping and 
multi-site stimulation setup. 
Methods: An elastic mesh sock, containing 128 evenly distributed stimulation/recording 
electrodes was ﬁtted over the ventricular epicardium of 8 canines. RS consisted of a 
patch of 4-6 single electrodes dispersed over approximately 4-10 cm2. The single 
electrode centered in the RS ﬁeld was used for SS pacing. The pacing scheme consisted 
of baseline right atrial pacing (RAP) followed by a randomly selected ventricular pacing 
sequence: SS or RS of the right ventricular free wall (RV), apical region (AP), and left 
ventricular free wall (LV). Systolic function was measured for each pacing scheme using 
an intracardiac pressure catheter and was expressed as a percent change in dP/dtmax 
from baseline RAP. 
Results: Each pacing scheme produced a decrease in dP/dtmax (more dyssynchrony) from 
baseline (average of -15.2% ±1.1). RS of the RV, AP, and LV produced a greater percent 
decrease in dP/dtmax (greater dyssynchrony) than SS pacing of the same region (relative 
difference of 19.8 ± 1.3%, 60.0 ± 1.6%, 55.4% ± 1.3%, respectively) with all p <0.05. 
Conclusion: SS generates superior chamber hemodynamics as compared with multi-site 
RS pacing in RV, AP, and LV regions. Decreased function during RS may be attributed 
a reduction in mechanical wave propagation due to simultaneous stimulation of a large 
region of myocardium that then becomes more susceptible to late-systolic stretching. 
Further studies using a tagged-MRI motion analysis are needed to further evaluate the 
mechanical effects of regional stimulation.
1051-262 Greater Sensitivity of Cardiac Function to Ventricular 
Pacing Lead Location in Patients With vs. Without Left 
Ventricular Dysfunction
Randy Lieberman, Luigi Padeletti, William Eastman, Douglas A. Hettrick, Harper 
Hospital, Detroit, MI, University of Florence, Florence, Italy
Background: Results of pacing trials comparing right ventricular (RV) and left ventricular 
(LV) lead location have been equivocal and may depend on the population studied. We 
compared LV function during acute RV, LV and bi-ventricular (BiV) pacing in patients 
with vs. without LV dysfunction. Methods: LV pressure and volume data were recorded 
during electrophysiology study in 20 patients prospectively stratiﬁed by (High) LV ejection 
fraction (EF) ≥ 35% (n=14; 63±12 y; 4M; EF=28±4%) or (Low) EF < 35% (n=6; 65±11 y, 
3M; EF=52±12%). QRS width was 95±13 and 93±18 ms, respectively. Constant atrial 
overdrive pacing was maintained (78±13 bpm). LV pressure and volume were measured 
via a pressure-conductance catheter during acute dual chamber pacing from the RV 
apex, RV free wall, RV septum, LV and BiV(LV- RV septum). AV delay was programmed 
to the atrial-pace to His potential interval minus 10 ms to avoid fusion. Stroke work (SW), 
stroke volume (SV), ejection fraction (EF), +dP/dt, efﬁciency (SW/SV) and synchrony 
index (SYN) were compared between sites and between groups. Results: Multiple indices 
of LV function including SW, SV, +dP/dt, EF, LVSP, SW/SV and SYN varied signiﬁcantly 
(p<0.05) with pacing site. Also, the mean coefﬁcient of variation for different pacing sites 
was lower in the High EF group for multiple indices of LV function (Table). Conclusions: 
RV and LV pacing sites may have greater impact on acute LV function in populations with 
more severe LV dysfunction. Long term outcome trials are ongoing.
Variability in LV Function Indices 
Coefﬁcient of Variability High EF(n=14)
Low EF
(n=6) p
SW 15.9±9.1% 27.1±6.4% 0.01
SV 16.3±8.4% 22.1±7.3% 0.16
SW/SV 5.5±3.5% 11.4±6.5% 0.02
+dP/dt 6.0±3.7% 11.8±4.4% 0.01
LVSP 4.9±3.1% 13.5±7.3% <0.01
SYN 15.2±6.5% 20.0±7.7% 0.17
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1078-257 Platelet Activation Promotes Formation Of Platelet-
Leukocyte Conjugates (PLC) In Non-Valvular Atrial 
Fibrillation (AF)
Julio A. Chirinos, Aurelio Castrellon, Juan P. Zambrano, Wenche Jy, Lawrence L. 
Horstman, Eugene R. Ahn, Joaquin J. Jimenez, Howard Willens, Agustin Castellanos, 
Robert J. Myerburg, Yeon S. Ahn, University of Miami School of Medicine, Miami, FL
Background: Increased platelet and leukocyte activation have been reported in atrial 
ﬁbrillation (AF). Formation of platelet-leukocyte conjugates (PLC) is an important 
mechanism by which leukocytes contribute to thrombosis. The mechanisms driving the 
formation of PLC in AF are unclear. We investigated the levels of PLC, platelet expression 
of P selectin, and leukocyte activation in patients with non-valvular AF. 
Methods: We studied 14 patients with chronic AF (mean age=62.9 years) and compared 
them to normal controls. Since we have shown that digitalis use is associated with platelet 
activation in AF, patients taking digitalis were excluded. We used ﬂow cytometry to measure 
platelet expression of P selectin and leukocyte expression of CD11b. Coexpression of 
CD41 and CD45 was used to measure PLC. 
Results: Comorbidities included hypertension (85%), diabetes mellitus (21%), coronary 
artery disease (35%) and congestive heart failure (28%). The mean heart rate was 80 
bpm. The mean BP was 127 / 75 mmHg. The mean left ventricular ejection fraction was 
49%.All patients were taking warfarin and 78% were taking aspirin. Patients with AF had 
markedly increased levels of P selectin (22.1 vs 5.0 FU; p=0.008), PLC (61±13% vs 
43±21%; p=0.001) and CD11b expression in leukocytes (16.4 vs. 7.9 FU; p=0.0003). PLC 
strongly correlated with P selectin expression (R= 0.80; R2=0.64; p<0.001) but not with 
leukocyte activation as measured by CD11b expression (R=0.41; R2= 0.17; p=0.14). 
Conclusions: Our ﬁndings indicate that (1) Patients with AF demonstrate increased 
levels of platelet and leukocyte activation; (2) Increased PLC formation occurs in AF; (3) 
Levels of PLC closely correlate with platelet activation but not with leukocyte activation, 
suggesting than PLC formation is driven by platelet activation rather than by leukocyte 
activation in this population. Clopidogrel, but not aspirin, has been shown to decrease 
the formation of PLC. Our data suggests that aspirin use in AF patients would not be 
anticipated to normalize platelet activation and PLC formation in AF patients, but other 
therapies aimed at decreasing PLC formation might decrease the thrombotic risk in AF.
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1078-258 Role of Follow-Up Transesophageal Echocardiography 
Before Elective Cardioversion in Patients With Atrial 
Fibrillation, Left Atrial Thrombus, and Effective 
Anticoagulation
Mohammad Saeed, Atiar Rahman, Giuseppe Augello, Adeel Afzal, Praveen Jammula, 
Ildiko Agoston, Yochai Birnbaum, Salvatore Rosanio, University of Texas Medical 
Branch, Galveston, TX, San Raffaele University Hospital, Milan, Italy
Background The value of transesophageal echocardiography (TEE) to prevent 
cardioversion-related thromboembolic events in patients with atrial ﬁbrillation (AF) and 
pre-existing atrial thrombus is unclear. We compared the embolic risk associated with a 
strategy of follow-up TEE-guided direct-current cardioversion (DCCV) with that of blind 
DCCV in patients with AF, pre-existing thrombus and effective anticoagulation.
Methods We identiﬁed 67 subjects with left atrial appendage (LAA) thrombi from a total 
of 520 consecutive patients with symptomatic non-rheumatic AF who were referred to 
us for elective DCCV. All patients received at least 4 weeks of adjusted-dose warfarin 
(target international normalized ratio, 2 to 3) before DCCV. At time of DCCV, 20 patients 
had follow-up TEE and 47 did not. After DCCV, all patients received warfarin for at least 
6 weeks.
Results There were no clinical and echocardiographic differences between the two 
groups. After a median follow-up of 6 weeks from DCCV, two thromboembolic events 
were observed in patients who were blindly cardioverted and one in patients in whom 
the follow-up TEE strategy was used. By multiple logistic regression analysis the TEE 
strategy was not associated with a lower risk of thromboembolism as compared to blind 
DCCV (odds ratio 1.37; 95% conﬁdence interval, 0.16% to 15.86%; p = 0.20). Thrombus 
resolution and no further formation occurred in all TEE patients but two (90%).
Conclusions In patients with AF, LAA thrombi and effective anticoagulation, there is no 
difference in the risk of clinical thromboembolism between DCCV with or without follow-
up TEE. Beneﬁts of warfarin are related to thrombus resolution and prevention of new 
thrombus formation. Cost analysis data will be soon available.
1078-259 Atrioventricular Nodal Ablation and Permanent 
Pacing Does Not Increase the Risk of Stroke in Atrial 
Fibrillation
Lin Y. Chen, Cevher Ozcan, Mahek Mirza, Jane M. Trusty, Peggy L. Weivoda, David O. 
Hodge, Arshad Jahangir, Win K. Shen, Mayo Clinic, Rochester, MN
Introduction: Although we previously showed that the survival of atrial ﬁbrillation (AF) 
patients who underwent atrioventricular nodal (AVN) ablation was similar to patients on 
drug therapy, the stroke risk after AVN ablation is unknown. We hypothesized that AVN 
ablation per se, does not increase stroke risk in AF.
Methods: We studied all patients with AF who underwent AVN ablation and pacing 
between 1990 and 2002. The stroke risk was estimated by the Kaplan-Meier method. 
Multivariate predictors for stroke were identiﬁed using a stepwise Cox proportional 
hazards model.
Results: A total of 605 patients (male 50.7%, mean age 69.5 ± 11.0 years, mean 
ejection fraction 48.1 ± 16.9%) were followed for a mean duration of 3.8 ± 2.9 years. 
The cumulative stroke risk at 8 years was 15% (95% CI, 10% to 20%)(Figure). Based on 
historical controls, the annual stroke risk in AF patients on warfarin is 1.9%. The use of 
warfarin after AVN ablation was 66.6%. The proportion of patients with hypertension and 
history of TIA/stroke were 55.2% and 20.2% respectively. The multivariate predictors for 
stroke were history of TIA/stroke (p=0.0003) and not using warfarin (p=0.0098).
Conclusion: The stroke risk in our study is comparable with the stroke risk in AF patients 
on warfarin as reported in past trials. AVN ablation per se, does not increase stroke risk in 
AF. Warfarin should be continued for stroke prophylaxis after AVN ablation. 
1078-260 Risk Of Thrombus Formation And Development Of 
Pulmonary Venous Obstruction After Percutaneous Left 
Atrial Appendage Occlusion
Heyder Omran, Harald Schmidt, Christoph Hammerstingl, Giso von der Recke, Berndt 
Lüderitz, David Hardung, St.-Marien-Hospital, Bonn, Germany, University of Bonn, 
Bonn, Germany
Background: A new interventional occlusion system for the left atrial appendage 
(PLAATO) has been introduced as an alternative treatment in patients with increased 
thromboembolic risk due to atrial ﬁbrillation (AF) and contraindications for oral 
anticoagulation (OAC). Occlusion of the left atrial appendage (LAA) may compress the 
left pulmonary vein and carries the risk of thrombus formation on the surface of the device. 
The aim of this prospective study was to evaluate the morphological and hemodynamical 
changes following the procedure by means of serial transthoracic and transesophageal 
echocardiographic examinations.
Methods: 34 patients with persistent AF were included in the study. Echocardiographic 
examinations were performed 24 hours prior to the procedure, during the occlusion 
procedure, prior to discharge of the hospital, after 1, 2, 6, 12 months and after 2 years. 
The echocardiographic analysis included the following parameters: size of the LAA prior 
to and after the procedure, peak pulmonary vein ﬂow and presence of thrombi on the 
surface of the device.
Results: The average size of the LAA area was 5.92 ± 2.07 cm2 prior to and 0.78 ± 
0.49 cm2 after implantation of the device (p < 0.0001). Presence of thrombi could be 
documented neither on the surface of the occluding device nor in the left atrium during 
the complete follow-up period. Peak ﬂow velocities of the pulmonary veins were not 
signiﬁcantly higher after the positioning of the occluding device (0.60 ± 0.15 prior versus 
0.67 ± 0.14 m/s after the occlusion, p = ns).
Conclusion: The implantation of a new percutaneous left atrial appendage occlusion 
system reduces the size of the LAA signiﬁcantly. Thrombotic appositions on the device 
were not documented in the follow-up period and obstruction of the left pulmonary vein 
was not observed after implantation of the device.
1078-261 Percutaneous Occlusion Of The Left Atrial Appendage: 
Cerebral Magnetic Resonance Imaging To Determine 
Long Term Risk Of Cerebral Embolism After The 
Procedure
Heyder Omran, Harald Schmidt, Christoph Hammerstingl, Giso von der Recke, Berndt 
Lüderitz, David Hardung, St.-Marien-Hospital, Bonn, Germany, University of Bonn, 
Bonn, Germany
Background: Percutaneous left atrial appendage occlusion has been introduced as an 
alternative treatment in patients with atrial ﬁbrillation and increased thromboembolic risk. 
However, the long term risk of cerebral embolism under this new treatment is unknown. 
The aim of the study was to evaluate the long-term risk of cerebral embolism by serial 
cerebral MRI scanning.
Methods: 34 Patients with contraindications to warfarin or bleeding complication under 
oral anticoagulation were enrolled in the study. Serial neurological and echocardiographic 
examinations were undertaken prior to and during the procedure and in addition at 1 
month, 2 months, 6, 12 and 24 months. Cerebral MRI including diffusion weighted 
sequences was performed prior to the procedure, 48 hours after and 6, 12 and 24 months 
after the procedure to assess for cerebral microembolism.
Results: Cerebral MRI performed prior to the occlusion procedure detected the presence 
of former cerebral embolism in 12 out of the 34 patients. Follow-up MRI studies excluded 
the presence of new cerebral microembolism in all patients. TTE and TEE examinations 
did not reveal de novo thrombus formation in the LA or thrombotic appositions on the 
surface of the occlusion device during the follow-up period.
Conclusions: Long term follow-up of patients with occlusion of the left atrial appendage 
did not reveal cerebral thromboembolism. Percutaneous left atrial appendage occlusion is 
an alternative treatment in patients at high risk of thromboembolism and contraindications 
to oral anticoagulation therapy.
1078-262 Histopathological Study of Thrombogenesis in Left 
Atrial Appendage Obtained at the Operation for Atrial 
Fibrillation
Tsunenori Saito, Koichi Tamura, Mayuko Togashi, Daisuke Uchida, Tomonari Saito, 
Yuichi Sugisaki, Nippon Medical School, Tokyo, Japan
Background: Thromboembolism is a most important complication to provide the 
prognosis of patients with atrial ﬁbrillation (AF). To evaluate the mechanism of thrombus 
formation, histopathological changes including localization of thrombi in resected left atrial 
appendages (LAA) of valvular AF patients were investigated.
Methods: Clinicopathological studies were made on 56 AF cases: 30 with mitral 
regurgitation (MR), 3 with mitral stenosis (MS), and 23 with MSR. Pathological ﬁndings of 
thrombi in LAA were compared with clinical features, including history of valvular diseases 
and embolism, and ﬁndings of echocardiography (UCG). Results were analyzed by Chi 
square test, Fisher’s exact method or Welch’s t test.
Results: LAA thrombi were categorized into 2 types. Membranous thrombi (M-thrombi) 
that widely attached and organized to collagenous neointima were found on LAA 
endocardium in 49 patients (88%). Polypoid-shape thrombi (P-thrombi) were observed on 
M-thrombi in 15 patients (27%). Fresh P-thrombi were found on the ruptured old thrombi 
in 4 cases. P-thrombi were seen in patients with large left atrials (58 ± 12 vs 50 ± 11 mm; 
p < 0.05); a larger number of MS and MSR patients had P-thrombi in LAA than MR cases 
(42 vs 13%; p < 0.05). Patients with P-thrombi had higher prevalence of past embolism 
(50 vs 19%; p < 0.025) and longer duration of valvular disorders as the basal disease (18 
± 20 vs 8 ± 10 years; p < 0.05). Patients with MS had no peculiar localization of thrombi 
in LAA cavity, but in MR cases, more patients had thrombi in the oriﬁce than the tip of 
LAA (35 vs 19%; p < 0.01). In UCG, MR ﬂow was classiﬁed into 3 directions: hitting roof, 
anteroseptal, and posterolateral wall of the left atrium. Patients that MR ﬂow jet struck 
posterolateral wall near the entrance of LAA had a higher rate of LAA thrombi than others 
(57 vs 20%; p = 0.016).
Conclusion: The development of LAA thrombi is inﬂuenced by blood stasis and/
or direction of MR ﬂow in the left atrium. Great majority of patients with AF have M-
thrombi in LAA that are difﬁcult to ﬁnd by UCG. Instability of M-thrombi including surface 
rupture before complete organization relates to P-thrombi formation which results in high 
incidence of embolism in AF patients.
2005_3_CardiacArrhyth.indd   101 12/23/04   10:01:06 AM
102A ABSTRACTS - Cardiac Arrhythmias JACC February 1, 2005
C
ar
di
ac
 A
rr
hy
th
m
ia
s
POSTER SESSION
1079  Permanent Pacemakers: Effects, 
Programming, and Implantation 
Techniques
Monday, March 07, 2005, 9:00 a.m.-12:30 p.m.
Orange County Convention Center, Hall E1
Presentation Hour: 9:00 a.m.-10:00 a.m.
1079-247 The Mechanical Effect of Biatrial Delivery of Non-
excitatory Electrical Current.
Joseph Y.S. Chan, Jeffery W.H. Fung, Hamish C.K. Chan, Winnie W.L. Chan, Henry C.M. 
Yu, John E. Sanderson, Prince of Wales Hospital, The Chinese University of Hong Kong, 
Hong Kong, Hong Kong
Background: Nonexcitatory (NE) electrical current applying to the ventricle improves 
myocardial contractility and attenuates ventricle remodeling in animal heart failure models. 
The aim of the study is to investigate the effect of NE electrical current on human atrium.
Methods: 10 patients were recruited (8 females and 2 males, age 45.8±8.5 years). 
Echocardiogram of left atrium with measurements of peak atrial systolic velocity (AM) at the 
annulus level and atrial strain rate (SR) were performed after 5 minutes of steady pacing at 4 
protocols as shown in the table below. Biatrial pacing at high right atrium and distal coronary 
sinus (lateral left atrium) through distal poles of endocardial pacing catheters at rate above 
the intrinsic heart rate were performed at twice diastolic threshold. NE electrical current was 
commenced by introduction of a 20mA at 2.0msec pulse width electrical impulse at 50msec 
(refractory period) after every preceding captured pacing impulse.
Results: Using one-way ANOVA analysis it was shown that NE current signiﬁcantly 
increased the atrial strain rate of both septal and lateral left atrium when compare to 
baseline. 
* = p<0.05 Baseline Biatrial pacing Biatrial pacing +NE Isoprenaline
Septal AM (cm/sec) 4.25±1.01 5.16±1.26 5.63±6.96* 7.63±1.25*
Lateral AM
(cm/sec) 3.26±1.80 3.96±1.44 5.84±2.27* 5.78±1.74*
Septal SR (sec-1) 2.29±0.73 2.89±1.23 4.59±1.50* 3.65±1.28
Lateral SR(sec-1) 1.73±1.09 2.38±1.41 3.37±1.46* 3.02±1.18
Conclusions: Biatrial delivery of NE current improved global atrial contraction and the 
effect was observed even at site (left atrial septum) distant from the application sites of 
NE current (lateral left atrium).
1079-248 Detection of Asymptomatic Atrial High Rate Events 
in Patients with Dual Chamber Pacemaker and Its 
Prognostic Signiﬁcance
Manish B. Undavia, Gagan Sahni, Jignesh Shah, Joe Lovecchio, Balendu C. Vasavada, 
Sabrina Wilbur, Long Island College Hospital, Brooklyn, NY
Background: The advent of dual chamber pacemakers with mode switch algorithms 
for detection of atrial high rate events (AHRE) have made the surveillance of atrial 
tachyarrhythmias feasible. Data regarding the clinical signiﬁcance of these events is still 
unclear. The purpose of the current study was to correlate AHRE with clinical variables 
and outcomes.
Methods: 101 consecutive patients from our pacemaker clinic were evaluated for 
occurrence of AHRE. Patients with a history of atrial ﬁbrillation (AF) and pacemakers set 
in a VVI mode were excluded from the analysis (N= 9). A total of 92 patients were then 
followed prospectively for 18+ 9.3 months. Statistical analysis was done using chi- square 
test for discrete and ANOVA for continuous variables.
Results: The mean age of the patient population was 70 + 13 years of which, 45% were 
females, 87% hypertensives, 22% diabetics, 22% with coronary artery disease (CAD) and 
32% with congestive heart failure (CHF). Patients with AHRE were older patients than 
those without AHRE (73 +12 vs. 64 +14; p = 0.001). There was no signiﬁcant difference in 
the number of AHRE in patients with regards to CAD, DM, or HTN. There were increased 
AHRE in patients with CHF (950 + 4,710 vs. 5,961 + 17,819; p = 0.03). Sub-group analysis 
of the patients with CHF showed a consistent increase in AHRE in patients with non-
ischemic cardiomyopathy (9,458+23,264 vs. 1,049 + 4,714; P = 0.004). Worsening CHF 
was associated with gradual but signiﬁcant increase in the number of AHRE (none or 
mild- 950 + 4,710 vs. moderate-5,080 + 17,549 vs. severe-13,006 + 22,407; p value 
= 0.05). During the follow-up period, patients with higher number of AHRE had more 
hospitalizations for cerebrovascular events (CVA), CHF and AF (p = 0.04). Longer duration 
(>24 hrs) of AHRE however, was not associated with increased hospitalization.
Conclusion: Patients with increased AHRE irrespective of its duration had an increased 
incidence of hospitalization for CVA, CHF and AF. Interestingly, CHF was not only 
associated with increased AHRE but a “dose response” curve was also noticed. AHRE as 
a surrogate for worsening CHF would be an exciting and, as yet, unexplored hypothesis.
1079-249 Withdrawal or Maintenance of Warfarin Therapy Guided 
by Implantable Device Datalogs in Patients With 
Refractory Atrial Fibrillation: A Novel Application of 
Device Monitoring in Recurrent Atrial Fibrillation 
Nandini Madan, Ibrahim El-Gabry, Sanjeev Saksena, Electrophysiology Research 
Foundation, Warren, NJ
Background: An increased incidence of stroke has been observed in AF pts who do 
not maintain warfarin (W) therapy even when a rhythm control (RC) strategy has been 
attempted. This may be due to incomplete RC or increased risk of thromboembolism 
due to the underlying disease. We examined the hypothesis that an objective device 
based documentation of RC or lack thereof can help guide W therapy. Methods: We 
used dual site right atrial pacemakers (DAP) in combination with antiarrhythmic drugs 
(AAD) &/or catheter ablation i.e. “hybrid” therapy in 113 pts with symptomatic paroxysmal 
(n=70) or persistent/permanent AF (n=43), mean age 69+9 yrs, mean LA diameter of 
42+8 mm, mean LV ejection fraction 47+14 %, refractory to 2+1 AAD. W was continued 
until pacemaker datalogs conﬁrmed restoration of stable RC without symptomatic or 
asymptomatic sustained AF for 1 yr. 
Results: Survival was 92% at 1 yr, 84% at 3 yrs and 80% at 5 years in the study population. 
30 pts (27%) were maintained without long-term W therapy based on the above criteria (Gp 
A) due to withdrawal (n=26), not initiated due to contraindications (n=2) or pt refusal (n=2) 
while the remainder continued on W (Gp B). These two groups were comparable for age 
and gender, but the proportion of pts with persistent AF was higher in Gp B (38 pts= 46%) 
compared to Gp A ( 5 pts= 17%). Using the device classiﬁcation of RC control to deﬁne 
W need, the overall stroke incidence was 1.1% per patient year, which is comparable to 
expected stroke event rates in age matched populations without AF. There were 3 stroke 
events, none of which occurred in Group A. Stroke events in Group B occured in patients 
with paroxysmal AF (2 pts) and persistent AF (1 pt) and could be causally related to refusal 
of W therapy (2 pts) and fatal intracerebral bleeding on W(1 pt). 
Conclusions: 1. W therapy guided by device monitoring for recurrent AF was not 
associated with increased risk of stroke.2. Device monitoring during a RC strategy may 
conﬁrm continued need for W therapy, possibly due to the detection of asymptomatic AF 
and has the potential to further reduce stroke rates in AF populations. 3. Long-term W 
therapy was safely withdrawn in selected pts with prolonged absence of recurrent AF on 
device monitoring.
1079-250 Do Aspirin and Clopidogrel Increase the Risk of Cardiac 
Device Implantation?
Gioia Turitto, Ruben Kandov, Linda Aponte, Neerat Patel, David Benson, Ronald 
Pedalino, Nabil El-Sherif, SUNY-Downstate Medical Center, Brooklyn, NY
Background: Aspirin+Clopidogrel (A+C) represents an increasingly popular combination 
therapy in patients with coronary artery disease. Its use has recently been associated with 
excess risk of bleeding following coronary artery bypass surgery. We investigated if A+C 
results into a higher complication rate following cardiac device implantation.
Methods: This study enrolled 300 patients (pts) undergoing pacemaker (n=169) or ICD 
(n=131) implantation while on therapy with A alone (118 pts), A+C (71pts), C alone (4 pts) 
or neither A or C (107 pts). Collected data were analyzed according to the presence or 
absence of C therapy and then corrected for A exposure.
Results: There was a total of 11 complications, of which 4 occurred in the Group on 
C therapy (Group I: 3 pocket hematomas, and 1 hemothorax), and 7 in Group off C 
therapy (Group II: 5 hematomas, 1 pneumothorax, and 1 hemothorax). Groups I and II 
were comparable in terms of age, gender, body surface area, preoperative platelet count, 
prothrombin time, activated partial thromboplastin time and creatinine values, as well as 
procedural times (adjusted according to the device type). Complication rates were similar 
in both Groups (5.3% vs 3.1%, p= NS). There was a higher prevalence of A exposure in 
Group I than in Group II (94.6 % vs 52.4 %, p < .0001). Pts with A exposure had longer 
procedure times (p=0.006) and were more likely to develop complications compared to 
pts without A exposure. Using a logistic regression analysis model, this difference was 
statistically signiﬁcant (5.29 % vs 0.90 %, p= 0.0055, odds ratio of 16.7).
Conclusion: Aspirin exposure is a risk factor for periprocedural adverse events in pts 
undergoing cardiac device implantation. Combination therapy with Clopidogrel does not 
signiﬁcantly increase this risk.
1079-251 The Effects Of Right Ventricular Apex Pacing On 
Tei Index And Bnp In Patients With A Dual Chamber 
Pacemaker
Naoya Oketani, Sanemasa Ishida, Shuichi Hamasaki, Kunitsugu Takasaki, Tomoko 
Ichiki, Manabu Setoguchi, Shin Kawazoe, Yasuhisa Iriki, Makoto Yamashita, Hitoshi 
Nakashima, Tatsuru Matsuoka, Chuwa Tei, National Hospital Organization Kyusyu 
Cardiovascular Center, Kagoshima, Japan, Kagoshima University, Kagoshima, Japan
Backgrounds: Synchronous electrical activation, as induced by right ventricular apex 
(RVA) pacing, causes various abnormalities in left ventricular (LV) function, especially in 
the context of severe LV dysfunction or structural heart disease. However, the effect of 
right ventricular apex pacing in patients with normal LV and right ventricular (RV) function 
has not been fully elucidated. The aim of this study was to characterize the effects of right 
ventricular apex pacing on LV and RV function by assessing isovolumic contraction time 
and isovolumic relaxation time divided by ejection time (Tei-index) and BNP. 
Methods: Doppler echocardiographic study and the measurement of BNP was 
performed in 76 patients with dual chamber pacemaker without structural heart disease 
(30 sick sinus syndrome, 46 atrio-ventricular block). Patients were divided into one of two 
groups according to the incidence rate of right ventricular apex (RVA) pacing by 24-hour 
ambulatory ECG that was recorded just before echocardiographic study: group A, n=44, 
patients with incidence of RVA>=50%, mean pacing rate 99.6 + 1.5%; group B, n=30, 
patients with incidence of RVA<50% mean pacing rate 2.5 + 6.3%. 
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Results: There was no signiﬁcant difference in mean heart rate derived from 24-hour 
ambulatory ECG recordings (66.4 + 11.3 bpm vs. 68.5 + 7.5 bpm) when comparing the 
two groups. LV Tei index in group A was signiﬁcantly higher than that in group B (0.67 
+ 0.17 vs. 0.45 + 0.09, P<0.0001). And RV Tei index in group A was signiﬁcantly higher 
than that in group B (0.34 + 0.19 vs. 0.25 + 0.09, P<0.05). And then BNP in group A 
was signiﬁcantly higher than that in group B (39.7 + 46.9 vs. 17.7 + 11.3, P<0.05). There 
were no signiﬁcant differences in other echocardiographic parameters when comparing 
the two groups, including left atrium diameter (35 + 8 mm vs. 34 + 5 mm), LV systolic 
dimension (30 + 6 mm vs. 29 + 7 mm), and ejection fraction (66 + 9% vs. 63 + 11%), 
except of LV diastolic dimension (49 + 5 mm vs. 45 + 5 mm, p<0.05). Conclusions: These 
ﬁndings suggest that right ventricular apex pacing results in global left ventricular and 
right ventricular function abnormalities in patients with dual chamber pacemakers.
1079-252 Individual Optimization Of Pacing Sensors Improves 
Exercise Capacity
Ayten Erol-Yilmaz, Tim A. Schrama, Jutta Schroeder Tanka, Arthur A. Wilde, Jan G. 
Tijssen, Raymond Tukkie, Academic Medical Center, Amsterdam, The Netherlands
Background: Programmable pacemaker sensor features are frequently used in default 
setting. Limited data are available about the effect of sensor optimization on exercise 
capacity and quality of life (QOL). Inﬂuence of individual optimization of sensors on QOL 
and exercise tolerance was investigated in a randomized, single blind study in patients 
with VVIR, DDDR or AAIR pacemakers.
Methods: Patients with ³ 75% pacing were randomized to optimized sensor settings 
(OSS) or default sensor setting (DSS). Standardized optimization was performed using 
three different exercise tests. QOL questionnaires (QOL-q: Hacettepe, Karolinska and 
RAND-36) were used for evaluation of the sensor optimalization. One month before and 
after optimalization, exercise capacity using CAEP and the three
QOL-q were assessed.
Results: Fifty-four patients (26 men, 28 female) with a mean age of 65 ± 16 years were 
enrolled in the study. In each group (OSS and DSS) 27 patients were included. One 
month after sensor optimization the achieved maximal HR and METS were signiﬁcantly 
higher in OSS compared to DSS (124± 28 vs. 108 ± 20 bpm, p=0.036; 7.3± 4 vs. 4.9 ± 
4 METS, p=0.045). Highest HR and METS were achieved in patients with pacemakers 
with accessible sensor algorithms. In patients with automatic slope settings (33 %), 
exercise capacity did not improve after sensor optimalization. QOL did not improve in 
OSS compared to DSS.
Conclusion: After 1 month of individual optimization of rate response pacemakers, 
exercise capacity was improved and maximum heart rate increased, although QOL 
remained unchanged. Accessible pacemaker sensor algorithms are mandatory for 
individual optimization.
1079-253 Is Inﬁltration Of Pacemaker Pocket By Antiseptic 
Solution Necessary At The Time Of Implant/
Replacement?
G. Muqtada Chaudhry, Michael V. Orlov, Gunjan Shukla, Jaydutt Patel, Patricia Pacetti, 
Charles I. Haffajee, Caritas St. Elizabeth’s Medical Center, Boston, MA
Background: Prophylactic inﬁltration of pocket with antiseptic solution following device 
implants is routine during surgical procedure. However its value in preventing infection is 
not established in cardiac device recipients. We sought to determine in randomized fashion 
whether such a practice has any beneﬁt in preventing subsequent infections in patients 
undergoing new pacemaker implant as well as those undergoing generator change. 
Methods: Consecutive patients undergoing pacemaker implants at two laboratories at 
our institution by same operators using same technique of patient preparation and implant 
procedure were studied. The patients were randomized to either have pocket inﬁltration 
with betadine or vancomycin solution (“inﬁltration group”) or no inﬁltration of pocket (“no 
inﬁltration group”) during implantation of a new pacemaker system or only generator 
replacement. All patients received prophylactic intravenous antibiotics followed by oral 
antibiotics for 5 days under a similar protocol.
Results: Over a period of 30 months 151 patients underwent new pacemaker implant 
and 27 had a generator replacement in the “no inﬁltration” group for standard indications. 
Over a similar period 176 patients had new implant and 39 had generator replacement in 
the “inﬁltration” group. Over a mean follow up of 15 months, one patient in “no inﬁltration” 
group and two patients in the “inﬁltration group” had device related infection of the pocket. 
Of these, 2/3 required explantation of the pacemaker system and subsequent implantation 
on the contralateral side. All patients who had infection had a new pacemaker system 
implanted, were diabetics and the infection was apparent within the ﬁrst three months. 
Conclusion: Inﬁltration of the pocket after pacemaker implantation is unnecessary for 
either new implants or generator replacements if prophylactic intravenous followed by oral 
antibiotics are used. Infection rates are low in general and are higher in diabetics.
1079-254 A New Technique For Direct His-bundle Pacing
Francesco Zanon, Enrico Baracca, Silvio Aggio, Graziano Boaretto, Paola Cardano, 
Valentina Rizzo, Gianluca Rigatelli, MariaPaola Galasso, Gabriele Zanazzi, Mauro 
Carraro, Pietro Zonzin, Rovigo General Hospital, Rovigo, Italy, Medtronic Italia, Milan, Italy
Introduction: increased clinical evidences show that conventional right ventricular 
pacing is detrimental to left ventricular function. A theoretical pacing system that could 
preserve the normal Purkinje activation should be considered the ideal pacing approach.
Aim of the study: to investigate the safety and the reliability of direct His bundle pacing 
(DHBP) using a new system composed by a steerable catheter and a new 4.1 Fr. Screw-
in lead.
Method: 15 patients (11 male, mean age 76 ± 10 years) with standard PM indication and 
a narrow QRS were enrolled and DHBP was attempted.
Results: DHBP was achieved in 13/15 patients; in two patients the Hissian area was 
achieved, but the paced QRS morphology and duration were different form the native 
ones. The mean time for lead positioning was 27 ± 23 minutes, the mean ﬂuoroscopy time 
was 20 ± 22 minutes and the total procedure time (skin to skin including the positioning 
of standard EP catheter for His recording) was 80 ± 33 minutes. In DHBP pacing, acute 
pacing threshold was 2.6 ± 1.2 V at a pulse width of 0.5 ms., whereas sensed potentials 
were 3.1 ± 2.2 mV. At one month follow-up the same QRS duration and morphology 
recorded at implant were observed in all patients, pacing threshold was 2.8 ± 1.8 V, with 
a ventricular sensing of 3.0 ± 2.0 mV, the sensing conﬁguration was changed from bipolar 
to unipolar in ﬁve patients to solve undersensing issues.
No major complications were observed. 
Conclusions: DHBP in patients with narrow QRS and standard PM indications is safe 
and feasible using a new system composed by a steerable catheter and a new screw-in 
lead. Further studies are needed to evaluate the clinical impact of this technique.
1079-255 The Effects of VOO Ventricular Pacing on Ventricular 
Function Using a New Intracardiac Imaging System 
Developed to Guide Multi-Site Pacing
Douglas N. Stephens, Kai Thomenius, K. Kirk Shung, Raymond Chia, Aaron Dentinger, 
Xunchang Chen, Matthew O’Donnell, James Pemberton, Crispin H. Davies, David J. Sahn, 
Oregon Health & Science University, Portland, OR, University of California, Davis, CA
Background: We studied 3 pigs during RV or LV pacing compared to NSR, using as 
guidance, a new high frequency ultrasound imaging catheter: 9 French with a 64-element, 
8-14 MHz, side-looking array. It is highly steerable with diagnostic electrodes and runs on 
a GE/VingMed Vivid 7 system.
Methods: The device was developed by an NHLBI Bioengineering Research Partnership 
focused on new tools for intracardiac imaging and interventional therapy. The device was 
easily introduced from femoral or jugular venous and manipulated without ﬂuoroscopy.
Results: High resolution images with tissue Doppler strain rate were easily obtained from 
the RA encompassing the whole RV and LV out to 8cm depth. For evaluating synchrony/
asynchrony on LV short axis views, we determined the time between ﬁrst and last peak 
systolic SR points on curves from 3 LV sample regions (septum, lateral and inferior walls) 
for 10 states of LV or RV pacing and compared them to NSR. This time period was 52 ± 17 
msec (SD) for LV pacing. The time for peak SR at the same LV regions was shorter during 
RV pacing (22 ± 7 msec, p = NS) 17 ± 4 msec for NSR (p < 0.01). Lastly, global strain and 
strain rate determined with a new 2D strain analysis program showed decreased global 
LV strain during both RV and LV pacing.
Conclusions: This new prototype ultrasound/EP device is easily steerable without 
ﬂuoroscopy from jugular or femoral venous positions and should be applicable for guiding 
resynchronization therapy in the cath lab thus possibly reducing ﬂuoroscopy time.
1079-256 Pronounced Left Ventricular Dilation and Scar Tissue 
Extension Preclude Reverse Remodeling Deriving From 
Cardiac Resynchronization Therapy In Patients With 
Ischemic Cardiomyopathy
Jacopo Dalle Mule, Felice Martinelli, Alessandro Proclemer, Eugenio Moro, Marco 
Mazzella, Maria Liberata Di Sipio, Pietro Scrimieri, UO Cardiologia Ospedale del 
Cadore, Pieve di Cadore, Italy, UO Medicina Nucleare Ospedale S Martino, Belluno, Italy
Background: Recent studies showed that cardiac resynchronization therapy (CRT) 
with pacing results in reverse remodeling, improvement in systolic left ventricular (LV) 
function, functional status and well being of patients with end stage chronic congestive 
heart failure. However, 20% to 30% of patients may not respond to CRT, particularly if 
cardiomyopathy is of ischemic origin. We examined the relation between LV features and 
absence of reverse remodelling after CRT.
Methods: Thirty-tree patients, age 66 ±8, with ischemic cardiomyopathy, NYHA 
class III or IV despite optimal medical therapy, LV ejection fraction (EF) <35%, LV end 
diastolic volume (EDV) >85 ml/m2, QRS > 120 ms and left bundle branch block received 
a biventricular pacemaker. At baseline and 6 months after implantation, we evaluated 
NYHA class, LV EF, LV EDV and end systolic (ESV) volumes, intra- and inter-ventricular 
dyssynchrony by equilibribium radionuclide ventriculography phase analysis. Stress and 
rest (early and 24-h late) myocardial perfusion scintigraphy was performed at baseline.
Results:  There were 15 patients with moderately dilated (ESV ≤90 ml/m2) (Group A) and 
18 with markedly dilated (ESV >90 ml/m2) (Group B) LV. LV EF (30 ±5 vs 29 ±4; p=0.5, 
respectively), NYHA class (3.3 ±0.5 vs 3.6 ±0.5; p=0.1, respectively) were similar in Group 
A and B. EDV (103 ±10 vs 168±9; p<0.0001, respectively), intraventricular dyssynchrony 
(SD of the LV phase angle: 52 ±14 vs 81 ±14; p<0.0001, respectively) and scar tissue 
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extension at perfusion scintigraphy (2.4 ±1.1 vs 5.4 ±0.9; p<0.0001, respectively) were 
smaller in Group A than in group B. There were 14/15 responders to reverse remodelling 
(reduction in LV ESV ≥15 ml after CRT) in Group A and 6/12 non-responders (<15 ml) in 
Group B (p=0.05); 14/15 responders to EF (improvement ≥ 5 units after CRT) in Group A 
and 7/18 non-responders in Group B (p=0.03).
By multiple regression analysis, independent parameters included LVEDV (p<0.01) and 
the number of scarred segments (p<0.01)
Conclusion: In patients with ischemic cardiomyopathy, a marked LV dilation and 
extension of scar tissue prevent ongoing LV remodeling after CRT and are associated 
with lack of LVEF and symptoms improvement
POSTER SESSION
1080  Implantable Deﬁbrillator:  
Testing and Use
Monday, March 07, 2005, 9:00 a.m.-12:30 p.m.
Orange County Convention Center, Hall E1
Presentation Hour: 9:00 a.m.-10:00 a.m.
1080-267 Deﬁbrillator Implantation Testing: How Can Patients 
Who Require System Modiﬁcation to Obtain an 
Adequate Safety Margin for Deﬁbrillation Be Identiﬁed?
Andrea M. Russo, William Sauer, Edward Gerstenfeld, David Lin, Henry H. Hsia, Ralph 
J. Verdino, Hemal Nayak, Joshua M. Cooper, Sanjay Dixit, David J. Callans, Vickas Patel, 
Francis E. Marchlinski, University of Pennsylvania Health System, Philadelphia, PA
Background: Ventricular ﬁbrillation (VF) is typically induced at ICD insertion or 
replacement. Despite availability of high output devices and biphasic waveforms, some 
patients (pts) still require system modiﬁcation (MOD) to obtain an adequate safety margin 
for deﬁbrillation. If factors predicting MOD were known, testing might be further minimized 
in some pts.
Methods: We reviewed data on 1085 consecutive pts who underwent ICD implantation 
with deﬁbrillation threshold (DFT) testing to determine factors predicting MOD. An 
adequate safety margin was felt to be present if ≥ 2 inductions of VF were effectively 
terminated with an output ≥10 joules below maximum device output.
Results: An unacceptable safety margin (<10 joule) was identiﬁed in 71 pts (6.5%). 
(Table) Multivariable analysis demonstrated that amiodarone users were >3 times more 
likely to need MOD (HR:3.35;CI:1.96-5.73, p<0.0001). Non-ischemic disease, younger 
age, and generator upgrade were also independent predictors of the need for MOD. Long-
term mortality was not different between groups (17% versus 20%, p=NS).
Conclusions: In a contemporary population of ICD pts, those at “highest risk” for 
requiring MOD to obtain an adequate safety margin for deﬁbrillation can be identiﬁed. 
Because “acceptable efﬁcacy” of ICDs in preventing sudden death without testing has not 
yet been deﬁned, DFT testing remains the standard of care. However, the results provide 
a starting point to altering these standards in selected pts.
Patients Who Required Modiﬁcation Vs. Those Who Did Not  
(Univariate Analysis): 
Modiﬁed
(N=71)
No Mod*
(N=754) P value
Age (years) 63 ± 14 66 ± 13 0.021
Female sex (% pts) 26% 25% 0.887
Presence CAD (% pts) 49% 69% <0.001
Ejection fraction (%) 29 ± 15% 32 ± 14% 0.034
Amiodarone 44% 19% <0.001
Right-sided implant 10% 5% 0.179
Abdominal generator 6% 6% 1.000
Upgrade/generator replacement 38% 25% 0.024
QRS duration </= 120 msec 42% 50% 0.268
1080-268 Inductionless Deﬁbrillator Implantations
John D. Day, Eric Putz, Demos Iskos, Christopher R. Cole, Curtis Li, David Lyon, Tamara 
Fritzel, Liz Mino, LDS Hospital, Salt Lake City, UT
Background: Deﬁbrillation threshold (DFT) testing has traditionally been used to ensure 
that an implantable cardioverter-deﬁbrillator (ICD) can detect and terminate ventricular 
ﬁbrillation (VF). Testing for the upper limit of vulnerability (ULV) is an alternative method 
to estimate the DFT that may avoid VF induction. ULV is the weakest shock strength at or 
above which VF is not induced when a stimulus is delivered during the vulnerable phase of 
the cardiac cycle. The purpose of the Multicenter Inductionless Deﬁbrillator Implantation 
Study (MIDIS) was to validate the ULV hypothesis in ICD implantations and allow for 
potentially inductionless implants.
Methods: 194 patients receiving a Guidant transvenous right ventricular apical dual-
coil shocking lead ICD system were recruited from multiple centers. At implantation, 
ULV screening at 14 Joules (T-wave shocks 20 msec before, 20 msec after, and at the 
peak of the latest peaking monophasic T-wave) was performed. Patients were considered 
inductionless if ULV screening at 14 J did not induce VF. Patients with no inducible 
VF during ULV testing had their initial ventricular tachycardia (VT) and VF therapy 
programmed at 21 J with the VT/VF detection rate set at 200 bpm (maximum output of 
ICD was 31 J).
Results: Of the 194 patients included, 151 with a left-sided ICD system were “inductionless” 
at implantation with ULV screening at 14 J. 100% of these “inductionless” patients who 
also underwent DFT testing had a DFT < 21 J (n=149, p<0.0001). In those patients who 
received clinical shocks, and in whom data were available, 10 of these 149 patients (7%) 
had a total of 19 pre-deﬁned qualifying lower energy shocks for fast VT/VF > 200 bpm 
during a mean follow-up time of 9.5 months. In 17 of the 19 (89%) clinical shocks, the fast 
VT/VF was terminated with the ﬁrst lower energy shock. In the 2 cases where fast VT/VF 
was not terminated with the ﬁrst shock, the second shock was successful.
Conclusions: ULV testing is a potentially safer method of ICD testing at implantation that 
allows for inductionless implantations in most patients. Programming a lower energy ﬁrst 
shock for clinical fast VT/VF episodes based on inductionless ULV testing at implantation 
appears to be safe.
1080-269 A New Step-Wise Approach to Implantable Cardioverter 
Deﬁbrillator Electrograms Tachycardia Discrimination
Felipe Atienza, Jesús Almendral, Javier García, Mercedes Ortiz, Estrella Munilla, Ana 
Sánchez, Esteban González-Torrecilla, Angel Arenal, Hospital General Universitario 
Gregorio Maranon, Madrid, Spain
Background: In patients with Implantable Cardioverter Deﬁbrillators (ICDs), comparison 
of stored electrograms (EGs) during tachycardia and sinus rhythm (SR) immediately 
before or after the episode is sometimes not possible/reliable because of limitations of 
memory capabilities or distortion of EGs after a discharge. We aimed to assess EGs 
characteristics that could help to distinguish SR/supraventricular tachycardia (SVT) from 
ventricular tachycardia (VT).
Methods: We evaluated EGs from a variety of models of chronically implanted ICDs from 
2 manufacturers (Medtronic & Guidant). The ﬁrst analysis searched for morphological 
coincidences in SR EGs of 59 consecutive patients. Then, SR EGs were compared with 
EGs of 39 VT and 17 SVT. We analyzed the characteristics of the unipolar and bipolar 
ICD EGs, and their duration and relative timing relationship, both in SR and during 
spontaneous tachycardia. 
Results: SR EG had a consistent morphologic pattern of dominant R wave in 98% of 
patients, provided a particular ICD model was excluded (in this model 70% had dominant 
S wave, suggesting a different electronic conﬁguration). Thus all EGs from this ICD 
model were excluded from further analysis. A dominant S pattern in the unipolar EG 
was present in 41% of VT-EG, but only 2% of SR-EG, and 7% of SVT-EG (p<0,001). 
SR-EG morphology was not inﬂuenced by bundle branch block (in 25 patients) or infarct 
location, as demonstrated in a simultaneous 12-lead ECG. The unipolar EG preceded the 
bipolar EG by a median of 16±15 ms during SR and by 56±26 ms during VT (p<0.001), 
but no signiﬁcant difference was found between SR-EG and SVT-EG timing. Duration 
of unipolar EG or bipolar EG, or bipolar EG morphology did not differ among groups. 
A multivariate analysis showed that morphology of unipolar EG and EGs timing were 
signiﬁcant independent predictors of rhythm mechanism. When the following step-wise 
approach was used: 1) S wave pattern= VT 2) EGs timing >20 ms=VT, 97% tachycardias 
were correctly classiﬁed.
Conclusions: The proposed step-wise approach could be useful for tachycardia 
classiﬁcation of ICD episodes.
1080-270 Reciprocal Relationship between Electrical Storm and 
Severity of Congestive Heart Failure in Implantable 
Cardioverter Deﬁbrillator Patients with Dilated 
Cardiomyopathy
Dai Yumino, Katsuya Kajimoto, Hirotaka Kawarai, Masayuki Mizuno, Kohei Tanizaki, 
Morio Shoda, Hiroshi Kasanuki, Tokyo Women’s Medical University, Tokyo, Japan
Background: It is suggested that an impaired left ventricular ejection fraction (LVEF) is 
associated with frequent ﬁres of implantable cardioverter deﬁbrillator (ICD) in pts with 
congestive heart failure (CHF). However, the relationship between electrical storm (ES) due 
to ventricular tachycardia/ﬁbrillation (VT/VF) and severity of CHF in ICD pts is not clear.
Methods:We studied 162 pts with dilated cardiomyopathy (DCM; ischemic in 54 and 
non-ischemic in 108) who were followed for 40±25 months. All pts had LVEF<40% and 
received ICD for secondary prevention. Clinical characteristics at baseline, HF-related 
morbidity and total mortality were compared between pts with ES (n=40) and without ES 
(n=122). ES was deﬁned as ≥ 3 separate episodes of VT/VF within 24 hrs.
Results: There were no statistical differences between pts with and without ES in NYHA 
class, LVEF, probability of ischemic DCM, and medication use at baseline. However, 
plasma BNP at baseline in pts with ES was signiﬁcantly lower than those without ES 
(164 vs. 328pg/ml, p<0.01). Multivariate analysis elucidated that lower plasma BNP 
level at baseline was an independent predictor for occurrence of ES (p<0.01). Moreover, 
HF-related morbidity was signiﬁcantly lower in pts with ES (p=0.02, Figure), while no 
signiﬁcant difference regarding total mortality during follow-up.
Conclusions: This study suggests that presence of ES has a reciprocal relationship with 
baseline BNP level, and with HF-related morbidity in ICD pts with DCM and VT/VF.
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1080-271 Predictors of Appropriate Deﬁbrillator Therapy in 
Patients with an Implantable Deﬁbrillator that Delivers 
Cardiac Resynchronization Therapy
Aseem D. Desai, Martin C. Burke, Thomas E. Hong, Susan Kim, Yasser Salem, Patrick 
G. Yong, Bradley P. Knight, University of Chicago Hospitals, Chicago, IL, Guidant 
Corporation, St. Paul, MN
Background. Little data exists about implantable cardioverter deﬁbrillator (ICD) therapies 
in patients with NYHA class IV congestive heart failure (CHF), because they have not 
been considered appropriate candidates for ICD therapy. Our purpose was to determine 
predictors of ICD therapy in a cardiac resynchronization therapy-deﬁbrillator (CRT-D) 
population, which includes class IV CHF patients.
Methods. Patients enrolled in the CONTAK CD study were treated with a CRT-D device 
and required to have class II-IV CHF, QRS duration ≥ 120 ms, and a Class I ICD indication. 
The database was retrospectively analyzed during the six-month post-implant period to 
identify predictors of appropriate ICD therapy.
Results. Patients were mostly male (83%), 66±11 yrs old, had coronary disease (69%), 
mean EF = 0.22±0.07, and class II (33%), III (58%), or IV (9%) CHF. During follow-up, 
73/501 (14%) patients received an appropriate therapy. Two independent predictors were 
identiﬁed: a history of spontaneous, sustained ventricular arrhythmias (HR=2.05; 95% 
CI=1.31-3.20; p=0.002) and class IV CHF (HR=1.81; 95% CI=1.10-2.96; p=0.019).
Conclusions. CRT-D patients with sustained ventricular arrhythmias or class IV CHF 
are twice as likely to receive an appropriate ICD therapy compared to patients without 
these factors. This study provides further evidence that advanced CHF is associated with 
ventricular arrhythmias independent of EF. Further studies are needed to determine if 
CHF therapy reduces ICD shocks.
1080-272 The Inﬂuence of Drive Cycle Length on the Initiation of 
Ventricular Fibrillation During Implantable Cardioverter 
Deﬁbrillator Threshold Testing: A Prospective 
Crossover Study
Neil K. Sanghvi, Paul Lelorier, Arjun Gururaj, Kevin Monahan, Boston Medical Center, 
Boston, MA
Background: Programmed electrical stimulation of the heart, as a method to induce 
tachyarrhythmias has been available since the 1960’s. To date, no study has examined 
optimal drive cycle length in the induction of ventricular ﬁbrillation during deﬁbrillation 
threshold testing after implantable cardioverter deﬁbrillator (ICD) placement. We 
hypothesized that longer drive cycle lengths, by means of the longer action potential 
duration, would promote intramyocardial phase 2 reentry and facilitate induction of 
ventricular ﬁbrillation.
Methods: Fifty consecutive implants were randomized into a prospective crossover format 
for this study. The group consisted of 40 men and 10 women, each patient receiving either 
a 400ms or 600ms initial drive train prior to 1.2J internal shock on the T wave with a 
goal to induce ventricular ﬁbrillation. The timing of the T wave shock was determined by 
measuring the interval from the beginning of the QRS to the apex of the T wave in lead II. 
Successful inductions were deﬁbrillated via the ICD. Patients were then crossed over and 
the protocol repeated. All statistics were calculated using Analyse-It™ for Excel v1.71.
Results: No signiﬁcant difference existed in age, ratio of males to females, ejection 
fraction, medications, or patients with diabetes between the drive train groups. Twenty of 
23 (87%) patients were successfully induced into VF in the initial 400ms drive train arm 
whereas 22 of 27 (81%) were successfully induced in the 600ms arm. Thus, a total of 44 
out of 50 (88%) patients were successfully induced at 400ms, 41 of 50 (82%) patients 
were successfully induced at 600ms, and 2 (4%) patients were not inducible at either 
cycle length. The 2-sided Fisher’s exact test returned an insigniﬁcant p=0.29.
Conclusion: No investigation to date has questioned whether a relationship exists 
between drive cycle length and initiation of ventricular ﬁbrillation. Our study addresses this 
question, though negative for difference between 400ms and 600ms drive trains. Further 
research into optimal strategies for inducing ventricular ﬁbrillation must be conducted 
in order to minimize patient sedation time and discomfort while undergoing deﬁbrillator 
threshold testing.
ORAL CONTRIBUTIONS
806FO  Featured Oral Session...Mapping and 
Ablation of Ventricular Tachycardia
Monday, March 07, 2005, 9:15 a.m.-10:30 a.m.
Orange County Convention Center, Room 230D
9:30 a.m.
806-4 Tachycardia-induced Cardiomyopathy In Patients With 
Repetitive Monomorphic Ventricular Ectopy Originating 
From The Right Ventricular Outﬂow Tract
Ravi K. Yarlagadda, Sei Iwai, Kenneth M. Stein, Steven M. Markowitz, Bindi K. Shah, 
Bruce B. Lerman, Suneet Mittal, Cornell University Medical Center, New York, NY
Background: Repetitive monomorphic ventricular ectopy (RMVE) often originates 
within the right ventricular outﬂow tract (RVOT). Although usually associated with a good 
prognosis, isolated cases of tachycardia-induced cardiomyopathy have been reported. 
We evaluated patients (pts) referred for catheter ablation of RMVE to (1) determine the 
incidence of tachycardia-induced cardiomyopathy and (2) assess the impact of ablation 
on left ventricular (LV) function.
Methods: We identiﬁed 29 consecutive pts who underwent ablation (using 3D mapping) 
of RMVE. In all pts, the ectopy had a left-bundle branch, inferior axis morphology. Patients 
with impaired LV function (EF ≤ 45%) were advised to undergo repeat assessment of LV 
function following ablation.
Results: The mean age of study pts was 47 ± 15 years (16F, EF 53 ± 11%). Ambulatory 
24-hour ECG recordings were available in 21 pts; a mean of 17,843 ± 12,019 premature 
beats were recorded. Non-sustained VT (up to 18 beats) was seen in 9 pts; no pt had 
sustained VT. Impaired LV function (40 ± 6 [range: 30-45%]) was present in 10 pts, and 
was considered idiopathic in 8 pts; the other 2 pts had a prior inferior wall MI. Patients with 
impaired LV function were more likely to be male (7/13 men, 54% vs. 3/16 women, 19%, 
p=0.06) and older (58 ± 13 vs. 42 ± 16, p=0.005) than pts with preserved LV function, 
but there was no difference in the amount of baseline ectopy among groups. Ectopy was 
successfully ablated from within the RVOT in 25 (86%) pts, including 9 (90%) pts with 
impaired LV function. Of these 9 pts, 7 had a follow-up assessment of LV function. The EF 
normalized in all 5 patients with an idiopathic cardiomyopathy; in both pts with an ischemic 
cardiomyopathy the EF also improved, although the degree of improvement was more 
limited (3 and 6% increase in EF).
Conclusions: (1) In our referred group of patients with RVOT RMVE, ~1/3 of pts have a 
tachycardia-induced cardiomyopathy. (2) Ablation should be considered in pts with RMVE, 
especially those in whom the cardiomyopathy is unexplained, since it may normalize LV 
function. (3) Younger patients with RMVE should be carefully followed since tachycardia-
induced cardiomyopathy may develop over time.
9:45 a.m.
806-5 Catheter Ablation of Unstable Ventricular Tachycardia 
Guided by Late Potentials
Mario D. Gonzalez, Jaime Rivera, Diego N. Velasco, Omer L. Shedd, Keith A. Kyker, 
Univeristy of Florida, Gainesville, FL
Introduction: Identiﬁcation of regions of slow conduction during sinus rhythm may 
facilitate catheter ablation of hemodynamically unstable ventricular tachycardia. We 
speculated that these regions would show late potentials (LP) with activation times 
independent of the direction of activation.
Methods and Results: Ablation of multiple, repetitive, hemodynamically unstable, 
ventricular tachycardias was performed in 12 patients with frequent ICD shocks, late post-
myocardial infarction (60±11 year old, 12 males, ejection fraction = 32±7%). Mapping of the 
left ventricle was performed using the Carto XP system (Biosense Webster). Voltage and 
activation maps were obtained. Detailed mapping was concentrated in regions showing a 
voltage ≤ 0.5 mV. Mapping during sinus rhythm was compared with that obtained during 
right and/or left ventricular stimulation. Late potentials targeted for ablation were those 
with constant QRS-LP interval independent of the V-LP interval (ﬁgure). A total of 22±17 
radiofrequency lesions were delivered to eliminate these potentials. All 12 patients were 
non-inducible at the end of the procedure. After a mean follow-up of 11±4 months 10/12 
patients had no recurrence of ventricular tachycardia.
Conclusion: The response to different direction of activation allows identiﬁcation of 
late potentials that may participate in reentrant ventricular tachycardias. Ablation of 
these potentials using radiofrequency current can eliminate un-mapable ventricular 
tachycardias. 
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806-6 Electroanatomic Mapping Characteristics of Ventricular 
Tachycardia in Patients With Arrhythmogenic Right 
Ventricular Dysplasia
Hielko Miljoen, Simona State, Christian de Chillou, Isabelle Magnin-Poull, Pierre Dotto, 
Marius Andronache, Ahmed Abdelaal, Etienne Aliot, University of Nancy, Nancy, France, 
University of Antwerp, Antwerp, Belgium
Background: Ventricular tachycardia in arrhythmogenic right ventricular cardiomyopahy/
dysplasia has been previously explored using entrainment mapping techniques but little 
is know about ventricular tachycardia mechanisms and the characteristics of their circuits 
using an electroanatomical mapping system.
Methods and Results: Three dimensional electroanatomical mapping was performed 
in 11 patients with well tolerated sustained ventricular tachycardia and arrhythmogenic 
right ventricular cardiomyopathy/dysplasia. Sinus rhythm mapping of the right ventricle 
was performed in 8 patients showing areas of low bipolar electrograms voltage (<1.2 
mV). In total 12 tachycardias (mean cycle length 382±62 ms) were induced and mapped. 
Complete maps demonstrated a reentry mechanism in 8 VTs and a focal activation 
pattern in 4 VTs. The reentrant circuits were localized around the tricuspid annulus (5 
VTs), around the right ventricular outﬂow tract (1 VT) and on the RV free lateral wall 
(2 VTs). The critical isthmus of the peritricuspid circuits were bounded by the tricuspid 
annulus and the area of low voltage close to the tricuspid annulus observed during the SR 
mapping. The isthmus of the RVOT tachycardia was delineated by the tricuspid annulus 
and a low voltage area localized on the posterior wall of the RVOT. The lateral circuits 
showed isthmus delineated by two parallel lines of double potentials. Focal tachycardias 
originated in the RV free lateral wall. Linear radiofrequency ablation performed across the 
critical isthmus was successful in 7 from the 8 reentrant tachycardias. The focal VTs was 
successfully ablated in 50% of cases. During a follow up of 9 to 50 months VT recurred in 
4 out of 8 initially successfully ablated VTs.
Conclusions: Detailed 3D electroanatomical mapping is helpful in deﬁning the VT 
mechanism and in reconstructing their circuits in patients with arrhythmogenic right 
ventricular cardiomyopathy/displasia.
10:15 a.m.
806-7 Characterization of Arrhythmogenic Substrate and 
Ventricular Tachycardia Circuits With Non-contact 
Unipolar Mapping in a Porcine Model of Myocardial 
Infarction
Jason T. Jacobson, Valtino X. Afonso, Greg Eisenman, John R. Schultz, John J. Michele, 
Mark E. Josephson, David J. Callans, University of Pennsylvania, Philadelphia, PA, 
Harvard University, Boston, MA
Background: Conventional mapping to guide radiofrequency (RF) ablation of scar-based 
ventricular tachycardia (VT) is limited in patients with hemodynamically untolerated or 
non-inducible VT. The present study investigates whether non-contact unipolar mapping 
can deﬁne arrhythmogenic substrate and VT circuits.
Methods: 5 pigs underwent experimental myocardial infarction by injection of agarose 
beads into the distal LAD. After 6 weeks, Dynamic Substrate Mapping (DSM) was 
performed. This technique deﬁned substrate as the intersection of low voltage areas (< 
50% of the largest unipolar deﬂection recorded in the chamber) identiﬁed in sinus rhythm 
and during pacing from all sides of the infarct. After DSM creation, pacing was performed 
at 3-5 sites within the substrate to determine the exit sites. RF lesions were placed at 
sites around the substrate to correlate DSM to gross scar. Programmed stimulation was 
performed to induce VT. VT was mapped and the circuit deﬁned using standard non-
contact mapping techniques. Animals were sacriﬁced to allow gross examination of the 
heart. Dimensions of the scar were measured, as were the distances from RF lesions to 
the scar. DSM was performed in 2 control animals.
Results: Anteroapical substrate and transmural scar were identiﬁed in all animals. A 
mean of 3.2 (2-5) pacing sites were used to construct the DSM substrate. The mean 
area (±SD) was 16.3 (±7.4) cm2 by DSM and 14.9 (±8.2) cm2 by pathology (p>0.7). The 
mean error of measurement of lesion distance from substrate by DSM was 5.4 (±4.4) 
mm. A mean of 3.6 (2-5) sites were paced within substrate. 10 of 18 sites exited from the 
substrate adjacent to the pacing area, 7 exited at distant areas and 1 had 2 exits (either 
side). VT was induced in all animals (mean 1.8 VT morphologies/animal). Except for one 
VT mapped to the epicardium, all circuit exit sites were located at DSM boundary points. 
Furthermore, VT circuit exit sites were at (6) or near (3) a pacing exit site. No substrate 
was identiﬁed in the control animals.
Conclusions: DSM is a reliable method of arrhythmogenic substrate localization in this 
model. Pacing within the substrate can predict VT exit sites and may prove useful for 
ablation of unmappable VT post MI.
ORAL CONTRIBUTIONS
813  Subcutaneous and Implantable 
Deﬁbrillators
Monday, March 07, 2005, 11:00 a.m.-12:15 p.m.
Orange County Convention Center, Room 231A
11:00 a.m.
813-3 Sub-Cutaneous Electrical Deﬁbrillation in Canines
Riccardo Cappato, Gust Bardy, University of Milan, San Donato Milanese, Milan, Italy, 
University of Washington, Seattle, WA
Background: We tested the efﬁcacy of electrical deﬁbrillation using a subcutaneous (S)-
only electrode approach.
Methods: In 9 dogs (weight 28 ± 3 kg), an initial 8 cm long horizontal incision was created 
in the 4th to 6th intercostal space along the anterior axillary line. Two pockets were created 
for placement of a ﬁrst S electrode (EL) with its leading edge in close proximity to the 
left edge of the sternum (ST) and a second S electrode at the site of incision along the 
lateral axillary line (L), such that the two ELs would lay 15±2 cm apart along the same 
horizontal line. ELs with active surface areas of 5, 10 and 20 cm² or with 8 cm-long rod 
were subsequently positioned in the two pockets and tested for DFT according to different 
combinations (Table). A custom high output biphasic waveform generator (Cameron 
Health, Inc.) was connected to the S ELs to conduct S DFT testing following 10 sec-long 
intervals of VF induced with AC through an endocardial RVA catheter.
Results: Using a step-down skip method for the different conﬁgurations, 64 DFT tests with 
7 EL conﬁgurations were performed. All EL conﬁgurations successfully terminated VF. The 
DFT (delivered energy) in the different EL conﬁgurations is summarized in the table.
Conclusion: All investigated S deﬁbrillation conﬁgurations proved effective within a range 
of energies between 10 and 75 J delivered from two ELs lying 15 cm apart in the left 
hemithorax space. These observations open the way for the development of an S-only 
implantable deﬁbrillator for human use.
ST/L E (cm²) 20/5 20/10 20/20 10/5 5/5 5/20 rod 8/20
Mean DFT (J) 65.3 38.2 13.8 30.6 48.9 58.7 39.9
± SD 8.9 16.1 3.7 8.8 26.6 21.4 8.6
11:15 a.m.
813-4 Feasibility of Left Chest Subcutaneous Electrodes in 
Terminating Ventricular Fibrillation
Martin C. Burke, James A. Coman, Adam W. Cates, Curtis C. Lindstrom, David Sandler, 
Aseem Desai, Bradley P. Knight, University of Chicago, Chicago, IL, Guidant, Inc., St. 
Paul, MN
Background: The feasibility of a speciﬁc subcutaneous (SQ) to cutaneous (Q) anterior 
left chest vector in terminating ventricular ﬁbrillation (VF) was studied during standard 
ICD implantation.
Methods: 18 patients (14 male, 63 ± 12 years, LVEF = 28 ± 14) were enrolled and tested 
with a study vector after intracardiac step down deﬁbrillation threshold testing (DFT) 
was completed. The study shocks were delivered from a biphasic HeartStart™ (Philips) 
external deﬁbrillator using an electrode conﬁguration consisting of a SQ active can 
emulator (Guidant) and a pediatric Q patch electrode (Philips) with an average spacing of 
13.3 cm. The SQ active can emulator was placed in the subclavian pocket created for the 
ICD. The Q patch was placed parallel to the inferior aspect of the heart near the apex as 
identiﬁed with ﬂuoroscopy. An ECD™ (Guidant) was attached to the ICD lead to provide 
a transvenous deﬁbrillator for rescue shocks. 2 episodes of VF were induced through the 
ICD lead by rapid pacing or DC current. The deﬁbrillation protocol consisted of 2 stages of 
patients. In Stage I, the 1st VF episode was treated with 70 joules (J) with a step down (50 
J) or step up (100 J) based on outcome. If 50 J shocks were successful in 7/10 patients in 
Stage I, then testing moved to Stage II. In Stage II, testing began at 50 J with a step down 
(30 J) or step up (70 J) based on outcome.
Results: Stage I was completed with 7/9 (78%) successes at 70 J (impedance (Z) = 86 
± 20 Ω) and 7/7 successes at 50 J (Z = 85 ± 19 Ω). Of the 2 patients with failures at 70 
J, one was immediately converted with 100 J while the other terminated 2 s after the 100 
J shock. The ICD DFTs for these 2 patients were 26 J and 6 J, respectively. Stage II was 
completed with 9/9 successes at 50 J (Z = 78 ± 20 Ω) and 7/9 (78%) successes at 30 J (Z 
= 80 ± 20 Ω). The ICD DFT for all patients was 10 ± 6.8 J and did not appear to correlate 
with the study vector deﬁbrillation outcome.
Conclusions: While the majority of patients were successfully deﬁbrillated with < 70J, 
greater than 10% required 100 J. These data suggest a bimodal distribution of DFT among 
patients. Further investigation is warranted to understand the population DFT distribution, 
safety margin requirements, and the need for implant testing.
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813-5 Markers of Arrhythmia Vulnerability Do Not Predict 
Deﬁbrillator Shocks in Patients With Hypertrophic 
Obstructive Cardiomyopathy
Scott W. Burke, Fred A. Crawford, III, William H. Spencer, III, Christopher D. Nielsen, Ron 
D B Simon, J. Lacy Sturdivant, J. Marcus Wharton, Robert B. Leman, Michael R. Gold, 
Medical University of South Carolina, Charleston, SC
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is associated with 
a higher risk of sudden cardiac death (SCD). Arrhythmia markers, including T-wave 
alternans (TWA), nonsustained VT (NSVT), and inducible ventricular arrhythmias at 
electrophysiology testing (EPS) predict SCD and deﬁbrillator shocks in some patient 
populations, but the role of these markers in HOCM is controversial.
Methods: We analyzed 90 consecutive patients with HOCM who underwent alcohol 
septal ablation and had deﬁbrillators implanted for primary prevention of SCD based on 
traditional risk factors. These risk factors include family history of SCD, syncope, septal 
thickness > 3.0 cm, and abnormal blood pressure response during exercise. The endpoint 
was appropriate deﬁbrillator shock.
Results: 64% of patients were male, with a mean age of 48 +15 years. Mean septal 
thickness was 2.3 +0.5 cm and patients had 1.7+1.1 SCD risk factors. 9 patients had 
appropriate ICD shocks over a mean follow-up of 23.1 months. Patients receiving shocks 
were older than those not receiving shocks (59 + 16 years vs. 47+14 years, p=0.01), but 
septal thickness did not differ between groups (2.1 +0.5 vs. 2.3+0.5 cm). There were no 
signiﬁcant differences in markers of arrhythmia vulnerability (See Table).
Conclusions: The annual risk of appropriate deﬁbrillator shock was 5.2%. Traditional 
arrhythmia vulnerability markers did not predict shocks, suggesting that these markers 
are not useful for risk-stratifying patients with HOCM for SCD.
TWA + NSVT EPS +
Shock 50% 50% 71%
No Shock 50% 62% 83%
11:45 a.m.
813-6 Different Clinical Characteristics and Worse Outcome in 
Octogenarians Who Received Implantable Cardioverter-
Deﬁbrillators During 2002 - 2003 Compared With 1993-2001
Lin Y. Chen, Paul A. Friedman, Mudassir Ashraf, David O. Hodge, Arshad Jahangir, Win 
K. Shen, Mayo Clinic, Rochester, MN
Background Although outcome data are limited in the elderly, ICD utilization continues 
to grow in octogenarians. In this study, we aimed to determine the clinical characteristics 
and the survival of octogenarians following ICD implantation before and after MADIT 
II publication. We hypothesized that a change in clinical characteristics will impact on 
survival in the very elderly.
Methods All octogenarians who had an ICD implanted at our hospital from 1993 - 
2003 were included in the study. The patients were separated into 2 groups as shown 
in the Table. We chose the cutoff of 2002 as this coincided with MADIT II publication 
and the expansion of ICD indication for primary sudden death prevention. Categorical 
and continuous variables were compared using the �2 test and rank-sum test respectively. 
Observed survivals were compared with expected age and sex matched Minnesota 
population rates. Differences between observed and expected survival were tested using 
a 1-sample log-rank test.
Results The observed survival in Group 1 was not different from expected (p=0.06), but 
the observed survival in Group 2 was worse than expected (p<0.001). Compared with 
Group 1, Group 2 patients were older, had lower EF, and fewer patients for secondary 
prevention.
Conclusions Octogenarians who had ICD implanted during 2002-2003 had worse 
survival outcome than those during 1993 - 2001. This was likely due to more implants in 
patients who were older and with lower EF. More studies to deﬁne ICD use in this growing 
elderly group are needed.
Patients’ characteristics, observed and expected survival
Characteristic Group 1 (implanted during 1993 - 2001) (n=70)
Group 2 (implanted 
during 2002 - 2003) 
(n=76)
P value
Mean age +/- standard deviation(years) 82.7 +/- 2.5 83.1 +/- 2.1 0.04
Male gender (%) 87 79 0.19
Mean Ejection Fraction +/- standard 
deviation (%) 32.0 +/- 12.7 27.8 +/- 12.1 0.04
Coronary artery disease (%) 70 59 0.17
Ventricular tachycardia (%) 64 43 0.01
Out of hospital cardiac arrest (%) 19 8 0.05
Proportion alive at 2 years [(%) and (95% 
conﬁdence interval)] 74 (63 to 86) 52 (34 to 79) 0.07
Expected survival at 2 years based on 
age and sex matched cohort (%) 82 86
 
 
 
Noon
813-7 Short QT Syndrome: The Treatment with Implantable 
Cardioverter Deﬁbrillators is Associated with an 
Inherent Risk of Inappropriate Discharges
Rainer Schimpf, Christian Wolpert, Francesca Bianchi, Carla Giustetto, Urs Bauersfeld, 
Fiorenzo Gaita, Martin Borggrefe, University Hospital Mannheim, Mannheim, Germany, 
Ospedale Civile Asti, Asti, Italy
Introduction: A congenital short QT-interval constitutes a new primary familial electrical 
abnormality, which is associated with syncope and/or sudden cardiac death. We report 
on the performance of implantable cardioverter deﬁbrillator (ICD) therapy in patients with 
inherited short QT-interval with respect to sensing abnormalities and detection issues.
Methods and Results: In ﬁve consecutive patients of two unrelated European families 
with structurally normal hearts, strong positive family history of sudden cardiac death and 
excessively shortened QT-intervals ICD devices were implanted for primary and secondary 
prevention (Atlas VR V-199, n=1, Photon Micro VR-194, n=3, St. Jude Medial Inc, Marquis 
VR 7230, n=1, Medtroinc Inc.). Mean QT-intervals were 252 ± 13 ms (QTc 287 ± 13 ms). 
Four of ﬁve patients experienced 54 ± 52 days after implantation inappropriate shock 
therapies for T-wave oversensing despite normal sensing behaviour during intra- and 
postoperative device testing. In two cases decrease of the R-wave amplitude or an increase 
of the T-wave amplitude were responsible for the detection of the short coupled T-wave by 
the automatic sensing algorithm. In one patient revision of the ventricular electrode had to 
be performed after inadequate shock therapies due to T-wave oversensing after a decrease 
of the maximal R-wave amplitude < 3 mV. Programming of lower sensitivities and decay 
delays in 3 of 4 patients prevented further inappropriate discharges.
Conclusions: ICD therapy is actually the therapy of choice in patients with a familial 
Short QT Syndrome. However, a risk of inappropriate ICD-therapy is inherent due to 
detection of short coupled and prominent T-waves. Careful testing of ICD-function and 
adaptation of sensing levels and decay delays without sacrifycing correct arrhythmia 
detection is essential.
POSTER SESSION
1106  Ventricular Tachycardia: Risk 
Stratiﬁcation and Anatomic Substrate
Monday, March 07, 2005, 1:30 p.m.-5:00 p.m.
Orange County Convention Center, Hall E1
Presentation Hour: 1:30 p.m.-2:30 p.m.
1106-253 Long Term Prognostic Value of Electrophysiologic 
Study After Myocardial Infarction: a Ten Year Follow-Up 
Study
Simona Sarzi Braga, Raffaella Vaninetti, Roberto Franco Enrico Pedretti, IRCCS 
Fondazione Maugeri, Tradate, Italy, TRADATE, Italy
The long-term prognostic power of inducible sustained ventricular tachycardia (VT) at an 
electrophysiologic study (EPS) performed 1 month after a myocardial infarction (MI) is 
still unknown. In order to evaluate the long-term prognostic value of inducible sustained 
VT after MI, we investigated the clinical outcome of a group of patients who underwent 
an EPS because of abnormal noninvasive testing. Of 305 consecutive patients admitted 
to our institution after myocardial infarction, 67 (22%) were eligible for EPS because of 
the presence of ≥ 2 of the following noninvasive risk markers: Lown 4A-B ventricular 
arrhythmias at Holter monitoring, presence of ventricular late potentials at signal-averaged 
ECG, and depressed left ventricular ejection fraction (LVEF<0.40) at echocardiographic 
evaluation. EPS was performed in 47 of 67 (70%) eligible patients (mean age 58 ± 7 
years, male gender 89%, anterior myocardial infarction 66%, thrombolysis treatment 
41%, LVEF < 0.40 77%, presence of ventricular late potentials 68%, Lown 4A-B 70%) and 
was considered positive when sustained monomorphic VT was induced. During a follow-
up of 9.5 ± 2.8 years, we observed 12 cardiac deaths (27%, sudden death in 3 cases) 
and 7 non cardiac deaths (16%); 5 deaths for unknown causes (11%) also occurred, 
3 (6%) patients were lost at follow-up, non fatal sustained ventricular tachyarrhythmias 
occurred in 7 pts (16%). The analysis was performed in 39 patients with known cause 
of death. At univariate analysis we found that inducibility of sustained monomorphic VT 
was signiﬁcantly different among patients with and without cardiac death as in patients 
with and without arrhythmic events (67% vs 26%, p = 0.02; 90% vs 24%, p = 0.001). 
At multivariate Cox regression analysis only LVEF manteined a signiﬁcant prognostic 
power. No signiﬁcant relationship was found between EPS result and all cause mortality. 
In conclusion, we report that inducible sustained monomorphic VT 1 month after a MI 
can suggest a poor cardiac prognosis in patients with high arrhythmic non-invasive risk 
proﬁle, but in long-term follow-up only LVEF may be considered a signiﬁcant predictor of 
adverse outcome.
1106-254 Postmortem Cardiac Channel Genetic Testing in 
Autopsy Negative Sudden Unexplained Death: a 
Molecular Autopsy of 49 Medical Examiner/Coroner’s 
Cases
David J. Tester, Michael J. Ackerman, Mayo Clinic College of Medicine, Rochester, MN
Background: Potentially heritable arrhythmia syndromes may account for a signiﬁcant 
number of autopsy negative, sudden unexplained deaths (SUD). Here, postmortem 
genetic testing (molecular autopsy) of the 5 cardiac channel genes implicated in 
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congenital long QT syndrome (LQTS) was performed in a cohort of medical examiner 
referred cases of SUD.
Methods: From September 1998 to March 2004, 49 cases of SUD (30 males, 13 with 
family history of syncope, cardiac arrest or sudden cardiac death, average age at death, 
14 + 11 years) were referred by Medical Examiners/Coroners to Mayo Clinic’s Sudden 
Death Genomics Laboratory for a cardiac channel molecular autopsy. Comprehensive 
mutational analysis of all 60 protein-encoding exons of KCNQ1 (LQT1), KCNH2 (LQT2), 
SCN5A (LQT3), KCNE1 (LQT5), and KCNE2 (LQT6) was performed using DHPLC and 
direct DNA sequencing on genomic DNA extracted from decedent tissue.
Results: Eight putative LQTS-associated missense mutations (5 novel) were discovered 
in 8 SUD cases (16%, 6 females, average age at death = 18.5 + 11 years). The activities 
at the time of SUD included sleep (4), exertion (2), auditory arousal (1), and undetermined 
(1). The mutations: L191fs/90-KCNQ1, G269S-KCNQ1, A302V-KCNQ1, W379R-KCNQ1, 
G584S-KCNQ1, R582fs/11-KCNH2, L799/sp-KCNH2, and I1768V-SCN5A, involved non-
conservative amino acid substitutions in highly conserved residues across species. Each 
mutation was absent in over 1500 reference alleles. Expansion of decedent pedigrees is 
underway to delineate familial versus spontaneous germline transmission.
Conclusions: This study represents the largest molecular autopsy series of SUD. Here, 16% 
have a putative LQTS-associated mutation. Combined with our previous identiﬁcation of 7 
putative CPVT1-associated mutations involving the RyR2-encoded calcium release channel, 
we have provided molecular evidence for an underlying cardiac channelopathy as the likely 
cause and a fatal ventricular arrhythmia as the presumed manner of death in nearly one 
third of SUD cases. Postmortem cardiac channel genetic testing should be considered as a 
standard part of the evaluation of autopsy negative, sudden unexplained death.
1106-255 Cardiac Event Rate During Childbearing Years in 
Women With Long QT Syndrome
G. Michael Vincent, Xiaolin Xue, Li Zhang, LDS Hospital, Salt Lake City, UT
Background: Cardiac event (CE) rates during the pregnant, post-partum, and pregnancy 
unrelated (not pregnant or post-partum) periods in women with Long QT syndrome 
(LQTS) are not well deﬁned, but an increased rate post-partum has been suggested. 
Methods: CEs during these periods were compared in 252 child- bearing women with 
739 pregnancies:101 LQT1 (16 KCNQ1 mutations), 46 LQT2 (22 KCNH2 mutations), 
2 LQT3 (2 SCN5A mutations), 1 KCNQ1+KCNH2, and 102 ungenotyped women with 
deﬁnitive phenotype, from 119 families. Our 31 year old LQTS database is unique in 
that many of our pedigrees have been extensively expanded and then used to direct 
aggressive, prospective, screening of extended family members for LQTS. This has 
allowed identiﬁcation of many asymptomatic and/or pre-symptomatic adults and children 
who otherwise would not come to medical attention. Post-partum was deﬁned as the 40 
weeks after delivery. 
Results: CE rates during the three time periods for all 252 patients are shown in the table. 
( ) show # of patients.
Time period Syncope Cardiac Arrest Sudden Death Total CE
Pregnancy unrelated 19.4% (49) 4.4 % (11) 4.4 % (11) 20.6 % (52)
Pregnant 2.8 % (7) 0.4% (1) 0 3.2% (8)
Post-partum 1.2 % (3) 0.8% (2) 0 2 % (5)
CE rates were also compared in genotyped LQT1 vs LQT2 patients to examine for 
genotype speciﬁc differences: pregnancy unrelated CE occurred in 16.8% vs 43%; 
pregnancy 4% vs 4%; and post-partum 1% vs 4%, respectively. 
Conclusions: CE in childbearing years occur primarily in the pregnancy unrelated period. 
CE rates during pregnancy and post-partum periods are much less frequent. The data 
also conﬁrm prior observations that LQT2 women have more CE in the childbearing age 
range than do LQT1 women.
1106-256 Sudden Cardiac Death in Patients with Arrhythmogenic 
Right Ventricular Dysplasia: A Series of 31 Cases from 
United States
Darshan Dalal, Kalpana Prakasa, Chandra Bomma, Jun Dong, Khurram Nasir, Crystal 
Tichnell, Cynthia James, Hugh Calkins, Johns Hopkins University School of Medicine, 
Baltimore, MD
Background: Arrhythmogenic right ventricular dysplasia (ARVD) is an important cause 
of sudden death (SCD) in young individuals. The purpose of our study was to examine the 
demographics, circumstances and clinical course of a series of ARVD patients from the 
United States who were diagnosed with ARVD on autopsy.
Methods: Our study population was comprised of 31 patients who died suddenly 
and in whom ARVD was present at autopsy. The medical history of each patient and 
circumstances of death was determined.
Results: There were 31 patients (16 male) with a mean age at death of 29±15 years. 
Symptoms prior to experiencing SCD were present in 11 patients (palpitations in 2, syncope 
in 8, near syncope in 1). In 20 patients, SCD was the ﬁrst manifestation of ARVD. Among 
the15 women in this series, one experienced SCD during pregnancy and one experienced 
her ﬁrst symptoms during pregnancy. The SCDs occurred during exercise in 9 patients 
(29%). SCD was most common between the 2nd and 4th decades of life. Death related to 
exercise was only observed in individuals who died before 40 years of age (ﬁgure).
Conclusions: The results of this study demonstrate that the majority of patients who 
experience sudden cardiac death from ARVD are young adults and do not have warning 
symptoms prior to SCD. Most deaths occur during routine activity. The probable association 
between SCD and pregnancy detected in this study needs further investigation and may 
have important implications for management of ARVD patients contemplating pregnancy.
1106-257 Can We Identify High-risk Patients With Non-ischemic 
Cardiomyopathy Who Present With Syncope? 
Suneet Mittal, Amit B. Guttigoli, Brian Wilner, Kenneth M. Stein, Steven M. Markowitz, 
Sei Iwai, Bindi K. Shah, Ravi K. Yarlagadda, Bruce B. Lerman, Cornell University Medical 
Center, New York, NY
Background: Based on recently published data, ICD implantation has been advocated 
in all patients (pts) with underlying non-ischemic cardiomyopathy who present with 
syncope, irrespective of the ﬁndings at electrophysiologic (EP) testing. However, it would 
be clinically useful to identify pts who beneﬁt most from this strategy. Therefore, we sought 
to identify long-term predictors of arrhythmic events and/or death in these pts.
Methods: We identiﬁed 35 consecutive pts (20 M, 63 ± 15 yrs, EF 29 ± 9 %) with non-
ischemic cardiomyopathy (LVEF < 45%) who underwent ICD implant for management 
of unexplained syncope. All pts underwent EP testing; however, an ICD was implanted 
irrespective of inducibility of VT. Pts were followed at 3-6 mo intervals and EGMs from 
their ICDs were retrieved.
Results: During a follow-up of 905 ± 672 days, 11 pts received appropriate ICD therapy 
[monomorphic VT (n=8) or VF (n=3)] and 6 pts died. There was no difference in age, 
gender, medications, NYHA class, QRS duration, or inducibility of VT between pts who 
did and did not meet the combined end-point of arrhythmia (VT/VF) or death. However, 
arrhythmia-free survival was signiﬁcantly less likely in pts with a LVEF <30% (n=17, 
dashed line) than in pts with a LVEF >30% (n=18, solid line, p=0.007, Figure). The 1 and 2 
year arrhythmia-free survival rate was 100% and 92% for pts with a LVEF > 30%, but only 
88% and 50% for pts with a LVEF < 30% .
Conclusions: Patients with a non-ischemic cardiomyopathy and history of syncope have 
good overall survival when treated with an ICD. However, our data suggest that in this patient 
population, an EF <30% identiﬁes pts who derive the greatest beneﬁt from ICD implantation. 
1106-258 Prophylactic Deﬁbrillator Therapy is Associated With 
Increased Mortality in Microvolt T-Wave Alternans 
Negative Patients with Ischemic Cardiomyopathy
Theodore Chow, Richard Cohen, Cheryl Bartone, Edward J. Schloss, Theodore Waller, 
Terri Booth, Eugene Chung, Santosh Menon, Dean Kereiakes, Ohio Heart Health 
Center, Cincinnati, OH
Background: Since deﬁbrillator (ICD) therapy is associated with some risk, including 
worsened heart failure and inappropriate shocks, prophylactic implantation in low risk 
patients could potentially increase mortality. Microvolt T-wave alternans (MTWA) is a test 
with excellent negative predictive value for sudden death risk. We evaluated the hypothesis 
that ICD therapy would increase mortality in MTWA negative patients.
Methods: Cardiology outpatients with LVEF≤ 40% within a large practice underwhent 
MTWA testing (primarily by treadmill exercise). MTWA tests were interpreted according to 
published criteria. Treatment strategy and ICD programming were per physician discretion. 
All patients were maintained in a prospective registry with follow-up by telephone contact 
and chart review. Subgroup analysis on patients with coronary diseasae (CAD) and LVEF 
≤ 30% was performed.
Results: 413 patients with CAD and LVEF ≤ 30% (average = 25%±5%) were followed 
for a mean of 362 days; 40/160 MTWA negative patients received ICDs. Kaplain-Meier 
analysis for freedom from death according to ICD treatment status in MTWA negative 
patients was performed (Figure). Survival at 300 days was 0.866 for ICD patients and 
0.966 for non-ICD patients (relative risk=4.0, p=0.035).
Conclusions: Prophylactic ICD treatment of MTWA negative patients with CAD and 
EF≤30% is associated with worse survival. Whether bradycardia pacing contributes to 
this outcome requires further study. 
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1106-259 Arrhythmia Or Thrombosis: What is the Dominant 
Mechanism of Sudden Cardiac Death Risk Conferred by 
LVH?
Celia Dervan, Eric C. Stecker, Carmen Miu, Kalpana Narapasetty, Catherine Vickers, 
Justin Waltz, Benjamin T. John, Karen Gunson, John H. McAnulty, Jr., Sumeet S. Chugh, 
Oregon Health and Science University, Portland, OR
Background: The Framingham Heart Study reported an independent association 
between left ventricular hypertrophy (LVH) and sudden cardiac death (SCD), but due to 
the absence of autopsy data, mechanisms of the terminal event are continually debated. 
We performed detailed postmortem examinations to evaluate the pathophysiology of SCD 
in subjects with LVH in an ongoing, community-based study.
Methods: The Oregon Sudden Unexplained Death Study (Ore-SUDS) is a prospective, 
multiple-source population-based study of SCD among all residents of Multnomah County 
OR (Pop. 660,486). SCD was deﬁned as unexpected death within 1 hr of symptoms 
(witnessed) or within 24 hrs of being observed healthy (un-witnessed). In addition, 
subjects with known, non-cardiac causes of death were excluded. During 2002 and 2003, 
ﬁndings in 32 SCD cases age 30-60 yrs (mean age 47 y; 78% male) that underwent 
detailed postmortem examination were compared with 29 age and sex-matched controls 
that suffered non-cardiac, unnatural death (mean age 44 y, 79% male ; p=NS vs. cases).
Results: LVH was signiﬁcantly more common in cases vs. controls (53 vs. 14%, p<0.01) 
with a higher body mass index in cases (33 vs. 28, p<0.01). Overall, 75% of cases had 
signiﬁcant coronary artery disease (CAD) vs. 28% of controls (p<0.05). Among cases with 
LVH, evidence of acute myocardial infarction (coronary thrombosis or fresh infarct) was 
identiﬁed only in 3 cases (18%). The remainder had signiﬁcant chronic CAD (n=10), other 
diagnoses (n=2; arrhythmogenic right ventricular dysplasia, pulmonary valve stenosis) 
and otherwise normal heart (n=2). Among controls with LVH, 3 subjects had additional 
cardiac abnormalities (CAD n=2; mitral valve prosthesis n=1).
Conclusions: These data conﬁrm the strong association between LVH and SCD and 
suggest that the mechanism of the terminal event is signiﬁcantly more likely to be fatal 
arrhythmia (82%) vs. acute coronary thrombosis (18%).
1106-260 Earlier Peak Systolic Strains Analyzed By Tagged MRI 
Are Related To Inducibility For Ventricular Tachycardia 
In Patients With Ischemic Cardiomyopathy
Boaz D. Rosen, Katherine C. Wu, Caterina Silva, Veronica Fernandes, Khurram Nasir, 
Ronald Berger, Joao AC Lima, Johns Hopkins Hospital, Baltimore, MD
Background: Sudden cardiac death due to ventricular arrhythmias is common in patients 
with ischemic cardiomyopathy (ICM). Existing non-invasive parameters cannot identify 
high risk patients reliably. We used myocardial tissue tagging to examine differences 
in regional myocardial deformation and relate them to inducibility for arrhythmia by 
electrophysiologic study (EPS).
Methods: 16 patients with ICM underwent tagged and contrast enhanced MRI studies to 
analyze regional LV function and infarction areas, respectively. All patients were recruited 
as part of the Johns Hopkins Reynolds project. Time to peak systolic circumferential 
strain (Ecc) was analyzed in 12 regions of short axis images. Segments were grouped 
according to distance from the infracted region deﬁned by delayed hyperenhancement 
into remote, adjacent and infarcted regions. All patients underwent invasive (n=3) or non-
invasive (n=13) EPS and those inducible for monomorphic VT were considered positive. 
Relationship between time to peak systolic strain and inducibility was studied.
Results: 7 patients were inducible. Both extent of infarction and ejection fraction were 
similar between groups. Importantly, mechanical activation expressed as time to peak 
systolic Ecc, was different between inducible and noninducible patients. Average time to 
peak Ecc was earlier in inducible compared to noninducible patients (304.3±117.1 versus 
381.7±188.5 ms, p<0.001) but only reached statistical signiﬁcance in the infarct and 
remote regions (303.8±118.6 vs 392.1±184.6, p=0.02, and 303.7±121.5 vs 376.7±196.3, 
p=0.03 in inducible and noninducible patients, respectively). In 9 out of 12 regions, the 
time to peak Ecc was greater than 360 ms in noninducible patients, while in inducible 
patients it was less than 360ms in all regions (p<0.0001 by Fisher exact test).
Conclusions: Earlier mechanical activation determined by peak systolic strain in patients 
with ischemic cardiomyopathy is related to inducibility for ventricular tachycardia and 
may help in understanding the anatomic substrate that underlies monomorphic reentry 
in these patients.
1106-261 Myocardial Scar Morphology as Determined by 
Magnetic Resonance Imaging Identiﬁes Substrate for 
Ventricular Tachycardia
Mark W. Kolasa, Carey O’Bryan, Richard Krasuski, Javier Roman-Gonzalez, Wilford Hall 
Medical Center, Lackland AFB, TX, Brooke Army Medical Center, San Antonio, TX
Background: Over 300,000 patients die annually due to sudden cardiac death. Left 
ventricular (LV) dysfunction has been identiﬁed as a principle risk factor for malignant 
arrhythmias. An electrophysiology study (EPS) using programmed ventricular stimulation 
is an invasive method of risk stratiﬁcation in patients with reduced LV function. Contrast 
enhanced cardiac magnetic resonance imaging (CMR) has been demonstrated to be an 
accurate method of detecting and characterizing myocardial scar. The spatial resolution 
provided by CMR allows clear delineation of scar location and thickness. We hypothesized 
that the extent of transmural scar and total scar burden would be predictive of inducible 
monomorphic ventricular tachycardia (MVT) at EPS.
Methods: Patients undergoing implantation of an Implantable Cardioverter Deﬁbrillator 
(ICD) for primary or secondary prevention of sudden cardiac death, according to current 
national guidelines, underwent contrast enhanced CMR. Myocardial scar was identiﬁed and 
characterized by location and thickness in the left ventricle. Additionally, scar burden was 
measured volumetrically. At the time of ICD implantation, patients underwent EPS for ventricular 
arrhythmia. The inducibility of MVT was compared to scar thickness and scar burden.
Results: CMR was completed on 18 patients prior to EPS. MVT was induced in 10 
patients. The mean ages of patients with and without inducible MVT were 69.2 +/- 7.3 
and 64.0 +/- 9.6 years respectively (p=0.23). The mean ejection fractions of the patients 
with and without inducible MVT were 27.0% +/- 2.9% and 27.3% +/- 6.1% respectively 
(p=0.89). In patients with inducible MVT, 29.7% +/- 21.6% of LV segments with scar had 
a scar thickness >75%, compared to 2.6% +/- 4.3% in patients who were noninducible 
(p=.02). Volumetric scar burden was not associated with increased inducibility.
Conclusion: In areas of scar, the number of left ventricular myocardial segments with 
thickness >75% as identiﬁed by contrast enhanced CMR is predictive of inducible MVT 
at EPS. In a population of patients at risk for ventricular arrhythmias, CMR may be an 
effective, non-invasive method of risk stratiﬁcation.
1106-262 The Demonstration of Ventricular Muscle Extensions 
into the Pulmonary Artery and Aorta Beyond the 
Semilunar Valves
Can Hasdemir, Saﬁye Aktas, Figen Gokmen, Ekin O. Aktas, Aytac Kocak, Okan Kok, 
Yasemin Turan, Cem Ulucan, Muge Ildizli, Oner Ozdogan, Meral Kayikcioglu, Levent 
H. Can, Serdar Payzın, Ege University School of Medicine, Izmir, Turkey, Behcet Uz 
Children Research Hospital, Izmir, Turkey
BACKGROUND: It has been shown that idiopathic ventricular tachycardia may originate 
from the aortic and pulmonary root. Therefore, we have studied tissue structure for ventricular 
muscle extensions into the pulmonary artery and aorta beyond the semilunar valves.
METHODS: 50 human hearts (mean age 44±17 years, male/female: 40/10) were 
examined and the extent of ventricular musculature beyond the semilunar valves studied. 
Tissue structure was assessed in parafﬁn-embedded tissue using Gomori trichrome 
staining in serial sections.
RESULTS: Ventricular muscle was seen extending into the pulmonary artery beyond the 
pulmonary valve in 5/50 cases (10%). This sleeve of ventricular muscle extended for 3±1.7 
mm (range 2-6 mm) into the pulmonary artery. Ventricular muscle was seen extending 
into the aorta beyond the aortic valve in 5/50 cases (10%). This sleeve of ventricular 
muscle extended for 4.4±1.7 mm (range 3-7 mm) into the aorta. While extensions into 
the pulmonary artery were circumferential, muscular extensions into the aorta primarily 
occured in relation to the left and non-coronary cusp.
CONCLUSIONS: Sleeves of ventricular muscle extend beyond the semilunar valves into the 
aorta and pulmonar artery. The role of these ventricular muscle extensions as the potential 
substrate for idiopathic ventricular tachycardia needs to be clariﬁed by further studies.
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1107-247 The Impact of Catecholamines on the Deﬁbrillation 
Threshold of Patients Receiving Carvedilol
Michael White, Brian F. Mcbride, Danette Guertin, Bokyung Min, Christopher Clyne, 
Jeffrey Kluger, Hartford Hospital, Hartford, CT, University of Connecticut, Storrs, CT
Background: Deﬁbrillation threshold (DFT) is the minimum energy required to 
successfully terminate ventricular ﬁbrillation. In a previous study in patients with an 
implantable cardioverter-deﬁbrillator (ICD), we found that norepinephrine lowered DFT 
regardless of baseline treatment with cardioselective beta-blockers or no beta-blockade 
(BB). Epinephrine reduced the DFT in those receiving cardioselective BB but increased 
it among those without BB. We hypothesized that alpha-1 receptor stimulation decreases 
DFT and attenuates the adverse effect of epinephrine on DFT in beta blocker treated 
patients, but that patients treated by the beta-nonselective and alpha-1 blocker carvedilol 
may respond differently. 
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Methods: In this double-blind study, DFT was determined by step-down method (Baseline 
DFT) and then patients (n=27, 28.7mg of carvedilol/day, 67.3 years, 70.0% male, 19% 
LVEF) were randomized to a seven-minute infusion of norepinephrine (2mcg/min), 
epinephrine (2mcg/min), or placebo. Following study infusion, DFT testing was repeated 
(Experimental DFT). 
Results: Following administration of norepinephrine, epinephrine, or placebo, no 
intragroup or intergroup DFT differences were observed (Table). 
Conclusions: Carvedilol prevents alterations in DFT produced by stress levels of 
catecholamines. This includes negativing the negative effects of epinephrine and positive 
effects of norepinephrine on DFT.
Baseline DFT Experimental DFT Intragroup P-value
Norepinephrine (n=9) 9.4±4.6 11.1±7.8 P=0.589
Epinephrine (n=9) 10.6±5.3 9.8±6.3 P=0.779
Placebo (n=9) 11.1±7.0 8.5±4.2 P=0.349
ANOVA Intergroup P-Value P=0.812 P=0.681
1107-248 Sildenaﬁl Citrate Markedly Increases Deﬁbrillation 
Threshold in Swine
Krekwit Shinlapawittayatorn, Rattapong Sangnoon, Siriporn Chattipakorn, Wanna 
Suriyasataporn, Nipon Chattipakorn, Chiang Mai University, Chiang Mai, Thailand
Background: Sildenaﬁl citrate is commonly used to treat erectile dysfunction. Although 
a growing number of reports have related this drug to the cause of fatal arrhythmia and 
sudden cardiac death, its effect on deﬁbrillation efﬁcacy has not been investigated. The 
aim of the present study was to test the hypothesis that Sildenaﬁl citrate increases the 
shock strength required to successfully deﬁbrillate during ventricular ﬁbrillation (VF). 
Methods and Results: Six pigs (20-30 kg) were used in this study. In each pig, the 
deﬁbrillation thredshold (DFT) was determined at the beginning of the study using a 
three-reversal up/down protocol. Each shock (RV-SVC, biphasic) was delivered after 10 
seconds of VF. After a control DFT was obtained, a solution contained 100 mg Sildenaﬁl 
citrate was injected intravenously at the rate of 2 cc/min over 50 minutes. The DFT (drug-
DFT) was determined again after the drug administration. The drug-DFT (478 + 66 V, 19 
+ 5 J) was signiﬁcantly (P<0.003 and P<0.01 respectively) higher than the control DFT 
(371 + 60 V, 12 + 4 J). There was no signiﬁcant change in the heart rate as well as the 
systolic blood pressure before and after drug infusion. Sildenaﬁl citrate increased the 
DFT ~29 % by leading-edge voltage, and ~58 % by total energy. Conclusion: Sildenaﬁl 
citrate, a cGMP-speciﬁc PDE5 inhibitor, signiﬁcantly increased the DFT. This ﬁnding 
indicates that VF occurring during Sildenaﬁl treatment will require a much stronger shock 
to successfully deﬁbrillate.
1107-249 Inﬂuence of Race and Gender on the Use of Implantable 
Deﬁbrillator Therapy among Medicare Beneﬁciaries
Andre J. Gauri, Andrew Davis, Thomas Hong, Aseem Desai, Martin C. Burke, Bradley P. 
Knight, University of Chicago Hospitals, Chicago, IL
Background: Implantable deﬁbrillator (ICD) is underutilized for the primary prevention 
of sudden cardiac death in patients with an ischemic cardiomyopathy (ICM) despite 
the results of randomized trials that support its use. Other studies have shown that the 
utilization of cardiac procedures is lower in women and black patients. The purpose of this 
study was to determine if there is a gender or racial bias in the use of ICD therapy.
Methods: 1,889,966 Medicare patients hospitalized in the United States during the 
year 2002 with a diagnosis of coronary artery disease, prior myocardial infarction, or 
congestive heart failure were identiﬁed from the Center for Medicare and Medicaid 
Services database. Using combinations of ICD-9-CM codes, patients with an ICM were 
identiﬁed. From this group, patients who underwent ICD implantation during the same 
year were identiﬁed. The demographics of the patients with an ICM were compared to 
those of the ICD recipients.
Results: 132,565 patients (7%) were identiﬁed as having an ICM. 10,370 of these 
potential ICD candidates (8%) underwent ICD implantation. The ICD recipients differed 
signiﬁcantly from the overall group of patients with an ICM on the basis of both gender 
(16% vs. 35%, women; p<0.001) and race (5.5% vs. 8.0%, black; p<0.001).
Conclusions: Women and black patients may be underrepresented in the elderly ICD 
population. Further exploration of gender and racial barriers to appropriate ICD use is 
indicated.
1107-250 Longevity in Octogenarians Following Cardiac 
Resynchronization Therapy: Is it worth it?
Jennifer E. Cummings, John L. Drago, William A. Belden, Patrick J. Tchou, Mina K. 
Chung, Cleveland Clinic Foundation, Cleveland, OH
As indications for device therapies increase and left ventricular lead implantation becomes 
more commonplace, the use of cardiac resynchronization is increasing rapidly. With aging 
of the population, a larger number of patients over the age of 80 are receiving such 
devices.
Methods: After new biventricular device implantation in 630 patients from 2/97-5/04, 
survival status was assessed by the Social Security Death Index. Univariate, multivariate, 
and survival analyses were performed to assess survival and predictors of mortality in 
octogenarians compared to younger patients.
Results: Over a follow-up period of 20.9±15.9 mos, 114 (18.1%) patients died. Patients 
over 80 years of age were lower in weight (72.4±10.4, 83.7±19.2, p<0.001) and had 
shorter procedures. Although mortality was signiﬁcantly associated with higher age, 
median survival in pts ≥80 years was >4 yrs. Interestingly, those patients > 80 years of 
age did not appear to have any additional beneﬁt in survival with the use of a biventricular 
deﬁbrillation device as compared to a biventricular pacing device.
Conclusions: Although older age is signiﬁcantly associated with higher mortality after 
CRT implantation, median survival was over 4 years in patients ≥ 80 years old. Use of 
an internal deﬁbrillator CRT did not appear to improve survival when compared to those 
receiving CRT alone. These ﬁndings support proceeding with CRT implantation with or 
without deﬁbrillation capacity in octogenarians with appropriate indications.
1107-251 Psychosocial Adjustment and Post-Implant Attenuation 
of ICD Preoccupation
Howard S. Farkas, Rena Binter, Julie Schmittdiel, Jane Kruse, Alan H. Kadish, Jeffrey J. 
Goldberger, Northwestern University Feinberg School of Medicine, Chicago, IL
Background: Implantation of an ICD may provoke patient anxiety. One measure of this 
is device preoccupation. The purpose of this study is to determine the time course for 
adjustment to an implanted ICD using preoccupation as the criterion.
Methods: A cross-sectional study of all patients followed in our ICD clinic was done over 
a 12-month period. During routine follow-up appointments, patients rated frequency of 
ICD-related thoughts. Adjustment was deﬁned as less than daily frequency.
Results: 416 patients (329 male, age 62.4 ± 14.8) were interviewed, with a total of 864 
observations. Up to 60 days post-implant, 66% of respondents reported at least daily ICD-
related thoughts (Fig.1). After 2 months, this dropped to 33%, and to 21% after 6 months. 
Beyond 8 months post-implant, fewer than 15% reported thinking about their device daily. 
By ANOVA, there was a signiﬁcant time-related reduction in ICD preoccupation (p<.001) 
with a greater degree of preoccupation in women (p=.02) and patients younger than age 
45 (p=.02).
Conclusion: Adjustment to an ICD normally takes two to six months. Notably, up to 15% 
of ICD patients report persistent ICD preoccupation even beyond the ﬁrst year. In the ﬁrst 
year, males and patients over age 45 adjust better than females and younger patients. 
Information about the normal time course for adjustment to the ICD may allay patient 
anxiety and enhance ICD acceptance. It can also help to identify patients who have 
difﬁculty adjusting and may beneﬁt from more intensive support.
1107-252 Elevated B-type Natriuretic Peptide Is Associated With 
Ventricular Tachyarrhythmic Events Determined By ICD 
Interrogation In Congestive Heart Failure Patients
Roland Klingenberg, Christian Zugck, Ruediger Becker, Dieter Schellberg, Robert 
Kell, Andrew Remppis, Wolfgang Schoels, Thomas J. Dengler, University Hospital 
Heidelberg, Heidelberg, Germany
Background: To evaluate whether B-type natriuretic peptide (NT-proBNP) is associated 
with ventricular tachyarrhythmic events as a surrogate of sudden cardiac death in 
congestive heart failure (CHF) patients and to determine its potential for predicting further 
events.
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Methods: In this retrospective analysis 51 CHF patients (NYHA I-III) with ejection fraction 
< 40% (63% dilated and 37% ischemic cardiomyopathy) and prior ICD-implantation for 
primary or secondary prevention of malignant ventricular tachyarrhythmia presenting to 
our institution from 1995-2002 were analyzed. The main outcome measures were the 
association of NT-proBNP with ventricular tachyarrhythmic events assessed by ICD 
interrogation and tachyarrhythmia-free survival according to NT-proBNP stratiﬁcation.
Results: Ventricular tachyarrhythmia was detected in 33 % of patients at ﬁrst visit. ROC 
analysis for the diagnosis of ventricular tachyarrhythmia was performed, yielding an AUC 
of 0.81 for a NT-proBNP level of 604 ng/l with a sensitivity of 66.7 %, speciﬁcity 91.1 %, 
negative predictive value 0.91 and a positive predictive value of 0.8. ICD interrogation 
was performed at 6 visits (median) during a mean follow-up (SD) of 2.07 (1.66) years. 
Tachyarrhythmia-free survival after one year was signiﬁcantly worse (p = 0.003) in 
patients with elevated NT-proBNP (optimized cut-off level of ≥ 675 ng/l). Univariate 
analysis identiﬁed LVEF (p = 0.002), NT-proBNP (p = 0.007), NHYA class (p = 0.025) 
and NSVT (p = 0.049) as signiﬁcant predictors of ventricular tachyarrhythmia. Multivariate 
pairwise analysis identiﬁed NT-proBNP as an independent predictor of ventricular 
tachyarrhythmia.
Conclusions: Elevated NT-proBNP adequately detects and predicts episodes of 
documented ventricular tachyarrhythmia in CHF patients with an ICD. Prospective 
evaluation of NT-proBNP to identify candidate CHF patients for ICD implantation appears 
appropriate.
1107-270 Successful Reimplantation of Pacemaker/Deﬁbrillator 
Systems following Complete Explantation for Infection
George A. Yesenosky, Sweta Chandela, Aditya Mehra, Scott Sinner, Steven P. Kutalek, 
Drexel University College of Medicine, Philadelphia, PA
BACKGROUND: Speciﬁc guidelines do not exist for managing pacemaker (PM) and 
deﬁbrillator (ICD) system infections, often life threatening. There is no consensus for 
antibiotic duration, value of presenting symptoms, or the role of comorbid conditions.
METHODS: We present our experience with PM/ICD infections with regard to clinical 
presentation, culprit pathogens, effect of comorbidities, and management. Demographics 
and clinical presentation of patients (pts) referred to our center for extraction are also 
reviewed.
RESULTS: Of 250 pts with PM/ICD infections, 241 had extraction of the entire device 
system (8 retained remnants, one with epicardial leads). There were 186 males. Device 
infection from implant occurred Early (0-28 days) =6%, Late (29-364 days) =22%, or 
Delayed (>365 days) =72%. Surgical device manipulation after ﬁrst implant occurred in 
95 pts. Comorbidity included diabetes - 84; dialysis - 19; ethanol abuse - 9; systemic 
steroids - 9; and IV drug abuse - 1. Systemic signs included fever/chills - 102; septic 
shock - 17; and lead vegetation - 59. Local signs included skin erosion - 95; pain - 78; 
erythema - 87; and pocket swelling - 89. Cultures were positive in blood in 112 pts and 
in wounds in 161 pts.
The most common organism was Staphylococcus in blood ( 35%) and wounds (59%). 
Enterococcus, Candida, Group B Streptococci, Eschrichia coli, Pseudomonas, 
Micrococcus, Mycobacterium, and polymicrobials infected 8% of blood cultures. 
Polymicrobials (15%), Propioibacterium, Pseudomonas, Enterococcus, Micrococcus, 
Eschrichia coli, Proteus, and Klebsiella (each < 3%) infected wounds. Citrobacter, 
Peptostreptomagnus, Enterobacter, Mycobacterium, Serratia and Streptococcus infected 
3% of wounds. The most common antibiotics were vancomycin and cephalosporins.
Treatment included contralateral reimplantation, after clearing blood cultures and 
vegetations, and IV antibiotics through reimplant; reinfection rate was < 1%.
CONCLUSIONS: Reimplantation of PM/ICDs following local or systemic infection is highly 
successful, with minimal recurrence, using aggressive complete system explant and IV 
antibiotics. Comorbidities have no adverse effect on long-term prognosis.
1107-271 Lower Current Density Ventricular Deﬁbrillation 
Thresholds With Dual Pathway Rectilinear Biphasic 
Shocks
Mark J. Niebauer, John Lof, Elizabeth Stolze, Sherry Westphal, Gretchen Andersen, 
Allen Missoi, Mike Petrocchi, James Brewer, University of Nebraska Medical Center, 
Omaha, NE
External ventricular deﬁbrillation using the rectilinear biphasic waveform (RBW) is 
effective, and requires less energy than the monophasic damped sine waveform (DSW). 
Earlier studies found that two dual pathway (DP), shocks using the DSW, improved 
deﬁbrillation effectiveness compared to single pathway shocks. Shocks delivered to the 
heart using 2 orthogonally positioned electrodes could more effectively stimulate a larger 
amount of the ventricle, since stimulation thresholds are lower for electric ﬁelds oriented 
in the long axis of the myocyte compared to the short axis. 
Methods: Using 12 anesthetized pigs, 34.7± 2.3 kg, we tested the single RBW and 
4 different DP-RBW positions for deﬁbrillation efﬁcacy, with DP shocks delivered both 
simultaneously (Sim) and sequentially (Seq). We used a “3-reversal” deﬁbrillation 
threshold value, calculated from the average of 4 shock values above and below the point 
of success. The threshold energies and the calculated intrathoracic current densities (CD) 
were obtained for each of the shock positions. The results were compared to the single 
anterior-posterior RBW shock using the paired t-test. 
Results: See means and SD in Table where * p< 0.05. 
Conclusion: While total selected energies at threshold from DP-RBW shocks are not 
signiﬁcantly different from the single pathway RBW shock, we found that the CD of the 
DP-RBW shocks in position 3 and the sequentially delivered shocks in Positions 1 and 2 
were signiﬁcantly lower than the single RBW shock vector.
 
Single RBW Position 1 Position 2 Position 3 Position 4
Energy Sim (J) 56.6 ± 19.3 71.5 ± 27.8 73.4 ± 34.0 48.1 ± 24.7 74.4 ± 22.1
Energy Seq (J) ------------------ 53.8 ± 26. 54.2 ± 19.0 53.1 ± 19.3 67.8 ± 20.4
CD Sim (mA/cm2) 94.3 ± 17.7 68.8 ± 16.8 70.4 ± 22.1 59.0 ± 15.2* 71.8 ± 11.2
CD Seq (mA/cm2) ------------------ 60.1 ±15.9* 63.8 ±12.5* 62.8 ± 10.0* 68.6 ± 11.3
1107-272 Adoption of MADIT II Guidelines by Private Health 
Insurers
Kenneth Martin Stein, Julio A. Casillas, Weill Medical College of Cornell University, New 
York, NY, Guidant CRM, Saint Paul, MN
Background: In March 2002, the MADIT II trial was published, showing a statistically 
signiﬁcant survival beneﬁt to prophylactic ICD implantation in pts with an EF < 30% after 
myocardial infarction. In August 2003, CMS issued a National Coverage Decision (NCD) 
including MADIT II criteria albeit with an additional requirement that patients have a QRS 
width > 120 ms. The present study was designed to examine the guidelines that large 
private health insurers use when considering coverage for MADIT II indications.
Methods: We surveyed 11 large national and regional private payer groups to identify 
speciﬁc coverage guidelines for MADIT II, how guidelines or policies were set, and what 
speciﬁc or clinical resources payers relied upon to set them. 
Results: The 11 private groups represent 152 plans covering approximately 152 million 
lives. All plans surveyed indicated adoption of some degree of coverage for MADIT II 
indications, but only 43% of plans published their guidelines. 143/152 plans representing 
147 million lives indicated that they would cover prophylactic ICD implantation for pts with 
EF < 30% following myocardial infarction. Only 9/152 plans (6%), covering 5.2 million lives 
(3% of covered lives) added a CMS-type QRS restriction to their coverage policy. No plan 
that had previously published a MADIT II coverage policy that reﬂected clinical indications, 
restricted coverage following publication of the CMS NCD. Finally, in contrast to CMS, 
many private payers assert that they will consider expanded coverage based on medical 
necessity on an individual basis, regardless of inﬂuencing standards, to allow providers 
the clinical discretion to treat patients.
Conclusion: The private insurance market has adopted MADIT II clinical guidelines 
widely. In this context, the CMS NCD had limited inﬂuence on private payer coverage 
determinations. The wide discrepancy between private and government payment 
policies for prophylactic ICD implantation raises the concern that patients and implanting 
physicians in the US must now contend with a de facto “two-tier” system when considering 
prophylactic ICD implantation.
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1108-267 Maintenance of Sinus Rhythm in Patients With Atrial 
Fibrillation Following Electrical Cardioversion Is 
Related to Reverse Electrical Remodeling of the Atrium
Nagib T. Chalfoun, David Harnick, Davendra Mehta, Elena Pe, J. Anthony Gomes, Mount 
Sinai Medical Center, New York, NY
BACKGROUND: The signal-averaged ECG of the P wave (SAPW), which is a measure 
of intra-atrial conduction, has been shown to be a non-invasive marker of the risk of 
developing atrial ﬁbrillation (AF). We hypothesized that 1) atrial electrical reverse 
remodeling (AERM) occurs in patients who maintain sinus rhythm post cardioversion 
(CV) for persistent AF and 2) that AERM can be measured by changes in the SAPW 
parameters.
METHODS: To test this hypothesis, we prospectively enrolled 59 patients with persistent 
AF. SAPW parameters, including duration, root mean square voltage of the last 20/30/40 
milliseconds, and total integral of the p wave were measured the day of CV if the 
patient was successfully cardioverted to SR, and repeated at 1 month in those who 
maintained SR. These SAPW parameters were compared to other baseline indices for 
the recurrence of AF, including age, gender, left ventricular function, AF duration, left 
ventricular hypertrophy, hypertension, history of myocardial infarction, diabetes, alcohol, 
hyperthyroidism, history of chest surgery, atrial size, presence at least moderate mitral 
valvular disease, and antiarrhythmic therapy post CV.
RESULTS: 55 patients had successful CV; 29% females, 71% males. Mean age was 
61 + 13 years. At 1 month, 18 (33%) maintained SR, whereas 37 (67%) returned to AF. 
The SAPW duration decreased signiﬁcantly in those that remained in SR (159 ms + 19 
to 147 ms + 19; p<0.0001). Of the parameters tested, only the duration of AF (p=0.04) 
and presence of left ventricular hypertrophy (p=0.0003) were signiﬁcantly different in the 
patients who maintained SR versus those who reverted back to AF.
CONCLUSIONS: 1) This is the ﬁrst non-invasive study that documents atrial electrical 
reverse remodeling in patients with atrial ﬁbrillation who maintain sinus rhythm post 
cardioversion utilizing the SAPW. 2) Atrial electrical reverse remodeling is inversely 
related to the duration of atrial ﬁbrillation and the presence of left ventricular hypertrophy.
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1108-268 The Effect of ACE Inhibitors on Atrial Electrical 
Remodeling in Patients With Congestive Heart Failure
Shunsuke Tamaki, Naoyuki Misaki, Takahisa Yamada, Mitsutoshi Asai, Nobuhiko Makino, 
Hidetaka Kioka, Yasumasa Tsukamoto, Fumihiko Sano, Masaharu Masuda, Takaki 
Matsumoto, Masatake Fukunami, Osaka General Medical Center, Osaka, Japan
Background: Recent studies have shown that ACE inhibitors(ACEi) could reduce the 
risk of development of atrial ﬁbrillation(AF) in patients with congestive heart failure(CHF). 
We sought to elucidate the electrophysiological mechanism from a viewpoint of atrial 
electrical remodeling, by use of P-wave signal-averaged ECG(P-SAE).
Methods: We studied 63 CHF patients in sinus rhythm without a history of AF, whose 
radionuclide left ventricular ejection fraction was < 40%. P-SAE was repeated before and 
three years after the entry, to measure the total ﬁltered P wave duration(Ad) which might 
reﬂect the extent of ﬁbrosis as previously reported.
Results: There were no differences in age, gender, left atrial dimension, or ejection 
fraction between patients with and without ACEi. At the entry, there was no signiﬁcant 
difference in Ad between patients with and without ACEi(136.9±12.0 vs. 140.8±10.7 ms). 
However, three years after the entry, Ad in the patients with ACEi was signiﬁcantly shorter 
than that of without(138.4±11.6 vs. 146.0±13.8 ms, P = 0.04). Ad prolonged signiﬁcantly 
in the patients without ACEi(P = 0.04) but not in with ACEi. Incidentally, AF developed less 
frequently with than without ACEi during the follow-up period (8.5% vs. 25%, P = 0.077 
by log-rank test).
Conclusion: Our data showed that ACEi could inhibit the prolongation of Ad. These 
results suggest that ACEi could possibly attenuate atrial remodeling(ﬁbrosis) leading to 
AF substrate, resulting in suppression of the AF development in CHF. 
1108-269 Are Certain P Wave Abnormalities More Predictive of 
Cardiovascular or Pulmonary Causes of Death in Men?
Amir Kaykha, Kenneth Desser, Jonathan Myers, Gregory Engel, Afshin Ghayoumi, 
Victor Froelicher, Stanford University/VA Palo Alto Health Care System, Palo Alto, CA, 
Banner Good Samaritan Medical Center/Carl T Hayden VA Medical Center, Phoenix, AZ
Background: While certain P wave morphologies have been associated with pulmonary 
disease (P-pulmonale) and atrial size (left atrial abnormality or P-mitrale), their 
relationship to speciﬁc cause of death has not been reported. Our objective was to 
evaluate the prognostic value of P wave morphology as a predictor of cardiovascular (CV) 
and pulmonary causes of death.
Methods: Analyses were performed on the ﬁrst ECG digitally recorded on 46,917 
consecutive patients at the Palo Alto Veterans Affairs Medical Center since 1987. Females 
and ECGs exhibiting paced rhythms, Wolf-Parkinson-White syndrome, atrial ﬁbrillation 
and those in which the computer algorithm failed to detect the P wave were excluded, 
leaving 40,021 patients, with a mean age of 56 years. Using computerized algorithms, 
P wave amplitude in the inferior leads and P wave duration in 12 leads were measured. 
Left atrial abnormality and right atrial abnormality were deﬁned by standardized computer 
criteria. The main outcome measures were pulmonary and CV mortality.
Results: During a mean follow-up of 6 years there were 3,421 CV and 1,217 pulmonary 
deaths. After adjusting for age and heart rate in a Cox regression model, P wave amplitude 
in the inferior leads was the strongest predictor of pulmonary death [Hazard Ratio 3.1, CI 
2.3-4.0, p<0.0001 for an amplitude more than 2.5mm], outperforming all other ECG criteria 
for right atrial abnormality and right ventricular hypertrophy. However, P wave duration was 
inversely associated with pulmonary death. Conversely, P wave duration and the depth of P 
wave inversion in leads V1 and V2 were the strongest predictors of CV death [Hazard Ratio 
1.9, CI 1.6-2.3, p<0.0001; for a P wave inversion deeper than 1 mm].
Conclusion: P wave amplitude is directly associated with pulmonary death but inversely 
associated with CV death while the converse is true for P wave duration. P wave amplitude 
in the inferior leads is the strongest independent predictor of pulmonary death while P 
wave duration signiﬁcantly predicts CV death.
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830-3 Combined Electroanatomic and Non-contact Mapping 
to Identify Fixed and Functional Conduction Block after 
the Atriopulmonary Fontan Procedure.
Dominic J. Abrams, Mark J. Earley, Simon C. Sporton, Michael A. Gatzoulis, Michael 
J. Mullen, Janice A. Till, Saemus Cullen, John E. Deanﬁeld, Richard J. Schilling, St. 
Bartholomew’s Hospital, London, United Kingdom
Background: It has been proposed that atrial arrhythmia after the atriopulmonary 
Fontan (APF) procedure relates to ﬁxed anatomical barriers and/or scar, suggesting that 
an empiric ablation strategy may be possible. We proposed that functional block may also 
play an important role in these arrhythmias and may relate to atrial structure and patient 
characteristics.
Methods: We studied 10 pts (4M, 6F) aged 27.3 ± 10.9 yrs (range 16-44) who had 
undergone APF at 9.9 ± 7.6 yrs. All had sustained or recurrent arrhythmia for 5.0 ± 4.0 
yrs. Scar was 19.9 ± 9.9% of recorded contact points, and atrial volume 202 ± 105 mls. EP 
studies were performed using simultaneous electroanatomic and non-contact mapping 
during sinus rhythm, atrial pacing at up to 6 sites, and atrial arrhythmia to identify ﬁxed 
and functional conduction block, deﬁned as a delay in wave front progression of >50ms, 
the presence of widely split potentials (>50ms) or cessation of wave front progression. 
Scar was deﬁned as contact electrogram voltage <0.05mV. Fixed conduction block was 
present during all rhythms, whereas functional block was dependent on atrial cycle length 
and activation sequence. Results are expressed as mean ± SD.
Results: Twenty two arrhythmias were identiﬁed of cycle length (CL) 358 ± 117ms, 
which were macro-reentry (18), focal (3) and left atrial (1). Of the macro-reentrant circuits, 
5 (26%) had evidence of functional block critical to arrhythmia maintenance, all at the 
putative position of the crista terminalis (CT), whereas 13 were dependent on ﬁxed 
block - anterior wall scar (5), lateral wall scar (3), right AV valve patch (3), CT (2). No 
focal arrhythmia was successfully entrained. CL of circuits with functional block (267 ± 
43ms) was signiﬁcantly shorter than those without (384 ± 119ms) (p 0.005). Eight lines of 
functional block not maintaining circuits were seen at cristal (1) and non-cristal (7) sites. 
Functional circuits were associated with a smaller scar area (p 0.025), but not with age, 
age at APF or arrhythmia duration.
Conclusion: The crista terminalis is fundamental to the maintenance of certain macro-
reentrant arrhythmias post APF. Speciﬁc ablative strategies which target this area may 
improve outcome in the long-term.
4:15 p.m.
830-4 Focal Patterns of Activation in Patients with Atrial 
Tachycardias and Surgically Corrected Congenital Heart 
Disease.
Natasja M. de Groot, Nico Blom, Wing King Chan, Ernst E. van der Wall, Martin Schalij, 
Leiden University Medical Center, Leiden, The Netherlands
Atrial tachycardias (AT) in pts with surgically corrected congenital heart disease (CHD) are 
often atrial ﬂutter (AFL) or intra-atrial reentrant tachycardias (IART) with complex reentrant 
circuits embedded within areas of scar tissue. This study was aimed at characterising the 
underlying mechanisms of AT’s in pts with surgically corrected CHD.
Methods: Mapping studies were performed in pts (n= 20, 28±9 yrs) with CHD and drug-
refractory AT referred for catheter ablation. Extensive 3-D electro-anatomical mapping 
was performed during AT prior to ablation to 1) identify the underlying mechanism of the 
AT and 2) select target sites for ablation. Activation maps of the right atrium demonstrating 
a single (counter)-clockwise, cavo-tricuspid isthmus dependent macro-reentry circuit 
were labelled as typical atrial ﬂutter (AFL). All other atrial macro-reentrant tachycardias 
were classiﬁed as scar-related AT (s-ART). Activation maps characterized by a radially 
spreading wavefront arising from one single site were deﬁned as a focal atrial tachycardia 
(FAT). Successful ablation was deﬁned as termination during ablation (IART and FAT) or 
the assessment of a bi-directional conduction block (AFL).
Results: Underlying CHD is transposition of the great arteries (n=9), tricuspid atresia 
(n=8) or both (n=3). Mapping revealed 35 different AT’s including not only AFL (n=6, CL 
257±36 ms) and s-ART (n=24, CL 289±74 ms) but also focal atrial tachycardia (FAT, n=5, 
CL 394±100 ms). FAT originated from the isthmus (n=1), superior part of the septum, 
high (n=2) and lower part of the antero-lateral wall (n=2). Fragmented electrograms were 
recorded at the site of origin of all FAT. Ablation of IART was successful in 66% of the pts 
and in all pts with AFL and FAT.
Conclusion: Underlying mechanism of AT in pts with surgically corrected CHD included 
not only macro-reentry giving rise to s-ART or AFL, but also focal activity. These focal 
patterns of activation can be the result of micro-reentry, triggered activity or enhanced 
automaticity.
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4:30 p.m.
830-5 Spontaneous Termination Occurs In The Low Voltage 
Zone Produced By Pilsicainide -Analysis Of A Safety 
Factor Of Atrial Flutter
Kikuya Uno, Toru Iwa, Isao Kato, Yasushi Suzuki, Motoyuki Fukuta, Yasushi Wakita, 
Takayuki Ito, Kazuaki Shimamoto, Sapporo Medical University, Sapporo, Japan, Aichi 
Medical College, Aichi, Japan
Background: Few analyses of the effects of antiarrhythmic agents on atrial ﬂutter have 
been reported using noncontact mapping to analyze low voltage zones (LVZ), conduction 
velocity (CV) and block lines. The aim of the study was to explore the role and relationship 
of the dynamic LVZ, CV and BL in the spontaneous termination of atrial ﬂutter by the pure 
sodium channel blocker, pilsicainide by analysis with noncontact dynamic isopotential 
mapping (DIP-map). 
Methods: A right atrial (RA) incision was produced and placed on RA free wall in nine 
canines weighing 25-37 kg. Bipolar pacing needle-pairs were placed on three sites of RA. 
A 9F noncontact multielectrode array catheter was deployed in RA via the femoral vein. 
Raw data were recorded during sinus rhythm, rapid atrial pacing and induced atrial ﬂutter, 
and were superimposed onto the virtual 3-dimension-RA endocardium. Threshold of LVZ 
was set at 30% of the major peak negative (MPN) amplitude of RA. We analyzed LVZ, CV 
and block lines in DIP-map from the virtual electrograms. After inducing sustained stable 
atrial ﬂutter, pilsicainide was administered intravenously (5-30mg, 5mg/5min). Then, 
spontaneous termination was obtained during data sampling. Relationship between LVZ, 
CV and block lines was also analyzed with the atrial MPN from the DIP-map and virtual 
electrograms. 
Results: 1) Twenty-one episodes of atrial ﬂutter were induced in 9 canines. 2) The cycle 
length of atrial ﬂutter signiﬁcantly prolonged from 163+/-19 to 214+/-12 ms (p<0.05). 3) 
The CV in the LVZ signiﬁcantly changed before and after the PLS (1.6+/-0.6, 2.4+/-0.6 
m/s, p<0.05). 4) The extent of the LVZ dynamically enlarged from 13.4+/-1.6 to 25.4+/-
2.3 cm2 (p<0.05) after pilsicainide. 5) The LVZ enlarged with the BL and was functionally 
prolonged by the PLS. 6) Spontaneous termination occurred in the LVZ with a prolonged 
CV. 7) Dynamic MPN progressed into the LVZ and conducted decrementally, and 8) 
termination was observed in the area of LVZ. 
Conclusion: 1) PLS dynamically increased the extent of the LVZ, increasing the length 
of the block line and the delay of CV. 2) The decremental conduction in LVZ can be the 
crucial factor for atrial ﬂutter termination.
4:45 p.m.
830-6 Results from Electrophysiological and Pharmacological 
Assessments Suggest Concealed Atrio-Hisian Fibers 
Constitute Retrograde Limbs in Reentrant Circuits 
of Slow-Fast Type Atrioventricular Nodal Reentrant 
Tachycardias in One-third of Patients
Kiyoshi Otomo, Kazuhiro Suyama, Takashi Noda, Eiichiro Nakagawa, Kazuhiro 
Satomi, Wataru Shimizu, Takashi Kurita, Naohiko Aihara, Shiro Kamakura, National 
Cardiovascular Center, Suita City, Japan, Tokyo Medical and Dental University, Tokyo, 
Japan
Backgrounds: Some of the retrograde fast pathways (rFPs) in slow-fast type AV nodal 
reentrant tachycardias (AVNRTs) have been reported to exhibit little decremental property 
with short VA conduction time and high 2:1 VA block (VAB) rate and to be resistant to 
agents that suppress AV nodal conduction. The mechanisms for these “Kent bundle-like 
behaviors”of rFPs, however, have not been clearly elucidated.
Purposes: To characterize rFPs both electrophysiologically and pharmacologically and 
to elucidate the mechanisms by which rFPs behave like Kent bundles.
Methods & Results: Seventy-four patients with AVNRT were classiﬁed into 2 groups 
according to the responses of rFP conductions to boluses of 20mg of adenosine 
triphosphate (ATP) into inferior vena cava during RV pacing (100-120ppm); ATP-S (47 
patients, 63.5%): VAB and ATP-R (27 patients, 36.5%): no VAB. During incremental 
pacing from RV, all patients in ATP-R showed ﬁxed HA intervals at all paced cycle 
lengths upto development of 2:1 VAB, while ATP-S patients showed a little decremental 
property with prolongation in HA intervals at shorter paced cycle length (increments of HA 
intervals; ATP-R: 2±2ms vs ATP-S: 35±33ms, p<0.05). HA intervals were also measured 
during AVNRT (HAt) and entrainment from paraHisian RV without direct His bundle 
capture (HAe). It has been postulated that HAt would be the difference in conduction 
times between rFP (y) and lower common pathway (x) (HAt=y-x), whereas HAe would 
be the sum of them (HAe=y+x). Hence, x=(HAe-HAt)/2. x of >0 would suggest presence 
of lower common pathway between lower turnaround and His bundle, whereas x of <0 
would suggest absense of lower common pathway and the participation of concealed 
atrio-Hisian ﬁber as retrograde limb of reentrant circuit. As a result, x was signiﬁcantly less 
in ATP-R than in ATP-S (-6±5 vs 4±4ms, p<0.05) and was <0 in 23 patients (85%) of ATP-
R. Among 25 patients with x<0, 23 patients (92%) were classiﬁed into ATP-R.
Conclusions In one-third of AVNRTs, rFPs were shown to originate from His bundles 
and exhibit non-decremental property with resistance to ATP, suggesting that these rFPs 
might consist of concealed atrio-Hisian ﬁbers totally bypassing AV nodes.
5:00 p.m.
830-7 Evidence of Mechanoelectric Feedback in the Atria 
of Patients With Atrioventricular Nodal Reentrant 
Tachycardia
Emmanuel G. Manios, Emmanuel M. Kanoupakis, Hercules E. Mavrakis, Ioannis 
K. Karalis, Dimitris A. Arfanakis, Eleftherios Kallergis, Panos E. Vardas, Heraklion 
University Hospital, Heraklion, Greece
Background: AV nodal reentrant tachycardia (AVNRT) could serve as a clinical model to 
study the effects of mechanical stretch on the electrical properties of the human atrium.
Methods: We assessed 11 consecutive pts with AVNRT, admitted for RF ablation, atrial 
pressure (Pa) and atrial refractoriness (AERP) at right atrial appendage and lateral wall 
during atrial pacing at 3 basic cycle lengths (600, 500, 400 ms) and after 2 min of pacing 
at the cycle length of tachycardia. Measurements were repeated from the same position, 
after ventricular pacing and after 2 min of tachycardia.
Results: Peak, mean and minimal Pa increased from 6,2,0 mmHg at baseline to 9,5,2 
mmHg during atrial pacing at the cycle length of tachycardia. During ventricular pacing the 
Pa were 16,10,1 mmHg respectively and remained substantially unchanged when AVNRT 
was induced. A signiﬁcant reduction in AERP was observed during ventricular pacing 
compared with baseline values (table 1). Two mins of spontaneous AVNRT changed the 
AERP to values signiﬁcantly lower than those during atrial pacing at the cycle length of 
tachycardia at both sites (from 216±13 to 194±16ms, and from 212±15 to 192±17ms, 
p=0.004 and p=0.004, at the appendage and the lateral wall respectively).
Conclusions: AVNRT and ventricular pacing signiﬁcantly increase Pa and subsequently shorten 
AERP and increase its dispersion. These ﬁndings provide evidence that mechanoelectrical 
feedback plays an important role in the occurrence of reentrant atrial arrhythmias.
Table 1 
RA appendage RA lateral wall
600 ms 500 ms 400 ms 600 ms 500 ms 400 ms
Baseline 228±22 224±23 218±24 217±21 211±24 209±23
V pacing 212±31 207±28 192±26 208±25 198±21 190±24
p 0.046 0.01 0.039 0.042 0.045 0.043
5:15 p.m.
830-8 Prophylactic Catheter Ablation Reduces the Risk of 
Ventricular Fibrillation As First Clinical Presentation In 
The Asymptomatic WPW Syndrome
Carlo Pappone, Francesco Manguso, Giuseppe Augello, Amedeo Ferro, Gabriele 
Paglino, Gabriele Vicedomini, Nicoleta Sora, Vincenzo Santinelli, San Raffaele 
University Hospital, Milan, Italy
Background - Ventricular ﬁbrillation (VF) may be the ﬁrst clinical arrhythmia among 
asymptomatic WPW subjects.
Methods - We pooled data from our 3 recent studies in JACC and NEJM. In all studies, 
patients underwent an electrophysiologic testing for risk stratiﬁcation. In the JACC study 
47 high-risk subjects were identiﬁed; in the 2 NEJM trials, 119 high risk subjects were 
randomized to catheter ablation or no treatment.
Results -Ventricular ﬁbrillation occurred in 7 subjects (4%), all among high risk non-
ablated subjects (Figure). The characteristics of these subjects are reported in Table.
Conclusions - Asymptomatic WPW is not too benign, as previously thought. Prophylactic 
ablation among high-risk asymptomatic patients should be considered mandatory to 
prevent sudden death.
Patients with VF 
Variable Patient #1 Patient #2 Patient #3 Patient #4 Patient #5 Patient #6 Patient #7
Age (yr) 25 21 22 22 10 8 12
Male sex M F M M M M M
Structural heart disease no no no no no no no
APERP (ms) 250 230 220 220 210 220 210
Multiple AP yes yes yes yes yes yes yes
Inducibility yes yes yes yes yes yes yes
AVRT triggering AF yes yes yes yes yes yes yes
AVRT cycle (ms) 250 260 250 240 220 230 220
SPRR during sustained 
AF (ms) 230 230 220 200 200 190 200
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838FO  Featured Oral Session... Ablation  
of Atrial Fibrillation: Avoiding 
Esophageal Injury
Tuesday, March 08, 2005, 8:30 a.m.-10:00 a.m.
Orange County Convention Center, Room 232A
8:45 a.m.
838-4 Assessment Of The Highly Variable Course Of The 
Esophagus And Its Proximity To The Left Atrial 
Endocardium by 3D CT Scan
Jennifer E. Cummings, Nassir F. Marrouche, Robert Schweikert, Walid Saliba, Atul 
Verma, Fethi Kilicaslan, J. David Burkhardt, William A. Belden, David O. Martin, 
Oussama Wazni, Dhanumjaya Lakkireddy, Andrea Natale, The Cleveland Clinic 
Foundation, Cleveland, OH
Background: Left atrial-esophageal ﬁstula remains one of the most devastating and fatal 
complications of atrial ﬁbrillation ablation. There is no standard approach to identifying 
esophagus (Eso) location prior to ablation. 
Objective: To evaluate and compare different modalities for determining anatomical 
variation and proximity of Eso to the posterior wall of the left atrium (LA) 
Methods: Cardiac CT images in ﬁfty patients presenting for pulmonary vein antrum 
isolation (PVAI) were reviewed. The closest distance between the LA endocardial surface 
and Eso lumen was measured in each patient. The location of this closest approximation 
was categorized in location as right-inferior, right-superior, mid-inferior (between the 
right and left inferior antrums), left-inferior, and left superior. In 7 patients an esophageal 
electrode was placed at initiation of the procedure and a 3-D mapping and navigation 
(NAVX) was used to identify the course of the Eso during electrode pullback. 
Results: Thirty-eight of the 50 patients were male. Mean ejection fraction was 0.52±0.8 
and age was 48.3±24 years. The area of closest LA-Eso contact was dermined to be in 
the right inferior PV antrum in 10(20%), right superior in 1(2%), mid-inferior in 19(38%), 
left superior in 5(10%), and left inferior in 15 (30%) patients. The mean distance at closest 
approximation between LA endocardium and the ESO lumen was 4.4mm±1.2mm. Three 
patients had a LA-Eso distance of 2.8mm. In patients where NAVX was used, the Eso 
course was consistent with that documented on the 3-D CT scan in all patients. 
Conclusions: There is a signiﬁcant variability in the location of closest LA-Eso contact. 
These locations can be close to the PV antral regions. The area of closest contact between 
the LA and Eso may be <3mm. 3D NAVX mapping can be readily used to document 
the course of the Eso in relationship to the LA. Integration of 3D-CT scans into maping 
systems may be a reliable tool in identifying areas of increased risk for LA-Eso perforation 
during RF applications.
9:00 a.m.
838-5 Avoiding Esophageal Injury With Power Titrating During 
Left Atrial Ablation for Atrial Fibrillation: An Intracardiac 
Echocardiographic Imaging Study
Jian-Fang Ren, David J. Callans, Francis E. Marchlinski, Hemal Nayak, David Lin, 
Edward P. Gerstenfeld, University of Pennsylvania, Philadelphia, PA
Injury to esophagus (Eso) has occurred during left atrial (LA) ablation for atrial ﬁbrillation 
(AF) since the LA posterior wall (PW) is immediately contiguous to Eso wall (LAPW-
Eso). The aim of this study is to evaluate lesion morphologic and wall thickness changes 
with radiofrequency (RF) delivered at LAPW-Eso wall using AcuNav intracardiac 
echocardiography (ICE). Methods and Results: ICE was performed in 42 patients (age 
56±12 years, 33 men) with AF undergoing RF LA pulmonary vein (PV) electric isolation 
using 8mm electrode (70W, up to 50-52°C, 60sec) or Chili catheter (up to 40°C, 60sec). 
With ICE transducer placed in the right atrium and scanning between the lower right 
and left PV ostia, a longitudinal imaging view of the LAPW-Eso region was obtained in 
all patients. There was 4.3±3.2 lesions/patient delivered to this region during RF at PW 
around the lower/middle right and lower left PV ostia. The RF lesion morphologic changes 
were observed with wall swelling, dimpling, crater or echogenic enhancement. The LAPW-
Eso wall thickness and changes in echogenic lesion thickness were measured Pre- and 
Post-RF lesions under routine circumstance (n=44) and during RF power titration (PT, 
n=29) using ICE monitoring (Table). Conclusions: RF lesions with 8mm electrode or chili 
catheter delivered at LAPW-Eso wall induced echogenic lesion morphologic changes 
involving Eso anterior wall. Echogenic lesion morphologic changes may be controlled and 
limited within LAPW with power titrating under ICE lesion monitoring.
LAPW-Eso Wall
Echogenic 
wall thickness 
Post-RF
Echogenic wall 
thickness Post-RF PT
Mean±SD(mm) 6.1±0.9 10.8±2.2 4.8±1.5*
Range (mm) 5.0-8.5 7.0-15.0 3.0-8.3
*p<0.01:vs. Post-RF
 
9:15 a.m.
838-6 Computerized Tomographic Analysis of the Anatomy 
of the Left Atrium and the Esophagus: Implications for 
Left Atrial Catheter Ablation
Kristina Lemola, Michael Schneider, Benoit Desjardins, Ian Case, Jihn Han, Eric Good, 
Kamala Tamirisa, Ariane Tsemo, Aman Chugh, Frank Bogun, Frank Pelosi, Jr., Ella 
Kazerooni, Fred Morady, Hakan Oral, University of Michigan, Ann Arbor, MI
Background: During left atrial catheter ablation, an atrio-esophageal ﬁstula can develop 
due to thermal injury of the esophagus during ablation along the posterior left atrium 
(LA). No in vivo studies have examined the relationship of the esophagus to the LA. The 
purpose of this study was to describe the topographical anatomy of the esophagus and 
the posterior LA using computerized tomography (CT).
Methods: A spiral CT of the chest with 3-D reconstruction was performed in 50 patients 
(mean age = 54 ± 11 years) with atrial ﬁbrillation (AF) prior to an ablation procedure. 
Consecutive axial and sagital sections of the CT scan were examined to determine the 
relationship, size and thickness of the tissue layers between the LA and the esophagus.
Results: The mean length and width of the esophagus in contact with the posterior LA 
were 58 ± 14 mm, and 13 ± 6 mm, respectively. The esophagus had a variable course 
along the posterior LA. The esophagus was close (10 ± 6 mm from the ostia) and parallel 
to the left-sided pulmonary veins (PVs) in 56% of patients and had an oblique course 
from the left superior PV to the right inferior PV in 36% of patients. The mean thickness 
of the posterior LA and anterior esophageal walls were 2.2 ± 0.9 mm, and 3.6 ± 1.7 mm, 
respectively. In 98% of patients, there was a fat layer between the esophagus and the 
posterior LA. However, this layer often was discontinuous.
Conclusions: The esophagus and posterior LA wall are in close contact over a large 
area that may often lie within the AF ablation zone, and there is marked variation in the 
anatomical relationship of the esophagus and the posterior LA. Both the esophageal and 
atrial walls are quite thin. However, a layer of adipose tissue may serve to insulate the 
esophagus from thermal injury, explaining why atrio-esophageal ﬁstulas are rare.
9:30 a.m.
838-7 Esophageal Imaging Characteristics and Structural 
Measurement During Left Atrial Ablation for Atrial 
Fibrillation: An Intracardiac Echocardiographic Study
Jian-Fang Ren, Francis E. Marchlinski, David J. Callans, University of Pennsylvania, 
Philadelphia, PA
The esophagus (Eso) is immediately contiguous to the left atrial (LA) posterior wall (PW). 
Eso injury has been noted with inadvertent LA ablation for atrial ﬁbrillation (AF). The aim 
of this study is to conﬁrm Eso imaging features and quantify the Eso region contiguous to 
the LAPW (Eso-LAPW) using AcuNav intracardiac echocardiography (ICE). Methods and 
Results: We studied Eso imaging and measured Eso-LAPW structures using ICE in 42 
patients (age 56±12 years, 33 men) with AF undergoing LA ablation. With ICE transducer 
placed in the right atrium and scanning between the lower right and left pulmonary vein 
ostia, a longitudinal imaging view of the Eso-LAPW region was obtained in all patients. A 
variety of Eso imaging features including gas, ﬂuid-ﬁlled, movement within its segments, 
or collapsed lumen was identiﬁed with real-time ICE imaging during ablation procedure. 
Eso ﬂuid-ﬁlled, movement or saliva swallowing, all enhanced the Eso imaging. In all fasted 
patients, Eso gas caused signiﬁcant scattering of the ultrasonic beam, thus temporarily/
partially obscuring its deeper structure- the Eso PW in 25% patients. The Eso-LAPW 
length, Eso diameter and anterior wall, LAPW and LA diameter were measured with ICE 
imaging (Table). The Eso-LAPW length correlated to the LA diameter (r=0.78, p<0.01). 
Conclusions: Eso and Eso-LAPW region can be easily identiﬁed with ICE imaging. Real-
time ICE imaging of Eso-LAPW region may provide an important monitoring for avoiding 
inadvertent Eso injury during LA ablation.
(mm) Eso-LAPW length Eso diameter Eso wall LAPW LA diameter
Mean±SD(mm) 26.5±6.5 16.6±3.2 3.4±0.5 2.7±0.5 48±5
Range (mm) 15.0-47.0 9.0-22.0 2.5-4.5 2.0-4.0 38-63
9:45 a.m.
838-8 Esophageal Temperature Monitoring During Left Atrial 
Catheter Ablation for Atrial Fibrillation
David Cesario, Kalyanam Shivkumar, Miguel Valderrabano, Isaac Wiener, Charles 
Swerdlow, UCLA Medical Center, Los Angeles, CA, Cedars Sinai Medical Center, Los 
Angeles, CA
Background: Left atrial (LA) - esophageal (ESO) ﬁstula is a life-threatening complication 
of LA radiofrequency catheter ablation (CA) for atrial ﬁbrillation. We hypothesized that 
monitoring of ESO temperature (T) may detect early T rises to prevent ESO injury. 
Methods: We inserted an ESO T probe during LACA in 12 pts. The course of the ESO 
was marked on electroanatomic maps at the closest points on biplane ﬂuoroscopy. The T 
probe was positioned at the level of the 8-mm ablation tip for lesions on the posterior wall 
or roof, where maximum power and T were 40 - 50 W/50 - 55°. We stopped ablation for an 
abrupt rise in ESO T >0.5°. Results: Abrupt ESO T rises occurred in 11 pts (92%) at 1 - 4 
locations after 15 - 60 sec of ablation. ESO T rose for ~ 30 sec after termination of ablation 
by a maximum of 1.3 ± 0.3° (range 0.8 - 1.6°). Ablation sites with ESO T rises corresponded 
to the course of the ESO on electroanatomic maps, but were part of 3 different sets of 
linear lesions: LA-roof ablation line (2 pts) or encircling lines around left-sided (7 pts) 
or right-sided (2 pts) pulmonary veins. The Figure shows a typical electroanatomic map 
(posterior-anterior projection) with ablation sites (black), ESO (white), and sites of T rise 
(arrows). There were no acute or chronic complications. Conclusions: ESO T rises 
abruptly during LACA at sites adjacent to the ESO. T rises were associated with 3 different 
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lesion sets. The maximum T rise was small when ablation was stopped for a T increase of 
0.5°. Monitoring ESO T may reduce the risk of LA-ESO ﬁstula.
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1135  Ablation of Supraventricular  
and Atrial Tachycardias
Tuesday, March 08, 2005, 9:00 a.m.-12:30 p.m.
Orange County Convention Center, Hall E1
Presentation Hour: 11:00 a.m.-Noon
1135-257 Pooling Data Analysis To Identify The Number Needed 
To Treat For Prevention Of Arrhythmic Events In High-
risk Asymptomatic WPW
Carlo Pappone, Francesco Manguso, Giuseppe Augello, Amedeo Ferro, Valter 
Tortoriello, Gabriele Vicedomini, Vincenzo Santinelli, San Raffaele University Hospital, 
Milan, Italy
Background - Individual studies on asymptomatic WPW may be limited by small sample 
sizes for end points with relatively low incidences.
Objectives - To synthesize all available data by pooling data from our two recent 
randomized studies published in the New England Journal of Medicine.
Methods - In both studies, all patients underwent an electrophysiologic testing (EPT) 
for risk stratiﬁcation. Inducible subjects were considered at high-risk and thereafter 
randomized to catheter ablation or no treatment. By pooling all data, there were 119 high-
risk and 253 low-risk patients.
Results - Overall, 69 of 315 (22%) untreated subjects developed during follow-up 
arrhythmic events. By Kaplan-Meier analysis, arrhythmic events occurred in more 
than 60% of high-risk untreated subjects as compared to the 5% of ablated patients 
(p<0.001).
The number of high-risk patients needed to treat, calculated according to the method by 
Altman et al. , to prevent arrhythmic events in one high-risk patient was 7.6 at one year, 2.3 
at 2 years and 1.8 at 4 years (Figure).
Conclusions - Therefore, performing ablation in high-risk asymptomatic patients would 
lead to one event-free patient at 2 years for every 2.3 patients ablated. These results 
are clinically important as they demonstrate that ablation among high-risk asymptomatic 
patients is of durable beneﬁt and not harm at any point during follow-up. 
1135-258 Remote-controlled Catheter Ablation Of Common Type 
AVNRT Using The New Niobe Magnetic Navigation 
System
Sabine Ernst, Julian Chun, Feifan Ouyang, Matthias Antz, Karl-Heinz Kuck, St. Georg 
Hospital, Hamburg, Germany
Introduction: Atrio-ventricular nodal re-entrant tachycardia (AVNRT) can be cured by 
a focal radiofrequency current (RFC) applications. The new Niobe magnetic navigation 
system consists of two computer-controlled permanent magnets located on opposite sides 
of the patient table, and an ablation catheter equipped with one or three magnets which 
align with the user-deﬁned magnetic ﬁeld direction (0.08 Tesla). A motor drive, controlled via 
joystick, advances or retracts the catheter, thus enabling complete remote navigation.
Methods: A total of 71 pts (23 m, mean age 50 ± 16 years) were enrolled in the initial 
study using either the single (1M, 55 pts) or a three magnet (3M, 16 pts) ablation catheter 
and had documented episodes of common-type atrial ﬂutter. Both ablation catheters 
consist of a 4 mm solid tip to perform radiofrequency current (RFC) ablation (55°C, max 
40 W, 60 - 120 sec).
Results: In all pts, remote-controlled mapping of the target area successfully and 
safely performed. Using the 1M catheter, slow pathway modulation or ablation was 
achieved in all pts with mean procedure duration of 150 ± 48 min (mean RFC 7 ± 4.6, 
mean ﬂuoroscopy time 10.3 ± 8.5 min). Using the second generation 3M catheter with 
improved deﬂection properties, further shortening of procedure duration (123 ± 39 min) 
and necessary ﬂuoroscopy (6.4 ± 2.5 min) could be demonstrated, while using 6.5 ± 3.7 
RFC applications. There were no associated complications.
Conclusions: The Niobe system is a new platform technology allowing the remote-
controlled navigation using a 4 mm tip ablation catheter for both slow pathway modulation 
and ablation was safely and effectively performed in pts with typical atrio-ventricular nodal 
re-entrant tachycardia. By addition of two more magnets to the tip, catheter deﬂection force 
improved the catheter tissue contact, which resulted in improved procedural parameters 
such as ﬂuoroscopy time, number of RFC applications and procedure duration.
1135-259 Cryoablation of Supraventricular Tachycardia in 
Children and Adolescents: Predictive Value of 
Cryomapping
Thomas A. Kriebel, Claudia Broistedt, Maja Kroll, Christian Jux, Thomas Paul, Georg-
August-University, Göttingen, Germany
Background: Recently, cryoenergy application has evolved as a safe and effective 
alternative for ablation of arrhythmia substrates. Two speciﬁc features of this technique 
make it very attractive for pediatric patients: prediction of the effect of energy application 
by creating reversible block of conduction (cryomapping) and avoidance of dislodgment of 
the catheter by freezing of the catheter tip to the endocardium (cryoadhesion) therefore 
minimizing the risk of complications and the time of ﬂuoroscopy. The aim of the study was 
to analyse the predictive value of cryomapping in pediatric patients.
Methods: Since July 2003 31 patients (mean age 10.1 years) underwent electrophysiological 
study for symptomatic supraventricular tachycardia under the guidance of the Loca Lisa® 
system. After identiﬁcation of the arrhythmia substrate (AVNRT=12; accessory pathways 
(AP)=19) cryomapping was performed using the Freezor® 4 mm or Freezor Xtra® 
6 mm tip catheter with a target temperature of -30 ºC for a maximum of 60 seconds. 
If cryomapping was successful, cryoenergy was delivered at the same spot at -75 ºC 
veriﬁed by the Loca Lisa® system for a total of four minutes (cryoablation).
Results: In 23 of the 31 patients (74.21%) cryoablation was successful (AVNRT: 10/12, 
AP 13/19). A median of 2 (1-10) cryoablations were delivered. In the 8 remaining patients, 
radiofrequency catheter ablation was effective in 5 (overall success rate 90.3%). In 4 
patients with an AP cryomapping was unsuccessful. However, cryoablation resulted in 
AP interruption within 30 seconds at the identical location veriﬁed by the Loca Lisa® 
system. In addition, in 3 patients with AVNRT transient high grade AV-block occurred 
during cryoablation despite previous “safe” cryomapping at the same location.
Conclusion: According to our results cryomapping was not effective to predict cryoablation 
outcome in 7 out of 31 patients studied. These results may in part be explained by a 
smaller and therefore insufﬁcient lesion size during cryomapping.
1135-260 Prognostic Implication of Progressive Isthmus 
Conduction Delay During Successful Radiofrequency 
Current Application for Atrial Flutter
Yuji Okuyama, Takafumi Oka, Taku Sakai, Atsushi Hirayama, Kazuhisa Kodama, Osaka 
Police Hospital, Osaka, Japan
Aims: Cavotricuspid isthmus conduction (CIC) can be blocked completely with an abrupt 
prolongation of conduction time or with a gradual increase in conduction time during 
successful radiofrequency current (RFC) application for common atrial ﬂutter (AFL). 
This study sought to assess the prevalence and characteristics of a gradual increase 
in conduction time during successful RFC application and to deﬁne its predictors and its 
relationship with the results of long-term follow-up.
Methods and results: A total of 104 consecutive patients (76 men, 28 women, mean 
age 60 ± 13 years) who underwent successful AFL ablation were included. The procedure 
endpoint was deﬁned as complete bi-directional CIC block. Successful CIC block was 
achieved in 156 RFC applications in which CIC recurrence was observed after 52 RFC 
applications. During successful RFC applications, the incidence of a gradual increase 
in conduction time, deﬁned as more than 20% increase in time from pacing stimuli from 
coronary sinus ostium to the atrial potential just lateral to the presumed blocking line before 
complete CIC block during successful application of RFC, was 7.7% (8/104) in patients 
and 13.5% (21/156) in applications with CIC block. CIC block with a gradual increase 
in conduction time had a higher incidence of acute CIC resumption than those with an 
abrupt prolongation of conduction time (16/21 vs 36/135, p<0.05). The AFL recurrence 
rate was 5.8% (6/104) during a mean follow-up period of 13 ± 5 months. Patient with a 
gradual increase in conduction time had a higher incidence of AFL recurrence than those 
with an abrupt prolongation of conduction time (3/8 vs 3/96, p<0.01)
Conclusions: Our results suggest that a gradual increase in conduction time may be 
a potential risk for acute CIC resumption and clinical AFL recurrence during long-term 
follow-up. Observation time should be prolonged if a gradual increase in conduction time 
was observed during the application with CIC block.
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1135-261 Post-Operative Atrial Tachycardias in Patients with 
Mitral Valve Disease: what is the Location of the 
Arrhythmogenic Substrate ?
Natasja M. de Groot, Nico Blom, Ernst E. van der Wall, Martin Schalij, Leiden University 
Medical Center, Leiden, The Netherlands
Introduction: Atrial tachycardias (AT) in patients who underwent cardiac surgery for 
mitral valve disease (MVD) commonly originate from the left atrium. In this study, we 
analysed the underlying mechanism of the AT and the location of the arrhythmogenic 
substrate in patients with MVD and post-operative AT.
Methods: Electro-anatomical mapping of post-operative, drug-refractory AT’s was 
performed in pts (n=15, 8 male, age 55±12[43-74] yrs.) who had undergone cardiac 
surgery for MVD prior to ablation. Mapping was aimed at elucidating the underlying 
mechanism of the AT and to select target sites for ablation. Peak-to-peak voltages of bipolar 
electrograms were off-line analysed. Activation maps of the right atrium demonstrating a 
single (counter)-clockwise, cavo-tricuspid isthmus dependent macro-reentry circuit were 
labelled as typical atrial ﬂutter (AFL). All other atrial macro-reentrant tachycardias were 
classiﬁed as scar related-AT (s-AT). Activation maps characterized by a radially spreading 
wavefront arising from one single region were deﬁned as a focal atrial tachycardia (FAT).
Results: Seventeen different AT’s were mapped and ablated. All AT’s originated from the 
right atrium. Activation maps revealed a FAT (CL 280±66 ms, n=4/(24%)), s-AT (n=3/17%, 
CL 271±45 ms) or (AFL n=10/(59%), CL 235±60 ms). FAT were successfully ablated at 
the site of earliest endocardial activity. A bi-directional conduction block was assessed in 
all pts with AFL. s-AT was successfully ablated in 2/3 (66%) of the pts.
Conclusion: AT observed in MVD patients include not only s-AT but also AFL and FAT. 
Surprisingly, the arrhythmogenic substrate was located in the right atrium in all patients.
1135-262 Response to Adenosine Differentiates Atrial and 
Ventricular Tachycardias by Mechanism
Bindi K. Shah, Sei Iwai, Steven M. Markowitz, Suneet Mittal, Kenneth M. Stein, Ravi 
K. Yarlagadda, Jim Cheung, Vivian Tan, Bruce B. Lerman, Cornell University Medical 
Center, New York, NY
Background: Differentiation between reentrant and nonreentrant tachycardias and the 
relative dimensions of the tachycardia circuit (macro vs. focal) are demonstrated by 
entrainment (a relatively insensitive test) and multisite mapping.
Objectives: We hypothesized that adenosine (ADO) is a sensitive and speciﬁc mechanistic 
probe in atrial and ventricular tachycardia (AT and VT), differentiating between focal 
nonreentrant and macroreentrant circuits.
Methods: To this end, we examined the effects of ADO on 152 sustained tachycardias 
in 150 patients (54±14 years of age; 86 males): 74 ATs and 78 VTs. The mechanism of 
tachycardia was characterized by entrainment, 3D electroanatomic mapping, and results 
of successful radiofrequency ablation, as well as response to verapamil. The initial dose of 
ADO was determined by weight and titrated for deﬁnitive effect on the conduction system.
Results: The overall sensitivity and speciﬁcity of using ADO to determine whether an 
arrhythmia has a focal (nonreentrant) origin are 94% and 100%, respectively. For AT, 
the sensitivity and speciﬁcity are 98% and 100%, respectively. For VT, the sensitivity and 
speciﬁcity are 89% and 100%, respectively.
Response to Adenosine 
AT
Focal
AT
Nonfocal
VT
Focal
VT
Nonfocal
ADO
Sensitive 53 0 47 0
ADO
Insensitive 1 20 6 25
Conclusions: ADO has mechanism-speciﬁc effects on both AT and VT. Sensitivity of AT 
or VT to ADO is consistent with a nonreentrant mechanism and focal origin.
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1136-267 Echocardiographic Peak Right Ventricular Systolic 
Pressures Predict Adverse Outcomes in Cardiac 
Resynchronization Therapy
Usha B. Tedrow, Daniel Kramer, Lynne W. Stevenson, William G. Stevenson, Kenneth L. 
Baughman, Laurence M. Epstein, Eldrin F. Lewis, Brigham and Women’s Hospital, Boston, MA
Background: Cardiac resynchronization therapy (CRT) can improve outcomes in 2/3 
Class III or IV heart failure pts. We hypothesize poorer survival in patients (pts) with 
elevated right heart pressures.
Methods: We evaluated echo, ECG and clinical records from 75 consecutive CRT pts. 
RV systolic pressure (RVSP) was calculated from peak tricuspid regurgitant time velocity 
proﬁle. The primary endpoint was a composite of mortality, cardiac transplant, or LV assist 
device (22 events). Kaplan-Meier curves, log-rank test and Cox proportional hazard ratios 
(HR) were used to evaluate events and pt characteristics.
Results: Pts were grouped by RVSP > or < 35 mmHg. Clinical features were similar 
between groups, except for more chronic renal insufﬁciency (CRI) and RV dysfunction 
when RVSP >35 mmHg.
Univariate analysis identiﬁed diabetes (HR 2.45), CRI (HR 3.52), AF (HR 3.07), use of 
non-amiodarone anti-arrhythmics (HR 2.86), atrial pacing (HR 2.57), and prolonged PR 
interval (HR 1.009) as associated with poorer survival. Sinus rhythm (HR 0.34), LBBB 
(HR 0.44), and beta-blocker use (HR 0.47) were associated with improved survival. Three 
variables remained signiﬁcant in a multivariable model - high RVSP, (HR 3.71 95% CI 
1.31, 10.4), CRI (HR 3.18, 95% CI 1.29, 7.86) and AF (HR 4.22, 95% CI 1.54, 11.6).
Conclusions: RVSP >35 mmHg is associated with > 3-fold risk of decreased survival, 
which may reﬂect elevated left-sided pressures, pulmonary hypertension, or RV failure. 
High RVSP may guide choice of therapy in CRT candidates.
1136-268 Cardiac Resynchronization Therapy Improves 
Pulmonary Hypertension in Congestive Heart Failure
Yong-Mei Cha, Robert F. Rea, Win-Kuang Shen, Samuel J. Asirvatham, David M. 
Turnbull, Linda K. Hyberger, David L. Hayes, Mayo Clinic, Rochester, MN
Background: Pulmonary hypertension (PHT) is frequently present in patients (pts) with 
advanced congestive heart failure (CHF). Although trials have demonstrated that cardiac 
resynchronization therapy (CRT) improves left ventricular (LV) function and symptoms of 
CHF, little is known the impact of CRT on PHT. The aim of this study was to determine the 
hemodynamic effect of CRT on pulmonary artery systolic pressure (PASP) along with LV 
systolic function in pts with CHF. 
Methods: Database of 254 pts who received CRT at the Mayo Clinic during 1/2002 
to 12/2003 was screened. Sixty-three pts (male 51, female 12, mean age 65±11 yrs) 
had pre-implant evaluation and post-implant follow-up at our institution. Transthoracic 
echocardiograms were performed to assess PASP, LVEF, and LV diastolic dimension. 
PASP was determined by right ventricle-right atrium gradient that was calculated by using 
the simpliﬁed Bernoulli equation. NYHA function class was assessed. 
Results: The PASP was signiﬁcantly reduced by CRT, along with improvement in LVEF 
and NYHA function class (see table). Twenty-nine of 63 pts (46%) had moderate to 
severe PHT ranging 51 to 84 mmHg prior to CRT. The PASP in these pts was signiﬁcantly 
decreased from 62±10 to 49±16 mmHg (p=0.00003). 
Conclusion: CRT reduces PASP in pts with advanced CHF, accompanied with 
improvement of LV systolic function and reversal of LV remodeling. The favorable 
response of PHT to CRT may provide an important insight to the symptomatic and 
functional improvement of CHF.
Pre-CRT Post-CRT P
Pulmonary artery systolic pressure mmHg 51±15 44±14 0.002
LV ejection fraction % 21±7 27±10 <0.0001
LV diastolic dimension mm 69±10 65±9 0.002
NYHA class 3.0±0.6 2.3±0.9 <0.0001
1136-269 Lead Proximity to Infarct Site Does Not Affect the 
Hemodynamic Response to Cardiac Resynchronization 
Therapy
Daniel Arzola-Castaner, Cynthia Taub, E. Kevin Heist, Dali Fan, Michael H. Picard, 
Jeremy N. Ruskin, Jagmeet P. Singh, Massachusetts General Hospital, Boston, MA
Background: Current reports suggest that the optimal pacing site for cardiac 
resynchronization therapy (CRT) is in the region of the left ventricular lateral wall. Although 
pacing in the infarct site could impact the contractile response to CRT, there is little 
information regarding the acute hemodynamic effects of CRT, when the left ventricular 
lead lies either distant from or on the infarct site.
Methods: 38 consecutive patients (8 female, age 70 ± 10 years, EF 22 ± 6%), with ischemic 
cardiomyopathy underwent biventricular pacemaker implantation for standard indications 
and were included in the analysis. Echocardiographic assessment of contractility was 
measured by Doppler proﬁles of mitral regurgitation as a percentage change in dP/dt (�dP/
dt) with CRT on and off. A standard echocardiographic protocol was used for myocardial 
segmentation and scoring of the wall motion abnormalities. Regions of akinesia and/or 
dyskinesia were identiﬁed as prior infarct sites. LV lead position in relation to the infarct 
site was determined by the consensus of three different cardiologists. LV leads were 
categorized as being on (group 1) or off the infarct site (group 2). Acute responders were 
deﬁned as ΔdP/dt > 25%.
2005_3_CardiacArrhyth.indd   116 12/23/04   10:01:14 AM
JACC February 1, 2005 ABSTRACTS - Cardiac Arrhythmias  117A 
C
ardiac A
rrhythm
ias
Results: The magnitude of the hemodynamic response to CRT was similar in group 
1 (n=15) and group 2 (n=23). There was no signiﬁcant difference in the baseline dP/dt 
(Group 1, 661.3+235.1 vs, Group 2, 659.9+ 210.4 p=0.99) or �dP/dt (Group 1; 48.3 ± 
71.1% vs. Group 2; 31.9 ± 40.1%, p = 0.46). Lead placement in posterolateral (PL) or 
lateral (LL) positions was associated with better hemodynamic response when compared 
to anterolateral (AL) positions irrespective of proximity to scar (�dP/dt, PL, 50 ± 53% and 
LL, 29 ± 39 % vs. AL, -7 ± 23% respectively p < 0.05). LV lead on or off the infarct site did 
not distinguish between acute responders and nonresponders to CRT.
Conclusion: LV lead proximity to the infarct site is not a determinant of acute hemodynamic 
response to CRT. Optimal hemodynamic response may be obtained by LV lead placement 
in the lateral or posterolateral region irrespective of its proximity to the infarct.
1136-270 Long-Term Outcome in Heart Failure Patients Treated 
With Cardiac Resynchronisation Therapy: a Comparison 
Between Transvenous and Epicardial Leads
Santi Raffa, Cecilia Fantoni, Francois Regoli, Mihoko Kawabata, Helmut Klein, Angelo 
Auricchio, University Hospital, Magdeburg, Germany, University Hospital, Messina, Italy
Background: Long term outcome of heart failure patients (pts) implanted with different 
left ventricular lead types [transvenous, (TL) vs epicardial, (EL)] is still unknown.
Methods: We compared improvement of functional capacity and echo parameters at 1 
year follow-up and long term event free survival rate in 89 pts consecutively implanted 
with a TL and in 82 pts consecutively implanted with an EL. Events considered for the 
survival rate analysis were death for any cause, heart transplantation and left ventricular 
(LV) assist device implantation.
Results: Prevalence of male gender was higher among pts implanted with a TL (p<0,04). 
At baseline pts implanted with a TL had a lower LV ejection fraction (20±6 vs 22±7 %, 
p<0,01) and a higher pulmonary artery systolic pressure (43±17 vs 39±15 mmHg, p<0,05). 
There were no differences between the two groups in the other clinical, echocardiographic 
and hemodynamic variables. At one year follow-up pts with a TL showed a signiﬁcant 
higher percentage increase of LV ejection fraction (46±61 vs 22±44 %, p<0,01) and of 
peak oxygen consumption (24±24 vs 11±28 %, p<0,03). Over a mean follow-up time of 
762±581 days the event-free survival rate as assessed by Kaplan-Meyer curves was not 
signiﬁcantly different between the two groups.
Conclusions: Pts implanted with a TL have a signiﬁcantly better functional improvement 
after CRT compared to pts implanted with an EL. Nevertheless long term event-free 
survival rate do not differ between the two groups.
1136-271 QRS Duration Does Not Predict Ventricular Synchrony- 
A Tissue Doppler Imaging Study
Shrikanth P. Upadya, Craig McPherson, Sheikh Mahfuzul Hoq, Jeffrey Banker, 
Prince Mudagol, Gilead Lancaster, Stuart Zarich, Yale University School of Medicine, 
Bridgeport, CT
Background: Patients (pts) with QRS duration < 120 ms are excluded from cardiac 
resynchronization therapy (CRT) and as many as a third with QRS > 120 ms fail to beneﬁt 
from it. Pulsed Doppler tissue imaging (PDTI) may better identify ventricular dyssynchrony 
and thus pts who may beneﬁt from CRT.
Methods: We correlated QRS duration with the following indices of ventricular synchrony 
as measured by PDTI: 1) Intraventricular delay (LVD) = differences in electro-mechanical 
systolic delay in the lateral, septal, anterior, inferior and posterior LV walls (abnormal: >40 
ms); 2) Interventricular delay (RLVD) = difference between the RV free wall and the most 
delayed LV free wall (abnormal: > 40 ms); and 3) Sum dyssynchrony (Sum D) = LVD + 
RLVD (abnormal: >100 ms).
Results: Among 20 pts (15 men, 17 with ischemic cardiomyopathy, mean age = 70 
years), the LVEF was 33 ± 8% in 10 pts with QRS > 120 ms and 25 ± 10% in those with 
QRS < 120 (p=0.07). The PDTI indices did not distinguish those with QRS > 120 from pts 
with QRS < 120 (LVD = 130 ± 137 ms vs. 63 ± 30 ms; RLVD = 97 ± 127 ms vs. 57 ± 25 ms; 
Sum D = 196 ± 255 ms vs. 119 ms ± 54 ms; p=NS for all). LVD was abnormal in 5(50%) 
pts with QRS < 120, and 7(70%) with QRS > 120.
Conclusions: QRS duration does not correlate with PDTI measures of ventricular 
synchrony, both under and overestimating dyssynchrony. Thus, PDTI may be the superior 
method by which to select pts who will beneﬁt from CRT. 
1136-272 Cardiac Resynchronization Therapy Improves Left 
Ventricular Diastolic Function in Non-ischemic Heart 
Failure
Alan D. Waggoner, Mitchell N. Faddis, Marye J. Gleva, Lisa de las Fuentes, Sharon 
Heuerman, Victor G, Davila-Roman, Washington University, St. Louis, MO
Background: Cardiac resynchronization therapy (CRT) decreases left ventricular (LV) 
volumes and improves ejection fraction in patients with heart failure. The effects of CRT 
on LV diastolic function in patients with ischemic versus non-ischemic etiology have not 
been well characterized.
Methods: 52 patients [age 61 ± 12 years, 38 males, LV ejection fraction: 25 ± 5%, ischemic 
etiology in 16 (31%)] were studied prior to, and 4 ± 1 months after CRT. Two dimensional 
and pulsed-wave Doppler (PWD) echocardiographic measurements included: LV volumes 
and ejection fraction (EF), mitral E- and A-wave peak velocities, E/A ratio, deceleration 
time (DT), and diastolic ﬁlling time (DFT). Tissue Doppler imaging early diastolic (Em) 
mitral annular (septal) and color M-Mode ﬂow propagation (FP) velocities were measured 
in the apical 4 chamber view; PWD E-wave/Em and E/FP were calculated to estimate LV 
ﬁlling pressure.
Results: 
Ischemic
(n = 16)
Non-ischemic
(n = 36)
Variable Pre-CRT Post-CRT Pre-CRT Post-CRT
EDV (ml) 221 ± 68 193 ± 63 245 ± 101 211 ± 95*
ESV (ml) 172 ± 59 136 ± 56* 184 ± 86 146 ± 87*
LVEF (%) 23 ± 5 32 ± 10* 26 ± 5 34 ± 11*
E/A 2.3 ± 1.5 1.8 ± 1.3 1.1 ± 0.8 0.8 ± 0.3*
DT (ms) 178 ± 90 177 ± 47 193 ± 58 217±57*
DFT (ms) 351 ± 103 427 ± 113* 352 ± 105 399±126*
E/Em 15.7 ± 5.6 14.3 ± 6.0 13.3 ± 6.9 10.8±5.2*
E/FP 2.4 ± 0.6 2.1 ± 0.7 2.2 ± 0.7 1.7±0.7*
Mean ± SD; * p < .05 vs Pre CRT
Pre-CRT mitral E/A ratio was higher in ischemic patients (p < .001). LV end-systolic volume 
decreased, and the LV ejection fraction and DFT increased in both groups. Patients with 
ischemic etiology did not exhibit signiﬁcant changes in LV end-diastolic volume, mitral E/A 
ratio, DT, E/Em or E/FP after CRT.
Conclusions: Both ischemic and non-ischemic heart failure patients improve LV systolic 
performance after CRT. However, LV diastolic function only improves in non-ischemic 
patients and remains relatively unchanged in those with ischemic etiology.
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1137-247 Prognostic Value Of Heart Rate Variability In Patients 
With Unstable Angina
Gaetano A. Lanza, Alfonso Sestito, Giulia Angeloni, Domenico Cianﬂone, Antonio G. 
Rebuzzi, Filippo Crea, Attilio Maseri, for the “Stratiﬁcazione Prognostica dell’Angina 
Instablile” Investigators, Università Cattolica del Sacro Cuore, Rome, Italy, Università 
Vita e Salute, Milan, Italy
Previous studies showed that a reduced heart rate variability (HRV) is of prognostic 
value in patients with an acute myocardial infarction. Despite the recent interest in risk 
stratiﬁcation of patients with unstable angina (UA), the prognostic relevance of HRV in UA 
patients remains poorly known.
We analyzed Holter ECG recordings of 583 UA patients (63±10 years, 356 men) who 
underwent 24-hour Holter monitoring within 24 hours from hospital admission. HRV was 
assessed in the time-domain and in the frequency domain.
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During 6-month follow-up, there were 32 total deaths (6.5%). With regard to HRV 
variables, patients were dichotomized into those with values in the bottom quartile and 
those with values in the 3 upper quartiles. Low quartile values of most HRV variables were 
signiﬁcantly associated with increased mortality at univariate Cox regression analysis 
(Table). On multivariate Cox regression analysis, including several known prognostic 
variables (age, gender, cardiac risk factors, type of UA, previous myocardial infarction, 
ventricular arrhythmias, C-reactive protein and troponin I) reduced low frquency (LF) 
value was independently associated with both total (RR=2.32, 95% CL=1.1-4.63, p=0.03) 
and cardiac (RR=3.60, 95% CL=1.1-12.0, p=0.04) death. 
Relative risk (95% C.L.) P
RR interval <833 ms 2.06 (1.02-4.18) 0.044
SDNN <80 ms 1.56 (0.75-3.24) 0.23
SDANN <62 ms 1.84 (0.90-3.74) 0.09
SDNNi <39 ms 3.00 (1.50-5.99) 0.002
VLF <31 ms 3.07 (1.53-6.14) 0.002
LF <15.7 ms 3.09 (1.54-6.17) 0.001
HF <11.2 ms 1.80 (0.88-3.69) 0.11
LF/HF <1.12 3.57 (1.78-7.15) 0.0003
Thus our data show, for the ﬁrst time, that decreased HRV is associated with increased 
mortality at 6-month follow-up in patients with UA, and therefore it can be helpful in risk 
stratiﬁcation in this clinical setting.
1137-248 Left Ventricular Ejection Fraction Can Be Derived From 
Simple ECG Measurements
Patrick R. Krake, Louisiana State University Health Sciences Center, Shreveport, LA
Background: During a non-ST elevation myocardial infarction (NSTEMI) or unstable 
angina (USA), rapid referral to an early invasive strategy has the greatest beneﬁt to 
patients with a depressed left ventricular systolic function. Does a reliable, cost effective 
and universally available source of information to determine the single most important 
cardiac prognostic factor, left ventricular systolic function, exist? Perhaps a simple 
tool of clinical medicine that satisﬁes those important criteria is the surface 12 lead 
electrocardiogram.
Methods: The study population included 399 consecutive patients who presented to the 
echocardiography lab, 254 African-Americans and 145 Caucasians, of which 219 were 
females and 180 were males. The data that was collected from a standard 12 lead surface 
ECG was summation of the positive and negative forces (R wave + S wave) in lead aVR 
(aVR) in millimeters. The data from the M-Mode echocardiogram was the left ventricular 
ejection fraction (LVEF) in percent. Age in years was obtained from the medical record.
Results: With an age adjustment, the simple linear regression model is clearly predictive 
of LVEF. F ratio is 1916.3 (p<0.001). Squared multiple R: 0.906
LVEF=β1aVR + β2Age
β1 = 2.264, SE = 0.185, T = 12.2, (p<0.001)
β2 = 0.645, SE = 0.033, T = 19.7, (p<0.001)
Therefore, a 50 year old with aVR = 10 mm would be expected to have a LVEF of 54.9 
%
Conclusion: Numerous studies have repeatedly demonstrated the importance of 
LVEF. A rapid, reliable and readily available estimation method of LVEF is crucial in the 
management of the vast majority of cardiac patients. Early risk stratiﬁcation based on 
LVEF can determine the urgency of invasive heart catheterization in NSTEMI or USA. 
In this gender robust and ethnically diverse population, by utilizing a simple arithmetic 
operation (R wave + S wave) in lead aVR and adjusting for age, the care of the cardiac 
patient can be optimized based on LVEF. This simple yet effective model has the additional 
utility secondary to the universal availability, cost effectiveness and ease of interpretation 
of the surface 12 lead ECG.
1137-249 Association Between Resting Electrocardiographic 
Parameters and Estimated 10-Year Risk for Coronary 
Heart Disease in U.S. Population
Hee-Yeol Kim, Don D. Sin, Jae-Hyung Kim, The Catholic University of Korea, Seoul, 
South Korea, University of British Columbia, Vancouver, BC, Canada
Background: Little is known about the association between parameters in resting 
electrocardiogram (ECG) and incident coronary heart disease (CHD). We sought to 
establish the association between ECG and estimated 10-year risk for CHD to analyze 
whether ECG analysis may yield information that is independent from and additive to 
traditional risk factors. Methods: We applied the risk prediction algorithm used by the 
National Cholesterol Education Program Adult Treatment Panel III guidelines to data 
from 6,399 participants (age 40 to 79 years) who had sinus rhythm, no previous heart 
disease, and no 12-lead Minnesota Code evidence of prior myocardial infarction in the 
Third National Health and Nutrition Examination Survey. Results: After adjusting for 
age, sex, race and BMI, subjects with high risk had higher levels of heart rate, LV mass 
index and cardiac infarction injury score, and longer intervals of PR, QRS and heart 
rate-corrected QT (QTc) than those of low risk. In fully adjusted models for coronary risk 
factors, participants with high risk were more likely to have upper quintiles of HR and QTc 
interval, and lower quintiles of PR interval than the controls (Table). Conclusions: These 
ﬁndings indicate that long QTc interval, high HR and short PR interval independently 
predict subjects with high risk for CHD. This suggests that the assessment of ECG 
parameters may potentially yield information that is additive to the analysis of traditional 
risk factors in a general population.
Relative odds of having upper quintiles of ECG  
parameters in subjects with high risk 
Variables Age-, race-, sex-adjusted P value
Age-, race-, sex-
, and
coronary risk 
factors-adjusted
P value
Heart rate, beats per minute
Q4, 71-77 1.68(1.30-2.18) <0.0001 1.65(1.22-2.22) 0.001
Q5, 78- 2.67(2.09-3.42) <0.0001 2.20(1.65-2.92) <0.0001
PR interval, msec
Q4, 168-182 0.81(0.62-1.04) 0.101 0.53(0.39-0.71) <0.0001
Q5, 183- 0.98(0.76-1.27) 0.894 0.70(0.52-0.94) 0.019
QTc interval, msec
Q4, 436-450 1.81(1.39-2.38) <0.0001 1.26(0.92-1.71) 0.149
Q5, 451- 3.10(2.38-4.05) <0.0001 1.75(1.29-2.37) <0.0001
1137-250 Do Q Waves on Electrocardiography Predict Non-Viable 
Myocardium After Acute Myocardial Infarction
Anil Kumar Taneja, Jonathan Swinburn, Bilal Iqbal, Mohammed Khan, Roxy Senior, 
Northwick Park Hospital, Harrow, United Kingdom
Background: Controversy exists regarding the signiﬁcance of pathological Q waves 
on electrocardiography (ECG) after established acute myocardial infarction (AMI) in 
predicting non-viable myocardium. Dobutamine stress echocardiography (DSE) is now 
widely used to assess viable myocardium after AMI.
Aim: The aim of the study is to ascertain the reliability of Q waves on the ECG to predict 
myocardial viability after AMI.
Methods: Accordingly, 178 patients who underwent both ECG and DSE, at a mean of 
4.9 days post AMI were assessed.. Non-viability on ECG is deﬁned as the presence of 
pathological Q waves in at least 4 out of the 6 precordial leads or Q waves in all 3 of the 
inferior leads. Non-viability on DSE is deﬁned as absence of contractile response in 7 out 
of the 9-anteroseptal segments or in 3 out of the 4 inferior region segments.
Results: Of the 178 patients, 45% (80) presented with anterior and 44% (78) with inferior 
AMI. The positive and negative predictive value of Q waves on ECG to predict non-viable 
myocardium is 24% and 90% respectively. The predictive accuracy was similar in both 
anterior (84%) and inferior (77%) Q waves.
Conclusion: The presence of extensive Q waves does not predict non-viable myocardium. 
However, absence of Q waves predicts the presence of viable myocardium.
Relationship Between Viability Detected by ECG and that by DSE 
DSE Viability DSE Non-Viability
ECG Viability 270 31
ECG Non-Viability 42 13
1137-251 QT-Dynamicity During Speciﬁc Sleep Stages in the 
Subacute Phase of Myocardial Infarction
Jana Noethges, Benina Majunke, Jasmin Ortak, Uwe K. Wiegand, Heribert Schunkert, 
Hendrik Bonnemeier, University Luebeck, Luebeck, Germany
BACKGROUND: Even though sudden cardiac death after myocardial infarction (MI) 
frequently occur at nightime, the impact of sleep on arrhythmogenesis in patients after 
MI is yet unknown. We therefore examined the effects of sleep stages on QT-dynamicity 
and tested the hypothesis that there is a differential effect of sleep stage on the QT/RR 
relationship in patients with a recent MI compared with healthy controls (HC).
METHODS: Twenty ﬁve male patients in the subacute phase of a ﬁrst uncomplicated 
MI and 10 healthy age-matched male volunteers without evidence of coronary artery 
disease underwent polysomnography and simultaneous ECG-recordings. Parameters of 
QT-interval and QT-dynamicity were measured during wakefulness, sleep stages 1 to 4 of 
non-REM sleep and during REM-sleep.
RESULTS: QT- and RR-interval increased through all sleep stages in both, MI-patients 
and HC. The Bazett-corrected QTc-interval remained stable from wakefulness through 
all sleep stages. QT/RR-slopes remained stable from wakefulness to sleep stage 3 in 
both groups, however, in contrast to MI-patients there was a signiﬁcant decrease during 
deep-sleep and REM-sleep in HC. QT/RR-slopes were signiﬁcantly steeper in MI-patients 
during these sleep stages.
CONCLUSION: MI causes an abnormal QT/RR relationship in deep sleep and REM-sleep, 
reﬂecting an inadequate shortening of repolarization with increasing heart rate, which may 
have important implications for sleep-selected ventricular arrhythmias after MI. 
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1137-252 ECG Predictors Of Left Main Coronary Artery 
Obstruction: ST Segment Deviation In Lead V6 Greater 
Than Or Equal To ST Segment Deviation In Lead V1.
Nitin Mahajan, Deepak Thekkoott, Brian Temple, Bilal Malik, Sunil Abrol, David Yens, 
Malcolm Rose, Jacob Shani, Edgar Lichstein, Gerald Hollander, Maimonides Medical 
Center, Brooklyn, NY
Background: Acute Coronary Syndrome (ACS) resulting from culprit lesion in left main 
coronary artery (LMCA) can cause rapid hemodynamic deterioration. It is important to 
identify these patients early to facilitate timely revascularization. ST segment elevation in 
aVR greater than or equal to V1 (aVR-V1≥0) has been suggested as a sensitive predictor 
of LMCA disease. As a result of balanced forces, we hypothesized that ST deviation in 
V6 greater than or equal to ST deviation in V1 (V6-V1≥0) might be a good determinant 
of LMCA disease.
Methods: We compared admission 12-lead ECGs of ACS resulting from culprit LMCA 
lesion (n=75:Group I) with ACS resulting from culprit left anterior descending artery 
(n=81:Group II). Group I was selected over a period of 10 years. We compared V6-V1≥0 
to aVR-V1≥0 in both groups. We also looked at ratio of ST deviations in V6,V1 (V6/V1≥1) 
and aVR,V1 (aVR/V1≥1) in cases where ST segment in V1 was not isoelectric(GpI-54/75: 
GpII-55/81).
Results: In group I, ST deviation in V6 was signiﬁcantly greater than ST deviation in V1 
(0.06, t=10.44,p<0.01). Figure 1 demonstrates the reliability of V6-V1≥0, V6/V1 ≥1, aVR-
V1≥0 and aVR/V1≥1 in predicting LMCA disease.
Conclusion: This is the largest series on ECG analysis on ACS resulting from culprit 
LMCA lesion. V6-V1≥0 is more sensitive in predicting LMCA as culprit vessel than 
previously reported aVR-V1≥0.
. 
1137-253 Relationship between Severity of Heart Failure and 
Repolarisation Abnormalities on the Surface ECG - 
Euro Heart Failure survey.
Periaswamy Velavan, Nasrin K. Khan, Alan S. Rigby, Michel Komajda, Ferenc Follath, 
Karl Swedberg, Andrew L. Clark, John G F Cleland, University of Hull, Hull, United 
Kingdom
Introduction: QT prolongation predicts arrhythmic events and indicates poor prognosis 
in heart failure. It is associated with increased risk of coronary disease and cardiovascular 
mortality.
Hypothesis: QT interval is prolonged in left ventricular systolic dysfunction (LVSD) and 
is linearly related to its severity.
Methods: From the EURO-HF survey, the QT, QTc, QRS and JT intervals were 
measured from 5829 ECGs with a digital caliper and related to LV function, assessed by 
echocardiography.
Mean age was 69 + 13 years; 41% were women; 64% had coronary disease; 54% had 
hypertension; 27% had diabetes and 18% had renal dysfunction.
Results: QT, QTc and QRS intervals were prolonged in LVSD and were related to its 
severity. The odds ratio for having moderate or severe LVSD increased with increasing 
QRS interval with a dose response effect: QRS 120-140 ms, OR 2.7; 141-160 ms, OR 
3.4; 161-180 ms, OR 3.9 and >180 ms, OR 4.6 (p=<0.0001). But there was no such effect 
seen with QTc interval: QTc 440-460 ms, OR 1.1; 461-480 ms, OR 1.3; 481-500 ms, OR 
1.2 and >500 ms, OR 1.0 (p=0.379).
Conclusions: QTc, QT and QRS intervals are prolonged in patients with LV systolic 
dysfunction and are related to its severity. The QT prolongation is mainly inﬂuenced by 
the increase in the QRS interval and probably reﬂects the severity of LV dysfunction in 
patients with heart failure rather than representing abnormal repolarisation.
. 
1137-254 Inaccuracy of the Minnesota Code for Recognition of 
Prior Myocardial Infarction
Sangeeta Shah, Frederico Asch, Anthon Fuisz, Ellen Pinnow, Joseph Lindsay, 
Washington Hospital Center, Washington, DC
Background: The ECG is valuable in epidemiological studies and in screening 
examinations for the identiﬁcation of prior MI. The Minnesota Code (MC), commonly 
used in such settings, provides criteria for the identiﬁcation of prior MI. Their accuracy 
is, however, unclear. We tested the MC Q and QS criteria for prior MI against a novel 
standard, the presence of myocardial scar as represented by delayed hyper-enhancement 
on magnetic resonance imaging (MRI).
Methods: Delayed hyper-enhancement of the myocardium after gadolinium injection was 
sought in 146 consecutive pts undergoing cardiac MRI. Most were examined to assess 
myocardial viability. 139 had ECG’s within 2 weeks. A physician, blinded to the ECG, 
assessed volume, location and transmural extent of scar. Two experienced cardiologists 
read the ECGs utilizing MC Q and QS criteria.
Results: 66 (47.5%) pts had delayed hyper-enhancement. 32 (48.5%) had Q or QS 
criteria. Sensitivity was affected by the size of scar but not independently by location. 
Of 26 pts with a scar ≥20% of left ventricular volume, 17 (65.4%) had MC criteria as 
compared to15 of 40 (37.5%) with a smaller scar. In 63 (95.5%) pts scar involved ≥75% of 
the wall thickness. Of them, 31 (49.2%) had MC criteria for MI. Of 73 pts without delayed 
hyper-enhancement, 12 (16.4%) had Q or QS criteria for MI.
Conclusions: When compared to the presence of myocardial scar as assessed by delayed 
hyper-enhancement, MC Q and QS criteria for MI have a sensitivity of approximately 50%. 
Scars ≥20% of LV volume were more often detected (65.4%) than those <20% (37.5%). 
MC criteria were found in 16.4% of pts with no scar. (speciﬁcity of 83.6%) Thus, in a 
population undergoing viability testing by MRI, MC code criteria are relatively insensitive, 
particularly for small scar, and less than ideally speciﬁc for the detection of prior MI.
1137-255 ST Segment Vector in ST Segment Elevation Myocardial 
Infarction Involving the Left Circumﬂex Artery
David N. Kenigsberg, Mouaz Al-Mallah, Mark E. Josephson, Subramaniam C. Krishnan, 
Sanjaya Khanal, Henry Ford Hospital, Detroit, MI, Beth Israel Deaconess Medical 
Center, Boston, MA
Background: The pattern of ST segment elevation (STE) in inferior myocardial infarction 
(IMI) is useful in predicting the culprit vessel. When the culprit is the right coronary artery, 
the ST segment vector is directed inferiorly and to the right, resulting in STE in lead III 
greater than II (III>II). Conversely, when the culprit is the circumﬂex artery (LCx), the ST 
vector is directed inferiorly and to the left, resulting in STE in lead II greater than III (II>III). 
This concept has not been well validated, especially in LCx infarcts. We examined the 
distribution of ST segment changes in the inferior (II,III,aVF), lateral (I,aVL) and early 
precordial leads (V1-V3) in patients with STE IMI where the culprit vessel was the LCx.
Methods: Using our catheterization laboratory database (1988-2003), of 370 patients 
undergoing angioplasty for IMI, 71 patients were identiﬁed where the culprit was the LCx 
. Of these, 49 had inferior STE on ECG.
Results: STE II>III was present in 12/49 (25%) of patients. These patients were more 
likely (58%) to have STE in I or aVL (p=0.0002). Posterior injury, deﬁned as STD V1-V3, 
was seen in 83% of this group (p=0.08). 17/49 patients (34.7%) had STE in III not greater 
than II. STE III>II was present in 21/49 (43%) of patients. They were more likely (76%) to 
have STD in I and/or aVL (p=0.01).
STE (n,%) STE I or aVL
STD I or 
aVL
Posterior Injury 
(STD V1-V3)
ST Segment 
Vector
RCA 
Dominance
II>III (12,25) 7 (58%) 2 (17%) 10 (83%) Inferior, Right to Left 11 (91%)
II not > III (17,35) 1 (6%) 6 (35%) 10 (59%) Inferior 10 (59%)
III>II (21,43) 1 (5%) 16 (76%) 12 (57%) Inferior, Left to Right 17 (81%)
Conclusion: In STE IMI due to LCx occlusion, only a minority (25%) of patients have the 
ST segment vector directed inferiorly and to the left (STE in II>III); of these, 58% have 
STE in I and/or aVL.
1137-256 Repolarization Duration in Postinfarction Patients with 
Conduction Disturbances
Katarzyna Piotrowicz, Wojciech Zareba, Scott McNitt, Arthur J. Moss, University of 
Rochester, Rochester, NY
The aim of the study was to compare different measures of repolarization duration in 
postinfarction patients with and without conduction disturbances and to evaluate the 
prognostic signiﬁcance of repolarization parameters for predicting mortality in patients 
with conduction abnormalities (LBBB,RBBB, IVCD).
Methods: Study population consisted of 3,282 pts after recent MI (mean age 57 years). 
Repolarization duration was measured using QTcB (Bazett corrected QTc), JTc (Bazett 
corrected QTc after subtracting QRS complex duration), and JTRR (formula by Rautaharju: 
JTRR=JT-155(60/HR-1)+k; k=34ms for male; 22ms for female).
Results: Table below shows mean±sd values of repolarization parameters in respective 
subgroups. QTcB in LBBB patients demonstrate excessive prolongation of repolarization, 
which could not be documented when using JTRR. There was 29% 2-year mortality in 363 
patients with conduction abnormalities. After adjustment for signiﬁcant clinical predictors 
(age, EF, NYHA class) of mortality, hazard ratios for variables dichotomized at 75th 
%-ile were: for JTc>360 = 1.31 (p=0.23), for JTRR >362 ms = 1.59 (p=0.027), and for 
QTc>480ms = 1.51 (p=0.055).
Conclusion: 1) Patients with LBBB, RBBB, IVCD show longer QTc than patients without 
these conduction disturbances. JTRR reﬂects better than QTc repolarization duration in 
patients with conduction disturbances. 2) JTRR signiﬁcantly and independently predicts 
mortality in postinfarction patients with conduction disturbances.
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* p<0.001 for comparison with normal conduction 
Normal Conduction
N=2919
IVCD
N=185
RBBB
N=131
LBBB
N=47
QRS (ms) 82 ± 9 111± 12* 128 ± 14* 138 ± 15*
QTcB (ms) 415 ± 37 445 ± 40* 452 ± 45* 495 ± 56*
JTc (ms) 333 ± 37 334 ± 50 325 ± 46 358 ± 40*
JTRR 350 ± 30 345 ± 38 335 ± 37* 355 ± 39
QTc >440(%) 22 52 60 85
JTRR >37(%) 24 20 11 34
ORAL CONTRIBUTIONS
847  Techniques and Outcomes of Atrial 
Fibrillation Ablation
Tuesday, March 08, 2005, 10:30 a.m.-Noon
Orange County Convention Center, Room 232A
10:30 a.m.
847-3 Comparative Evaluation of Platelet and Coagulation 
Activation During Transvenous Cryoablation and 
Radiofrequency Ablation for Pulmonary Vein Ablation in 
Patients with Atrial Fibrillation
Hung Fat Tse, Yok-Lam Kwong, Chu-Pak Lau, Department of Medicine, Queen Mary 
Hospital, University of Hong Kong, Hong Kong, Hong Kong
Background. The potential thromboembolic risk associated with radiofrequency ablation 
(RF) of pulmonary veins (PV) raises the question of whether use of cryoablation (Cryo) 
would provide a safer proﬁle. The aim of this study was to compare the thrombogenic 
potential of Cryo with RF ablation during PV ablation. 
Methods and Results. 30 patients (52±3 yrs, 23 M) with paroxysmal atrial ﬁbrillation were 
randomised to undergo PV isolation using either 4mm-tip RF (n=15) or Cryo (CryoCor, 
CA) (n=15). Blood samples were drawn to assess platelet (Plt) and coagulation (CA) 
activation at baseline, after transeptal puncture (TS), before ablation and after successful 
isolation of a superior PV. After TS, heparin was given to keep ACT>250s. Plt activation 
was assessed by ﬂow cytometry of P-selectin. CA activation was measured by ELISA 
assay of plasma level of prothrombin fragment 1+2 (F1+2) and thrombin-antithrombin III 
complex (TAT). Both Plt and CA activation were signiﬁantly increased after TS (Fig. A & B). 
The percentage changes in Plt activation from baseline were signiﬁcantly lower after Cryo 
compared to RF (Fig. A). However, there were no signiﬁcant differences in CA activation 
between RF and Cryo, with both of them decreasing after heparin (Fig B). Conclusions. 
Signiﬁcant Plt and CA activation were observed during PV isolation procedure. The use of 
Cryo was associated with a signiﬁcantly lower Plt activation compared to RF, suggesting 
potentially lower thrombogenic risk during PV isolation procedure. 
10:45 a.m.
847-4 Acute Efﬁcacy and Midterm Follow-up in Patients 
Treated by Circumferential Ostial Cryoisolation of 
Pulmonary Veins
Juergen Vogt, Johannes Heintze, Helga Buschler, Peter Schwartze, Dieter Horstkotte, 
Heart Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, 
Germany
Background: Segmental isolation of pulmonary veins (PV) with radiofrequency (RF) 
ablation is associated with reconducting muscle sleeves and the risk of PV stenoses. This 
study reports on the efﬁcacy of circumferential PV isolation using the new Arctic Circler 
(AC) (Cryocath, Canada).
Methods: Guided by a Lasso catheter before and after ablation, proximal PV isolation was 
performed using the up to 30 mm self-expanding AC over 4 minutes of cryoimpulses (CI) down 
to -85°C with N2O. Gaps were closed using a 6-/8-mm tip cryocatheter (Freezor xtra/max).
Results: 41 P (9 women, age 59±9 years, 38 with paroxysmal, 3 with persistent atrial 
ﬁbrillation (AF), 21 with lone AF, 12 with hypertension, 7 with CAD, 1 with mitral valve 
disease) were treated with the AC. 13 of 155 PV were isolated with 6 mm tip only. 142 PV 
(100%) were isolated, with AC alone in 44 % (62 PV) with additional gap closing in 56% 
(79 PV). During a follow-up of 8±4 months of 30 P after 1.4 procedures per P, 13 (43%) 
had no recurrence, 9 (30%) had a marked reduction of AF burden, i.e. an overall clinical 
improvement of 74%. 3 of 7 P without improvement had persistent AF. In 13 redos 43% 
(22 PV) of 51 PV were completely isolated (12 PV) or demonstrated 1-2 local inputs (10 
PV) only. Excluding persistent AF, the clinical success was 81%.
Conclusion: The combination of circumferential ostial PV isolation and gap closing 
with cryotechnique is highly effective. More cooling power is necessary to reduce PV 
reconduction. The risk of PV stenosis seems to be eliminated.
Targeted PV Diameter (mm)
Isolation 
AC
Freezor 
only
Isolation 
AC + 
Freezor
Isolation 
% total
Cryoimp 
AC
Cryoimp 
Freezor
left upper (n=41) 18±4 12 (29%) 1 28 100 5±2 6±4
left lower (n=36) 17±2 18 (50%) 5 13 100 3±1 5±2
right upper (n=41) 18±3 16 (39%) 3 22 100 4±1 5±4
right lower (n=34) 16±3 16 (47%) 4 14 100 3±1 4±3
right mid (n=3) 1 2 100
11:00 a.m.
847-5 Symptomatic and Asymptomatic Atrial Fibrillation in 
Patients Undergoing Radiofrequency Catheter Ablation
Chandrasekhar R. Vasamreddy, Darshan Dalal, Vinod Jayam, Zayd Eldadah, Timm 
Dickfeld, Jun Dong, Charles Henrickson, Glenn Meininger, Ronald Berger, Hugh 
Calkins, Johns Hopkins School of Medicine, Baltimore, MD
Background: The goals of this study are 1) to report the relationship between symptoms 
and atrial ﬁbrillation (AF), and 2) to report the efﬁcacy of catheter ablation procedure 
based on patient reported symptoms compared to the efﬁcacy based on monitoring 
systems that can detect both symptomatic and asymptomatic AF recurrences. 
Methods: 19 consecutive patients (12 men [63%]; age 60 + 6 years) with highly 
symptomatic drug refractory paroxysmal (6 patients [32%]), persistent (6 patients [32%]) 
or permanent (7 patients [38%]) AF underwent catheter ablation using the circumferential 
approach described by Pappone and colleagues. Patients were provided with mobile 
cardiac outpatient telemetry systems (MCOT) (CardioNet, USA) monitors and asked to 
wear it 5 days immediately before the ablation, and 5 days per month starting with the 
ablation for 6 consecutive months. When patients experienced any symptoms, they were 
asked to activate the system and asked to select one or more of the following symptoms: 
skipped beats, lightheadedness, fainting, shortness of breath, chest discomfort, fatigue, 
heart racing, and palpitations.
Results: A total of 494 days (11,856 hours) were monitored. During this period, 2870 
events occurred that were either triggered automatically [2480 (86%)] or by the patient 
[390(14%)] resulting in transmission of tracing. Of these 885 (31%) events were due to 
AF [156 (18%) symptomatic and 729 (82%) asymptomatic events]. Out of the total 390 
events triggered by patients’ symptoms, 40% were conﬁrmed as AF events (156) and 
60% were conﬁrmed as non-AF events (234). Out of the symptoms, only shortness of 
breath (OR: 5; P: 0.008) and chest discomfort (OR: 5; P=0.011) are highly associated with 
AF. Events with two or more symptoms are also highly associated with AF (OR: 6.7, P= 
0.001). At the end of 8 + 1 months of follow-up, 12 patients (63%) were considered to be 
free of AF based on the absence of symptomatic AF recurrences whereas 10 patients 
(53%) have achieved true success when asymptomatic AF recurrences were included in 
the outcome (p<0.05).
Conclusion: The reliance on patient reported symptoms appears to overestimate the 
efﬁcacy of catheter ablation of AF.
11:15 a.m.
847-6 Role of the Coronary Sinus in Atrial Arrhythmias 
Following Left Atrial Circumferential Ablation for Atrial 
Fibrillation
Aman Chugh, Hakan Oral, Kamala Tamirisa, Jihn Han, Eric Good, Kristina Lemola, 
Frank Bogun, Frank Pelosi, Jr., Fred Morady, University of Michigan, Ann Arbor, MI
BACKGROUND: The musculature of the coronary sinus (CS) has been implicated in 
a variety of supraventricular arrhythmias. Its role in arrhythmias following left atrial 
circumferential ablation for atrial ﬁbrillation (AF) is unknown. METHODS: Fourteen 
patients (Males=10, Age=55±10 years, EF=53±10, LA=4.3±0.5 cm, paroxysmal AF=9) 
were found to have atrial arrhythmias originating from the CS either during the initial 
procedure (4) or a repeat procedure for recurrent AF/atypical ﬂutter at follow up (10). 
A tachycardia was considered to be originating from the CS if the post pacing interval 
matched the tachycardia cycle length or if the tachycardia terminated during ablation in 
the coronary sinus or one of its branches. 
RESULTS: The mechanism was macroreentry in 13 patients (93%) and focal in one 
patient. The mean cycle length of the tachycardia in patients with macroreentry was 
260±29 ms (range, 190-310 ms). The cycle length of the focal tachycardia was 725 ms. 
The successful site was the proximal CS in 6 patients (43%) and distal CS in 8 patients 
(57%). Catheter ablation was successful in 13 patients (93%). Ablation was not performed 
in one patient because of high impedance. In six patients (43%), ≥45 W and >50° C were 
required for successful ablation. There were no complications. 
CONCLUSIONS: The musculature of the CS may serve as a site for macroreentrant atypical 
ﬂutter or focal atrial tachycardia following linear left atrial ablation for AF. Catheter ablation 
of these arrhythmias seems to be safe and effective. Although low power and temperature 
settings are usually recommended during radiofrequency application in the CS, a number of 
patients required signiﬁcantly higher energy delivery for successful ablation.
11:30 a.m.
847-7 Segmental Disconnection and Tissue Anisotropy at the 
Human Pulmonary Vein-Atrial Junction: Implications for 
Catheter Ablation of Atrial Fibrillation
Alex Y. Tan, Hongmei Li, Peng-Sheng Chen, Michael C. Fishbein, Cedars-Sinai Medical 
Center, Los Angeles, CA, David Geffen School of Medicine, UCLA, Los Angeles, CA
Background: We previously showed that in canines, pulmonary vein (PV) and left 
atrial (LA) muscle are disconnected preferentially in the anterior compared to posterior 
segments. This arrangement suggests that the posterior PV-LA junction may serve as the 
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preferred ablation target in PV-LA electrical disconnection, if this segmental variation is 
also present in the human PV-LA junction.
Methods: Parafﬁn embedded sections of PVs and adjoining LA were obtained from 7 adult 
human hearts at postmortem (age 54 ± 17 years). None had AF, structural heart disease or 
died of cardiac causes. Each vein was sectioned along its long axis into 6 segments (3 anterior, 
3 posterior) and stained with hematoxylin and eosin and Masson’s trichrome. Analysis was 
performed in blinded fashion with the aid of computer-assisted morphometry.
Results: Out of 168 sections from 28 veins, partial or complete PV-LA disconnection was 
observed in 74 sections (44%), more commonly in the anterior vs posterior junction (55 vs 
19, p<0.001). The gap between PV and LA muscle was 0.4 ± 0.23mm. LA to PV transition 
was marked by abrupt reduction of muscle sleeve thickness more prominent in the anterior vs 
posterior junction (by 75 ± 12% vs 52 ± 17%, P=0.003). Fiber orientation was more complex at 
the PV-LA junction than in the LA or distal PV, with 41 (24%) PV-LA junctions showing abrupt 
90-degree ﬁber direction changes from perpendicular to parallel or vice-versa. This ﬁnding 
was more common in the anterior vs the posterior junction (30 vs 11, p<0.001).
Conclusions: Segmental disconnection of PV and LA is more common and ﬁber 
orientation changes more pronounced in the anterior than posterior PV/LA junction. This 
anisotropy would favor impulse propagation in the posterior junction and suggests that 
catheter ablation targeting the posterior junction may be most efﬁcacious in disconnecting 
PV from LA in the treatment of atrial ﬁbrillation.
11:45 a.m.
847-8 Catheter Ablation for Persistent and Permanent Atrial 
ﬁbrillation: Left Atrial Ablation Alone Versus Biatrial 
Ablation
Leonardo Calo’, Filippo Lamberti, Maria Luisa Loricchio, Ermenegildo de Ruvo, Claudio 
Pandozi, Massimo Santini, San Filippo Neri Hospital, Rome, Italy
Background: Catheter ablation of atrial ﬁbrillation (AF) has a low efﬁcacy in patients 
(pts) with persistent and permanent AF.
Methods: Sixty patients with persistent (35 pts) and permanent AF (25 pts) highly 
symptomatic and refractory to anti-arrhythmic drugs (AAD) (22 women, 59± 9 yrs, 48 
pts with structural heart disease) were prospectively randomized to 2 different ablation 
approaches guided by CARTO mapping. Thirty pts underwent to circumferential pulmonary 
vein (PV) ablation and cavotricuspid isthmus ablation (approach A). In the other 30 pts 
the following lesions were added in the right atrium (approach B): 1) Intercaval posterior 
line; 2) Intercaval septal line through the fossa ovalis and the coronary sinus where a 
circumferential line around the ostium was performed; 3) Electrical disconnection of the 
superior vena cava. The clinical characteristics of the pts in the 2 groups were similar. All 
pts continued previously ineffective AAD for at least 6 months.
Results: During a mean follow-up of 12 ± 4 months, 63% of patients (19/30) who 
underwent left atrial and cavo-tricuspid ablation were AF free compared with 87% of 
patients (26/30) who underwent biatrial ablation (p=0,039, log rank test). Post-ablation 
re-mapping showed the absence of discrete electrical activity inside and just around 
ablation lines both in the left and in the right atrium. The mean duration of procedure 
and ﬂuoroscopy times for the approach A were 165±26 and 30±10 minutes, and for the 
approach B were 226±30 and 40±13 minutes. An hemothorax and a retroperitoneal 
hematoma occurred in 2 pts of the left atrial ablation group. During the follow-up left atrial 
ﬂutter, which resolved spontaneously, developed in 3 pts.
Conclusion: Our biatrial approach showed to be feasible, safe and effective to modify 
the right and left AF substrate. This study ﬁrst demonstrates that in pts with persistent and 
permanent AF the circumferential PV ablation in combination with linear lesions in the 
right atrium determines a signiﬁcant higher success rate than circumferential PV ablation 
and cavo-tricuspid isthmus ablation alone. These preliminary data need to be conﬁrmed 
in a randomized trial with larger population and longer follow-up.
POSTER SESSION
1163  Clinical and Basic Insights Into the 
Mechanisms of Atrial and Ventricular 
Fibrillation
Tuesday, March 08, 2005, 1:30 p.m.-5:00 p.m.
Orange County Convention Center, Hall E1
Presentation Hour: 3:30 p.m.-4:30 p.m.
1163-253 Enhanced Vagal Tone Has Disparate Effects on 
Atrioventricular Node Dual Pathway Electrophysiology 
During Atrial Fibrillation
Youhua Zhang, Seil Oh, Todor N. Mazgalev, Cleveland Clinic Foundation, Cleveland, OH
Background: The effects of enhanced vagal tone on atrioventricular node (AVN) dual 
pathway electrophysiology, especially during atrial ﬁbrillation (AF), is not clear. We used 
a novel index, His electrogram alternans (Circulation 2003;107:1059), to monitor the fast 
(FP) and slow pathway (SP) conduction on a beat-by-beat basis during AF in response 
to enhanced vagal tone.
Methods: Physostigmine (an acetylcholinesterase inhibitor) was used to enhance the 
vagal tone in 5 rabbit AVN preparations. Standard AVN conduction curves were generated 
by programmed stimulation and 500 RR intervals were collected during pace-induced AF, 
in control and after perfusion with Physostigmine (5x10-7M to 1x10-6M). Atropine (2x10-6M) 
was added ﬁnally to conﬁrm vagal effects.
Results: See ﬁgure. Physostigmine increased basic AVN conduction time (BCT) and 
functional refractory period (FRP) in a dose-dependent manner. The effective refractory 
periods (ERP) of both pathways were prolonged, but FP-ERP increased more than SP-
ERP (ΔFP-ERP=97 ms, vs ΔSP-ERP=57 ms at 1x10-6M physostigmine, p<0.05). During 
AF, the average RR intervals prolonged and the proportion of beats conducted via FP 
(%FP) declined (57% in control, to 23% at 1x10-6M physostigmine, p<0.05). These effects 
were abolished by atropine.
Conclusions: Enhanced vagal tone inhibited both FP and SP, but FP was more sensitive 
than the SP. Under enhanced vagal tone, SP played a dominant role in determining the 
ventricular rate during AF. 
1163-254 Atrial Fibrillation in Humans Is Not Associated With 
Atrial Sympathetic Hyperinnervation
Paul A. Gould, Michael Yii, Samara Finch, Tanneale Marshall, Flora Socratos, Gavin 
Lambert, David M. Kaye, Baker Heart Research Institute, Melbourne, Australia, 
Department of Cardiothoracic Surgery St Vincent’s Hospital, Melbourne, Australia
Background: Pacing animal models of atrial ﬁbrillation (AF) have demonstrated 
sympathetic hyper-innervation of the left and right atrium. We believed this is secondary 
to pacing and not related to AF. As this ﬁnding may have implications for management of 
AF in humans, we sought to investigate atrial sympathetic innervation in human AF and 
compare this with sinus rhythm (SR).
Methods: In 24 patients (12 in SR and 12 in AF) undergoing bypass surgery we collected 
right atrial appendages and also 12 left atrial appendages in AF patients only. We then 
performed immuno-histochemistal staining for tyrosine hydroxylase (TH) and growth 
associated protein (GAP43). In addition we performed real time polymerase chain reaction to 
quantify expression of nerve growth factor (NGF) RNA and measured tissue norepinephrine 
using high performance liquid chromatography and electrochemical detection.
Results: The amount of TH (AF 0.23 ± 0.1%, SR 0.19 ± 0.07%, p=0.90) and GAP43 (AF 
0.83 ± 0.7% , SR 0.69 ± 0.3% , p=0.67) neural staining as assessed by percentage area 
of 10 ﬁelds at 10X magniﬁcation using light microscopy was not signiﬁcantly different 
between right atria from either AF or SR group. NGF RNA expression (p = 0.81) and 
tissue norepinephrine content (p= 0.27) were also not signiﬁcantly different between right 
atria in SR or AF. However in the AF group, tissue norepinephrine (p<0.001) and TH 
staining (p= 0.049) were signiﬁcantly greater in the right atrial appendage compared with 
the left, implying greater sympathetic innervation on the right.
Conclusion: AF in humans is not associated with sympathetic hyper-innervation. That 
seen in pacing induced animal AF is likely secondary to pacing. In human AF there is 
greater sympathetic innervation of the right atrium compared with the left.
1163-255 Nerve Sprouting and a Canine Model of Paroxysmal 
Atrial Fibrillation
Moshe Swissa, Shengmei Zhou, Ofﬁr Paz, Michael C. Fishbein, Lan S. Chen, Peng-
Sheng Chen, Cedars-Sinai Medical Center, Los Angeles, CA, Childrens Hospital Los 
Angeles and USC Keck School of Medicine, Los Angeles, CA
Background: We hypothesize that the induction of atrial nerve sprouting and sympathetic 
hyperinnervation in dogs with electrical remodeling may create a model of paroxysmal 
atrial ﬁbrillation (PAF) and paroxysmal atrial ﬂutter (PAFL).
Methods and Results: We studied 6 dogs (experimental group) with complete heart 
block, myocardial infarction and sympathetic hyperinnervation induced either by nerve 
growth factor (NGF) infusion (N=2) or subthreshold electrical stimulation (N=4) of the left 
stellate ganglion (LSG). Cardiac rhythm was continuously monitored by a Data Sciences 
International (DSI) transmitter for 43±31 days. Three normal dogs were also monitored to 
serve as rhythm control. Six additional normal dogs were used for histology control. PAF 
and PAFL were documented in all dogs of experimental group, with an average of 3.9±3.3 
episodes per day including 1.7±1.7 episodes of PAF and 2.2±2.1 episodes of PAFL. The 
duration averaged 314±648 s (range 7 s - 4000 s). There was a circadian pattern of 
arrhythmia onset (P<0.01), with the highest incidence in morning and early afternoon. 
Normal dogs did not have either PAF or PAFL. The hearts from dogs with LSG electrical 
stimulation had a higher density of nerve structures immunopositive (P<0.01) in both right 
and left atria than that of control dogs.
Conclusions: Induction of nerve sprouting and sympathetic hyperinnervation in dogs 
with AV block and myocardial infarction creates a model of PAF and PAFL. The circadian 
pattern of arrhythmia onset suggests that the sympathetic tone played an important role 
in the generation of PAF and PAFL.
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1163-256 Altered Patterns of Gene Expression in Response to 
Chronic Atrial Fibrillation
Youngkeun Ahn, Nam Ho Kim, Seok Kyu Oh, Myung Ho Jeong, Jeong Gwan Cho, 
Byung Hee Ahn, Jong Bum Choi, Hyun Kook, Jong Chun Park, Jin-Won Jeong, Jung 
Chaee Kang, Chonnam National University Hospital, Gwangju, South Korea
Background: To obtain more insight into atrial remodeling at the molecular level we 
analyzed the changes in the gene expression in human atrial tissue between the patients 
with chronic AF and those with normal sinus rhythm (NSR). 
Methods: cDNA microarray analysis was used to identify genes differentially expressed 
during sustained AF of more than 6 months (n=8, mean age=45±12, M:F=2:1) as compared 
to those with NSR (n=8, mean age=47±13, M:F=2:1). Western blot analysis was performed 
to conﬁrm the altered gene expressionand to establish the changes in protein expression 
between those with chronic AF and the NSR group. DNA gel electrophoresis to establish 
the DNA ladder formation which was associated with apoptosis in response to chronic AF 
was performed in the chronic AF and NSR groups. Microscopic ﬁndings were observed via 
electron microscopy between the patient with chronic AF and the NSR group. 
Results: In the microarray analysis, out of 8,167 candidate genes, 66 genes showed a 
signiﬁcant change in the expression level in the patients with chronic AF, which was in 
contrast to those with NSR. Among those, 31 genes were consistently down-regulated 
and 35 up-regulated more than 2-fold. The relative amounts of the Bcl-2 and p27 in the 
atrial tissue were decreased (p=0.017, p=0.014, respectively) and AT2-R and p21 were 
increased (p=0.035, p=0.045, respectively) in the patients with chronic AF as compared to 
those with NSR. The atrial cardiomyocytes in chronic AF showed a prominent DNA ladder, 
which is a biochemical hallmark of apoptosis. An abnormal ultrastructure was seen in the 
mitochondria, intercalated disks, and sarcomeres in the atrial tissue samples taken from 
the patients with chronic AF. 
Conclusions: The expression of Bcl-2, AT2-R, p21, and p27 was consistent with 
a signiﬁcant role in the apoptosis of cardiac myocytes in the patients with chronic AF. 
Further study on the effect of the drugs which modulate the expression of these proteins 
in patients with chronic AF will be needed.
1163-257 New Insights into the Atrial Flutter Reentry Circuit - 
Studies during Entrainment
Naomichi Matsumoto, Celeen M. Khrestian, Kyungmoo Ryu, Albert L. Waldo, Case 
Western Reserve University, Cleveland, OH
Background: Atrial ﬂutter (AFL) due either to single loop or double loop reentry occurs in 
the canine sterile pericarditis model. We tested the hypothesis that in this model: 1) the cavo-
tricuspid (CT) isthmus is a critical part of both types of AFL; 2) an area of slow conduction in 
the reentrant circuit is always present in the right atrial (RA) free wall, not the CT isthmus.
Methods: Studies were performed 4 days after the creation of sterile pericarditis in 6 
dogs. During induced, sustained AFL (> 10 minutes), simultaneous, multisite, epicardial 
mapping was performed from 404 electrodes placed on both atria in the open chest state 
together with either a halo electrode catheter (10 pairs) at the tricuspid annulus or a 
quadripolar catheter at the CT isthmus. Entrainment pacing during AFL was performed 
from the CT isthmus at cycle lengths (CLs) 5-10 ms less than the AFL CLs. Sites were 
considered to be within the AFL reentrant circuit when the post pacing interval (PPI) 
minus AFL CL was ≤ 30 ms. The PPI was deﬁned as the time from the last captured 
electrogram to the onset of the ﬁrst post pacing electrogram at a site immediately adjacent 
to the pacing site. Results: During 6 episodes of AFL (mean CL 159±21 ms, range 138-
193 ms), 3 single loop reentry circuits and 1 double loop reentry circuit were shown to 
have the CT isthmus within the AFL reentry circuit (PPI minus AFL CLs were < 20 ms, 
mean 10±5 ms). In all of these examples, atrial septal activation was part of the reentrant 
circuit. Mapping and entrainment pacing during the other 2 AFL episodes demonstrated 
RA free wall reentry without involvement of the CT isthmus in the AFL reentry circuit (PPI 
minus AFL CLs were > 30 ms, mean 40±14 ms). Also, the PPI was signiﬁcantly longer 
than when the CT isthmus was in the circuit (p < 0.01). The area of slow conduction was 
in the RA free wall, and showed increased crowding of isochrones as the pacing CL was 
decreased during entrainment pacing.
Conclusions: In the canine sterile pericarditis model of AFL, 1) the CT isthmus is not 
always part of the reentry circuit; 2) the area of slow conduction is always in the RA 
free wall.
1163-258 Autonomic Innervation of the Pulmonary Veins
Joseph S. Ulphani, Alan Kadish, Firdous Inderyas, David Gordon, Kathleen Harris, 
Jeffrey Goldberger, Robert Decker, Alexander Morris, Shawana Zahir, Jason Ng, Rishi 
Arora, Northwestern University, Chicago, IL
BACKGROUND: The autonomic nervous system is believed to play a role in the 
genesis of focal atrial ﬁbrillation. However, the precise distribution of sympathetic and 
parasympathetic nerves within the pulmonary veins (PV) has not been systematically 
described.
METHODS: Serial circumferential cross-sections from normal canine PVs (N=6) were 
studied. The PV myocardium was immunostained for sympathetic (tyrosine hydroxylase, 
dopamine beta-hydroxylase) and parasympathetic nerves (acetylcholine esterase, 
choline acetyltransferase).
RESULTS: Sympathetic and parasympathetic innervation was noted in the PV myocardial 
sleeves; nerve bundles were mostly localized to the subepicardial aspect of the PVs. 
Double-staining revealed predominatly parasympathetic nerves within individual nerve 
bundles. The ﬁgure shows parasympathetic staining (brown wavy nerve ﬁbers) and 
sympathetic staining (dark blue) within a single nerve bundle from a circumferential 
section at 40X magniﬁcation.
CONCLUSIONS: Sympathetic and parasympathetic innervation of the PVs appears to 
be heterogeneous in nature; this heterogeneity may contribute to the electrophysiologic 
substrate for focal atrial ﬁbrillation.
 
1163-259 Sustained Atrial Fibrillation and Enhanced 
Susceptibility to Ventricular Tachycardia in the Annexin 
A7-Deﬁcient Mouse
Jan W. Schrickel, Claudia Herr, Christoph S. Clemen, Martina Rick, Christian Grohé, 
Rainer Meyer, Klaus Tiemann, Rolf Schroeder, Angelika A. Noegel, Berndt Luederitz, 
Thorsten Lewalter, University of Bonn, Bonn, Germany
Background: Annexin A7 (anxA7) is thought to be involved in membrane organization 
and Ca2+-dependent signalling processes. In isolated cardiomyocytes of anxA7-/- mice, 
altered cell shortening frequency relation has been detected and attributed to anxA7 
related changes of Ca2+ homeostasis. The aim of the present investigation was to evaluate 
cardiac electrophysiologic properties in anxA7-deﬁcient mice in vivo.
Methods: 33 male mice (12.7±0.5 weeks, 14 anxA7+/+, 19 anxA7-/-) were examined in 
inhalative anaesthesia by transvenous intracardiac atrial and ventricular stimulation. 
Baseline ECG- and electrophysiologic parameters as well as incidence and inducibility of 
atrial and ventricular arrhythmias were evaluated.
Results: The surface ECG of anxA7-/- showed a signiﬁcantly shorter P-wave (14.9±3.7ms 
vs. 18.1±2.7ms; P<0.01) and QRS-interval (15.3±2.4ms vs. 17.4±2.7ms, P<0.05) as 
compared to anxA7+/+. AnxA7-/- showed signiﬁcant higher susceptibility to induction 
of atrial ﬁbrillation (AF) (4.4±1.7 vs. 2.7±2.0 inducible episodes/animal; p<0.02). As 
major ﬁnding, sustained AF >30min was found in 4 of 19 anxA7-/-, whereas the longest 
episode in anxA7+/+ lasted only 480.1sec. Incidence of ventricular tachycardia (VT) was 
signiﬁcantly higher in anxA7-/- after programmed (3.8±3.1 vs. 0.6±1.1 inducible episodes/
animal; P<0.01) and burst ventricular stimulation (2.6±3.2 vs. 0.7±1.1 episodes/animal; 
P<0.05); VT lasted signiﬁcantly longer in mutant mice. These ﬁndings were accompanied 
by the presence of relevant Ca2+-overload in anxA7-/- ventricular tissue.
Conclusions:AnxA7-deﬁciency signiﬁcantly elevates susceptibility to atrial and 
ventricular arrhythmia and perpetuates AF in a relevant part of the investigated animals. 
These observations might be attributable to alterations of Ca2+-homeostasis and Ca2+-
overload in murine cardiomyocytes.
1163-260 Enalapril Preserves Sinus Node Function in a Canine 
Atrial Fibrillation Model Induced by Rapid Atrial Pacing
Masao Sakabe, Akira Fujiki, Hidehiko Nagasawa, Kunihiro Nishida, Masataka Sugao, 
Takayuki Tsuneda, Hiroshi Inoue, Toyama Medical and Pharmaceutical University, 
Toyama, Japan
Effects of enalapril on canine sinus node (SN) dysfunction induced by rapid atrial pacing 
were investigated. 
Methods: Seventeen beagles were pretreated with placebo (G-I, n=9) or enalapril 1mg/
kg/day (G-II, n=8). All beagles were paced at 500bpm from the right atrial appendage for 
4 weeks. Six sham dogs were serving as the control for histological analyses.
After 30 sec overdrive pacing, the longest interval from the last paced atrial depolarization 
to the ﬁrst spontaneous sinus cycle was recorded as sinus node recovery time (SNRT). 
SNRT, intrinsic SN cycle length (SCL), atrial effective refractory period (AERP) and the 
duration of AF were measured every week. Corrected SNRT (CSNRT) was deﬁned as 
SNRT minus SCL.
After 4 weeks pacing, quantitative analysis of interstitial ﬁbrosis (IF) and fatty degeneration 
in SN was performed with Masson’s trichrome stain, and apoptosis of sinus nodal cell was 
detected with TUNEL method.
Results: In G-I, rapid atrial pacing progressively prolonged CSNRT (from 260.0 ± 25.8 to 
717.4 ± 51.5 ms:p<0.005). In G-II enalapril shortened CSNRT (409.8 ± 37.2ms: p<0.005) 
compared with in G-I after 4weeks of pacing. SCL was shorter in G-II than in G-I after 
4weeks of pacing (426 ± 33.7 v.s. 567.6 ± 72.6ms:p<0.05). AERP did not differ between 
two groups. The duration of AF was signiﬁcantly shorter in G-II (3.6 ± 0.7sec) than in G-I 
(48.3 ± 10.5sec: p<0.005).
In the SN area IF in G-I (9.7 ± 1.9%: p<0.05) was greater than in sham group (2.4 ± 0.9%). 
Enalapril signiﬁcantly suppressed the ﬁbrosis in G-II (4.0 ± 2.0%: p<0.05). Inﬁltration of 
fat into the SN was signiﬁcantly greater in G-I (32.6 ± 5.9%) compared with sham group 
(4.2 ± 2.1%: p<0.005) and G-II (4.0 ± 1.7%: p<0.005). In regard to atrium, IF was also 
signiﬁcantly greater in G-I (13.3 ± 5.1%) compared with sham group (1.4 ± 0.5%: p<0.05) 
and G-II (1.5 ± 0.4%: p<0.05). TUNNEL positive cells were observed in three of nine dogs 
in Group-I, but none in sham and Group-II.
Conclusions: Rapid atrial pacing impaired sinus node function with ﬁbrosis and fatty 
degeneration of sinus nodal cells and enalapril prevented the change. These ﬁndings 
suggest the suppression of degenerative changes in SN by enalapril may preserve sinus 
node function in AF.
1163-261 Three Dimensional Mapping of Postshock Activation 
After Ventricular Deﬁbrillation in Pig Hearts
Xianhong Fang, Gregory P. Walcott, Cheryl R. Killingsworth, Dennis Rollins, Anthony 
L. Sims, William Smith, Raymond E. Ideker, University of Alabama at Birmingham, 
Birmingham, AL
Background: The exact mechanism of deﬁbrillation is still controversial. One debated 
issue is the spread pattern of postshock activation. Reentrant and focal activation patterns 
both have been observed in previous studies with a shock strength near the deﬁbrillation 
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threshold (DFT). Since mapping in most of these studies was conﬁned to the epicardium, 
we evaluated postshock activation after deﬁbrillation in 3 dimensions in vivo in pig hearts 
using plunge needles.
Methods: In 6 open-chest pigs, 84 plunge needles each containing 6 (LV) or 4 (RV) 
electrodes 2 mm apart were inserted throughout both ventricular free walls. After inducing 
ventricular ﬁbrillation, shocks of DFT strength and of sub-DFT strength (20% below DFT 
voltage) were given from deﬁbrillation electrodes in the RV and SVC. After the study, 
the distances between electrodes were determined by manual digitization of the plunge 
needle locations.
Results: In 28 of the 43 (65%) deﬁbrillation episodes, the site of earliest postshock 
activation was recorded in the subepicardial electrodes within 4 mm of the epicardium 
near the LV apex. A total of 141 double potentials (DPs) were recorded near the earliest 
postshock activation site, 68 (48%) of which were in the subepicardium. In 31 of the 43 
deﬁbrillation episodes, a complete intramural reentrant circuit was observed near the LV 
apex. The perimeter of this reentrant circuit was signiﬁcantly larger following sub-DFT 
shocks than following DFT strength shocks (55±10 versus 46±9 mm, p<0.01).
Conclusion: This 3 dimensional mapping study revealed intramural reentry during the 
ﬁrst postshock activation cycle in most failed deﬁbrillation episodes. As the shock strength 
increased nearer to the DFT, the size of the reentrant pathway decreased. Approximately 
two-thirds of the earliest postshock activation sites and and half of DPs were located in the 
subepicardium, the most distal extent of the Purkinje ﬁber distribution in pig hearts.
1163-262 Decreased Arrhythmia Vulnerability in a Novel Rabbit 
Model of Left Ventricular Aneurysm Repair
Hirotsugu Yamada, Yoshio Ootaki, Zoran Popovic, Masao Daimon, Keiji Kamohara, Don 
Wallick, James Thomas, David Van Wagoner, Kiyotaka Fukamachi, Yuanna Cheng, The 
Cleveland Clinic Foundation, Cleveland, OH
Background: Left ventricular (LV) aneurysm repair is a surgical technique that aims to 
restore cardiac geometry and function. The electrophysiologic impact of such surgical 
intervention is less known.
Methods: Myocardial infarction (MI) was created by ligation of proximal left circumﬂex 
artery in 4 rabbits, resulting in LV apical aneurysm. After 4 weeks, rabbits underwent 
LV repair by plication of the akinetic LV region using epicardial and transesophageal 
echocardiography (echo) via intracardiac ultrasound catheter. LV end-diastolic (EDV) and 
end-systolic (ESV) volumes were measured by transthoracic echo before and weekly 
after LV repair. Fast ﬂuorescence imaging with voltage-sensitive dyes was performed on 
Langendorff-perfused rabbit hearts 4 weeks post-plication. Shock-induced vulnerability 
was assessed using monophasic shocks of ±100V, ±130V, ±160V, ±190V and ±220V 
applied at 25%, 50% and 75% of action potential duration (APD), delivered via a right 
ventricular lead from a 150µF capacitor deﬁbrillator. Vulnerability data were compared 
with data from structurally normal (n=8) and healed-infarct hearts (4 weeks or older, n=8) 
by grouping anodal or cathodal shocks applied at all phases of APD.
Results: LV repair reduced EDV (4.7±1.0 to 3.5±0.6 ml, p<0.05) and ESV (2.6±0.6 
to 1.5±0.2 ml, p<0.01) and increased LV ejection fraction (EF) (44.6±6.8 to 56.7±5.8 
%, p<0.01). EF was 54.8±6.2% at 1 week and 52.0±1.8% at 3 weeks after plication. 
Incidence of shock-induced sustained arrhythmia (6 or more post-shock extra beats) 
post-plication was comparable to normal hearts but substantially reduced compared to 
infarcted, nonplicated hearts (anodal shocks: 6.7% vs. 33%, p<0.001; cathodal shocks: 
33% vs. 70%, p<0.001). There was also striking reduction in the incidence of long lasting 
arrhythmia (>30 sec, required rescue shock to terminate) in plicated vs. infarcted hearts 
(anodal shocks: 0% vs. 30%, p<0.001; cathodal shocks: 6.7% vs. 59%, p<0.001).
Conclusion: This study demonstrates that hemodynamic improvement following infarct 
plication is accompanied by a striking reduction of arrhythmia vulnerability and incidence, 
suggesting a potential beneﬁt of this therapeutic approach.
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1164-247 Signiﬁcance Of A Thermal Effect On Vagal Nerve 
System During Ablation In Pulmonary Veins; Analysis 
Using Our Thermal Balloon Catheter
Kazushi Tanaka, Hiroshi Sohara, Shuutaro Satake, Shigeru Saitou, Yoshio Watanabe, 
Shonan Kamakura General Hospital, Kamakura-shi, Japan
We retrospectively evaluated an effect of vagal modiﬁcation (VM) induced by pulmonary 
vein (PV) isolation on the recurrence of paroxysmal atrial ﬁbrillation (PAF).
Methods: The study population consisted of 21 patients with PAF treated by radiofrequency 
catheter ablation (RFA) using our original thermal balloon catheter. Exclusion criteria were 
as follows; sick sinus syndrome, injection of atropine sulfate during the procedure, frequent 
appearance of atrial premature beats or taking a beta-blocker. The initial RFA targeting 
the left superior PV was commenced at 55°C of the balloon surface temperature with 
energy delivery duration for 3-5 minutes. Unless the elimination of all the PV potentials 
could be obtained, the procedure was repeated in a step-up of the temperature by 2-3°C. 
Subsequently, the same protocol was applied to the right superior PV, and if possible, 
next the left inferior PV and ﬁnally the right inferior PV. To evaluate the vagal activity, all 
the sinus cycle lengths (SCLs) during the energy delivery were measured. The ﬂuctuation 
exceeding 100ms of the SCLs was conveniently determined as the VM; namely, the 
prolongation of the SCLs as the vagal reﬂex and the shortening of the SCLs following the 
reﬂex as the vagal denervation. 
Results: Mean attempts of the energy delivery for the left superior PVs, right superior 
PVs, left inferior PVs and right inferior PVs were 2.8, 1.7, 1.8 and 1.5, respectively. After 
all, the vagal reﬂex and/or denervation were observed in 10 patients (the group VM+, a 
mean age of 56 ± 11 years), and the remaining 11 patients were assigned to the group 
VM- (56 ± 11 years). In the group VM+, the VM was observed during the RFAs of the left 
superior PVs in all patients, in one of whom it also appeared during the left inferior PV. 
However, this phenomenon could not be induced during the RFAs of the right PVs. In a 
mean follow-up period of 24 ± 5 (17-30) months, the recurrence of PAF was observed in 
10% of the group VM+ vs. in 45% of the group VM- (P=0.0127 by log-rank test).
Conclusions: These results may indicate that the vagal innervation near the PVs is 
inhomogeneous and has a trend to converge around the left superior PV and that the VM 
can reduce the recurrence rate of PAF in a chronic period.
1164-248 Changes in Left Atrial Size and Function by Magnetic 
Resonance Imaging After Left Atrial Linear Ablation
Thomas M. Meyer, Robert L. Eisner, David B. Delurgio, Fernando V. Mera, Angel R. 
Leon, Emory Crawford Long Hospital, Atlanta, GA
Background: Left atrial (LA) linear radiofrequency (RF) ablation has been shown to be 
effective in the elimination of atrial ﬁbrillation (AF). Whether the extensive LA lesions 
involved in this procedure affect atrial function and geometry has not been thoroughly 
studied. Therefore, we sought to determine the effects of LA linear ablation on atrial 
remodeling by measuring changes in LA volume and ejection fraction (EF).
Methods: Eleven patients with AF underwent LA ablation. Contrast-enhanced magnetic 
resonance angiography (CE-MRA) and cine magnetic resonance (MR) of the left atrium 
were performed before and 3 months after ablation. LA volume was measured from the 
CE-MRA. In addition, for six patients that were in sinus rhythm during both the pre and post 
MR, an atrial ejection fraction (EF) was measured by cine magnetic resonance (MR).
Results: Changes in LA volume and EF before and after ablation for individual patients 
and as a mean are reported in the Table. Most patients (except Patients 2 & 4) had a 
signiﬁcant decrease in LA volume after ablation. In the six patients in whom EF could be 
calculated, all but Patient 1 had a decrease in LA EF.
Conclusions: In most patients, LA linear RF ablation results in a reduction in LA volumes. 
However, this apparent positive remodeling does not translate into improved atrial function as 
measured by LA EF. In fact, atrial function may actually worsen after extensive LA ablation.
Table
Patient
LA 
Volume,ml
(pre)
LA 
Volume,ml
(post)
Volume 
Change (%)
LA EF %
(pre)
LA EF %
(post)
EF Change 
%
1 116 101 -13% 40 43 +8
2 72 95 +32% 54 40 -26
3 99 76 -23% 48 34 -29
4 83 104 +25% 46 35 -24
5 94 92 -2% 45 40 -11
6 92 63 -32% 46 37 -20
7 71 53 -25% N/A N/A
8 115 89 -23% N/A N/A
9 72 67 -7% N/A N/A
10 81 73 -10% N/A N/A
11 136 124 -9% N/A N/A
MEAN 94 (+/-21) 85 (+/-21) -8% (+/-20) (p=0.13) 52 (+/-14) 38 (+/-3)
-17%(+/-14) 
(p=0.10)
1164-249 A Combined Approach in the Catheter Ablation of Atrial 
Fibrillation: Circumferential Left Atrial Ablation With 
Electrical Isolation of the Pulmonary Veins
Jesse S. Sethi, Bryan Piedad, John R. Bullinga, David Feigenblum, Jason Chinitz, 
Douglas Holmes, Neil Bernstein, Larry Chinitz, NYU Medical Center, New York, NY
Background- Circumferential left atrial catheter ablation (LACA) and segmental 
ostial catheter ablation (SOCA) of the pulmonary veins (PV) have both been shown to 
be efﬁcacious techniques in the treatment of atrial ﬁbrillation (AF). However, there is 
conﬂicting data as to which approach confers better clinical outcomes. We employed a 
combined approach, performing LACA followed by SOCA to ensure PV isolation. There is 
no prior data reported on such an approach.
Methods- 154 consecutive patients (mean age 55 ± 11 yrs, 119 males) with paroxysmal 
(133 pts) or persistent (21 pts) AF underwent either SOCA (91 pts) or a combined approach 
(LACA+SOCA - 63 pts). SOCA was performed using an 8-mm tip ablation catheter and 
a 10-pole circular mapping catheter. LACA+SOCA utilized an 8-mm tip ablation catheter 
and the assistance of a non-ﬂuoroscopic, three-dimensional, surface electrode-based 
navigation system (NavX, Endocardial Solutions). After LACA, the circular mapping 
catheter was positioned at the ostia of each of the PVs, and SOCA was performed.
Results- The mean procedure time was 165 ± 50 min in the SOCA group and 179 ± 59 
min in the LACA+SOCA group (p=NS). After completion of LACA, there was incomplete 
electrical isolation in a mean of 2.61 ± 0.78 PVs per patient. Subsequent SOCA required 
a mean of 18.1 ± 7 additional ablation lesions per patient (mean of 10 ± 4.5 min of ablation 
time) to achieve complete electrical isolation of the PVs. At a mean follow-up of 13.9 ± 9.3 
months, the incidence of AF recurrence was 32.9% in the patients who underwent SOCA 
and 17.5% in the patients who underwent LACA+SOCA (p=0.03). Among the variables 
of male sex, age, presence of persistent AF, hypertension, diabetes, enlarged left atrium 
or reduced left ventricular ejection fraction, only the utilization of the SOCA technique as 
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opposed to SOCA+LACA was an independent predictor of AF recurrence. There were 
two adverse events in the SOCA group (stroke, tamponade) and one (tamponade) in the 
LACA+SOCA group (p=NS).
Conclusions- A combined approach of LACA followed by SOCA signiﬁcantly reduces 
AF recurrence compared with SOCA alone, and ensures an electrical endpoint without a 
signiﬁcant increase in complications or procedure time.
1164-250 Pulmonary Vein Isolation Yields High Success Rates in 
Persistent Atrial Fibrillation
Tina C. Sichrovsky, Aysha Arshad, Sandeep Joshi, Amit Kamra, Lance Weathers, 
Jonathan S. Steinberg, St.Luke’s-Roosevelt Hospital Center, New York, NY
Background: Pulmonary vein isolation (PVI) for the treatment of paroxysmal atrial 
ﬁbrillation (PAF) has excellent success rates. Since published outcomes for persistent 
(pers) AF are low (<25%), many centers use alternative approaches. The lower success 
rate may be due to pronounced, but potentially reversible, remodeling. We compared our 
PVI experience in persAF, when pretreated with cardioversion and antiarrhythmic drugs 
(AAD), to PAF.
Methods and Results: 185 consecutive patients (pts), (age 56±11 years, 73% male) 
underwent PVI, 142 (76%) had PAF and 43 (24%) persAF. There was no difference in 
age, underlying cardiovascular disease, left ventricular function or left atrial enlargement 
between groups. Pts with persAF had a shorter total history of AF (1.0±0.8 vs 6.3 ±6.5 
years, p< 0.001) than pts with PAF.
Pts with persAF received dofetilide (40%), amiodarone (19%) or sotalol (12%) for 1 month 
pre- and post-PVI and 66% were in sinus rhythm (SR) at PVI. AADs were discontinued at 
1 month, and during follow-up of 585±351 days, freedom from recurrence off AADs was 
achieved in 81% of pts with persAF compared to 87% of pts with PAF (p=NS). Marked 
improvement with decreased AF burden was achieved in 85% of pts with persAF and 95% 
of pts with PAF (p=NS)
Conclusions: Pts with persAF have outcomes after PVI comparable to pts with PAF, 
perhaps related to peri-procedure reverse remodeling facilitated by return to SR with 
cardioversion and short-term AAD treatment. These pts should be considered acceptable 
candidates for PVI. 
1164-251 Time Interval From Pulmonary Vein Isolation Using 
Cryoablation to the First Atrial Fibrillation Recurrence
Yves Van Belle, Carl Timmermans, Randy Manusama, Maud Van De Schoot, Suzanne 
Philippens, Harry Crijns, Luz-Maria Rodriguez, Academic Hospital Maastricht, 
Maastricht, The Netherlands
BACKGROUND: This study was designed to observe the time interval from pulmonary 
vein isolation (PVI) to the ﬁrst recurrence of atrial ﬁbrillation.
METHODS: Forty patients (31 men; age 47±10 years) underwent segmental PVI with 
cryoablation (single session: n=37, double session: n=3). All patients had drug resistant 
PAF (2.0±1.3 failed AAD’s) without structural heart disease (LA diameter 40±5 mm, LVEF 
59±9%, AF duration 4±3 years). Transtelephonic Holter monitoring was used on a daily 
and symptomatic basis during 1 month before PVI and 3 to 6 months after, followed by 
visits to our outpatient clinic every 2 months. Patients were all highly symptomatic and 
kept a diary of AF related symptoms during that same period.
RESULTS: A mean of 2.5±0.7 PV’s per patient were ablated. AF recurrence was observed 
in 30 out of 40 patients (75%). The mean time to ﬁrst recurrence was 17.5 days (range 
1-165). The majority of recurrences (83%) occurred within 14 days after PVI (ﬁgure). After 
a follow up of 490±351 days 63% of patients (25/40) were free of AF.
CONCLUSIONS: Long term follow-up shows that the ﬁrst AF recurrence after cryoablation 
for pulmonary vein isolation occurs frequently and especially early after the procedure. 
Although a large number of patients have short term recurrence, the majority of them 
(63%) become free of AF after more than a year. 
1164-252 Does Increased Area of Pulmonary Vein Isolation 
Decrease the Number of Non Pulmonary Initiators  
of Atrial Fibrillation?
Ron D b Simon, Scott Burke, Lacy Sturdivant, Robert Leman, Michael R. Gold, Barbara 
Knick, J Marcus Wharton, MUSC, Charleston, SC
Background: Atrial ﬁbrillation (AF) ablation should probably involve pulmonary vein (PV) 
isolation and ablation of non-pulmonary initiators (NPIs). The optimal method for achieving 
this remains controversial. Three possible approaches are: Method 1: an ostial segmental 
PV isolation; Method 2: a periostial anatomical PV isolation; and Method 3: a wide area 
circumferential ablation (WACA) including a roof and left atrial isthmus line guided by 
electroanatomical mapping. Theoretically, the number of NPI sites in the left atrium will 
be reduced by Method 2 and more so by Method 3, compared with Method 1, making the 
subsequent ablation of NPIs less arduous and possibly unnecessary.
Methods: We performed AF ablation on 171 consecutive patients using Methods 1, 2, 
and 3 in consecutive cohorts. NPIs were then mapped and ablated. NPIs caused either 
repetitive premature atrial complexes, atrial tachycardia and/or AF, either spontaneously 
or after atrial burst pacing or induction of AF followed by DC cardioversion, on or off 
isoproterenol. The percentage of patients with NPIs in each ablation group seen after PV 
isolation was analyzed.
Results: AF ablations were performed in 171 patients, with groups equivalently matched 
for age, gender, and presence of cardiovascular disease. The percentage of patients 
with NPIs with Methods 1, 2, and 3 was similar (49%, 53%, and 55%, respectively). The 
percentage of right sided NPIs in each group were 23%, 44%, and 35%. The percentage 
of left sided NPIs were 38%, 35% and 26%. The percentage of patients free of AF at 5 
months was 75%, 75% and 95%, respectively, for Methods 1, 2, and 3.
Conclusions: The total number of NPIs is high and unaffected by the ablation method. 
WACA does not reduce the number of NPIs and additional ablation of NPIs with WACA 
may increase the single procedure success rate.
1164-267 Mechanisms And Management Of Left Atrial 
Tachycardia Following Circumferential Left Atrial 
Ablation For Atrial Fibrillation
Carlo Pappone, Giuseppe Augello, Francesco Manguso, Nicoleta Sora, Valter Tortoriello, 
Gabriele Vicedomini, Vincenzo Santinelli, San Raffaele University Hospital, Milan, Italy
Background - We demonstrated that a modiﬁed circumferential PV ablation (CPVA-M) 
approach including additional lines on posterior wall and the mitral isthmus, reduces the 
incidence of left atrial tachycardia (LAT) after ablation.
Methods - A total of 420 patients underwent CPVA-M and were followed for 1 year. The 
endpoint was freedom from LAT after CPVA-M. There was a six-week blanking period 
during which arrhythmia occurrence was regarded as a transient phenomenon.
Results - Overall, 54 (13%) patients had recurrent AF beyond the blanking period. During 
the six-week blanking period, 38 (9%) patients had episodes of LAT. Beyond this blanking 
period, AT spontaneously resolved in 21 (56%, p = 0.01) patients. As a result, 17 of 
420 (4%, including 2 with AF recurrence) continued to experience AT. The mean time 
interval between the initial procedure and the ﬁrst occurrence of AT was 2.8±0.7 months. 
AT was incessant in all patients and in 12 of them resulted in syncope. Patients with 
incessant AT underwent a repeat procedure 4.8±0.6 months after the index procedure. 
Only multiple gaps were found in the 73% at the second procedure, whereas at the end of 
the ﬁrst procedure single gaps were present in 9%, and multiple in 64%, suggesting that 
recovery of conduction was an important factor in the occurrence of AT. Among patients 
with macroreentrant AT, the critical isthmus was localized to the area between the mitral 
annulus and the left inferior PVin 4 after CPVA-M, the area between the right PVs (4) or 
between the left PVs (4) with the circuit passing between the two ipsilateral veins at the 
site where previous intervenous lines were performed. In less than one third of patients 
AT was focal. RF ablation was successful in eliminating AT in all patients with up to 5 
RF applications delivered on the earliest site for focal AT and on the critical isthmus for 
macroreentrant AT.
Conclusions. Incessant AT after CPVA is a relatively common complication and its 
persistence often can result in syncope. Incessant AT requires a repeat procedure. 
However, postablation AT may be a transient phenomenon in more than a half of cases.
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1164-268 Successful Outcome with Targeted Ablation Strategy for 
Atrial Fibrillation: Patient Characteristics
William H. Sauer, Stuart Jay Beldner, Melissa L. McKernan, David Lin, Sanjay 
Dixit, Edward P. Gerstenfeld, David J. Callans, Francis E. Marchlinski, University of 
Pennsylvania, Philadelphia, PA
Background: An anatomic approach with empiric isolation of all pulmonary veins 
(PVs) for ablation of atrial ﬁbrillation (AF) has been advocated. However, some patients 
may beneﬁt from a more selective approach targeting AF triggers, thereby minimizing 
the potential for ablation related complications. We attempted to identify the clinical 
characteristics of such patients.
Methods: Data on 278 patients undergoing AF ablation between November 2000 and 
May 2003 was retrospectively analyzed to assess for potential clinical characteristics 
associated with fewer AF triggers. Electrophysiological studies using multipolar catheters 
in both atria during isoproterenol infusion (titrated up to 20 mcg/min) identiﬁed triggers 
initiating AF as originating from a pulmonary vein or other atrial source. Atrial ﬁbrillation 
control was deﬁned as no atrial ﬁbrillation on or off an anti-arrhythmic drug, or marked 
(>90%) reduction in symptoms. Follow up data included trans-telephonic monitoring and 
clinical data collection from patient interviews. The clinical characteristics of patients with 
successful ablation targeting 3 PV isolations.
Results: The average follow up for patients with AF control was 21.2 +/- 9.1 months 
(range 6 to 47 months). AF control was achieved in 190 of the 213 patients (89%) with 
more than 2 veins isolated and 57 of the 65 patients (88%) with fewer triggers of AF 
ablated. Of these 57 patients, 11 patients had 1 PV, 42 patients had 2 PVs, and 5 patients 
had non-PV triggers targeted. There were no signiﬁcant differences between the two 
groups of patients with respect to gender, duration of AF symptoms, left atrial size, or 
presence of mitral regurgitation or LV dysfunction. Successful ablation of AF triggers in 
2 veins or fewer was associated with younger age (51 vs. 56 years; P=0.01), absence 
of hypertension (27.3% vs. 47.3%; P=0.01), and a history of paroxysmal AF (93.7 % vs 
73.2%; P<0.01).
Conclusion: Absence of hypertension, younger age, and history of paroxysmal AF 
are associated with the presence of fewer arrhythmogenic pulmonary veins. Therefore, 
empiric isolation of all pulmonary veins in this group of patients may be unnecessary.
1164-269 The Need For Atrial Flutter Ablation Following 
Pulmonary Vein Antrum Isolation in Patients With And 
Without Prior Cardiac Surgery
Fethi Kilicaslan, Hirosuke Yamaji, Atul Verma, Nassir F Marrouche, Oussama Wazni, 
Jennifer E Cummings, Steven Hao, Michael Williams Andrews, Salwa Beheiry, William 
A Belden, Stephan Minor, George Joseph, David O Martin, J David Burkhardt, Walid 
Saliba, Robert A Schweikert, Andrea Natale, The Cleveland Clinic Foundation, 
Cleveland, OH, Sutter Pasiﬁc Heart Centers, San Francisco, CA
Background: Atrial ﬁbrillation (AF) and atrial ﬂutter (AFL) often coexist. Pulmonary vein 
(PV) triggers may induce both arrhythmias and pulmonary vein antrum isolation (PVAI) may 
be sufﬁcient to control both. However, in patients with prior cardiac surgery (PCS), atrial 
incisions and scar areas may cause AFL recurrence despite elimination of PV triggers. 
Objectives: To assess the incidence of AFL after PVAI in patients with PCS in comparison 
to patients without PCS and to assess the need for AFL ablation in both groups. 
Methods: Data from 1125 patients who had PVAI between 10/2000 and 12/2003 were 
analyzed. Of them, 63 patients (Group 1, 12 female, mean age 57±13 years) had PCS > 
6 months ago and the remaining 1062 had no history of PCS (Group 2, 212 female, mean 
age 55±12 years). Patients who had AFL ablation before or during PVAI were excluded 
from analysis. Patients with and without PCS did not differ in their age, duration and type 
of AF. Patients in Group 1 had larger left atrial diameter (4.7±0.7 vs 4.4±0.6, p=0.0001), 
higher incidence of AFL pre-PVAI (38% vs 22%, p=0.005), and lower ejection fraction 
(49±10 vs 54±8, p=0.0001). 
Results: There was no signiﬁcant difference in post-PVAI AF recurrence between 
Groups 1 and 2 (21% vs. 19% respectively, p=0.74). But AFL incidence post-PVAI was 
signiﬁcantly higher in Group 1. 21 patients (33%) in Group 1 had AFL (7 typical, 14 
atypical) compared to 43 patients (4%) in Group 2 (28 typical, 15 atypical). Ablation of the 
AFL in Group 1 patients resulted in an 81% acute success rate with 12% recurrence over 
a mean follow-up of 357±201 days. 
Conclusions: In patients with PCS, post-PVAI AF recurrence is similar to patients without 
PCS. However, history of PCS is associated with a higher recurrence of AFL after PVAI. In 
a signiﬁcant number of patients with PCS, AFL ablation is required to achieve cure.
1164-270 Cost-Effectiveness of Left Atrial Catheter Ablation, Anti-
Arrhythmic Therapy, and Rate Control for Paroxysmal 
and Chronic Atrial Fibrillation
Paul Chan, Sandeep Vijan, Fred Morady, Hakan Oral, University of Michigan, Ann Arbor, MI
Background: Left atrial catheter ablation (LACA) has been performed for paroxysmal 
and chronic atrial ﬁbrillation (AF). However there is limited data on cost-effectiveness of 
LACA for AF.
Objectives: To compare the cost-effectiveness of LACA, rhythm control with amiodarone, 
and rate control in patients with paroxysmal (PAF) and chronic AF (CAF) at low and 
moderate risk for stroke.
Methods: Based on published data and hospital accounting information, cost-effectiveness 
of 3 therapeutic strategies of LACA, anti-arrhythmic therapy with amiodarone, and rate 
control with antithrombotic therapy (aspirin or warfarin for low risk, and warfarin for moderate 
risk) were assessed in 2 hypothetical cohorts of 55 year-old patients with PAF at low risk 
for stroke, and 65 year-old patients with PAF and CAF at low and moderate risks for stroke 
using a Markov model. Outcomes of expected cost, quality-adjusted life years (QALYs), and 
incremental cost-effectiveness were determined for patient life-time, at 6-month cycles.
Results: For 65 year-old AF patients at low risk for stroke (1.4%/year), each treatment 
strategy when paired with aspirin dominated therapy with warfarin. LACA with aspirin 
was the most cost-effective ($51,387/QALY for PAF and $61,700/QALY for CAF). LACA 
with aspirin therapy also was more cost-effective for 55 year-old patients with PAF 
($27,697/QALY). For AF patients with moderate stroke risk (3.0%/year), LACA with 
warfarin therapy was the most cost-effective ($18,742/QALY for PAF and $21,629/QALY 
for CAF). Sensitivity analyses demonstrated that the choice of optimal strategy and cost-
effectiveness was primarily inﬂuenced by the baseline stroke risk, rate of stroke in sinus 
rhythm, efﬁcacy of coumadin and aspirin therapy in preventing stroke, efﬁcacy of the three 
therapies, and cost of LACA.
Conclusion: LACA is cost-effective in patients with PAF and CAF who are at moderate 
risk for stroke. Among patients who are at low risk for stroke, LACA is cost-effective in the 
55 year-old cohort with PAF, whereas for the 65 year-old cohort with PAF or CAF, decisions 
for LACA therapy depend largely on patient preferences, efﬁcacy of the procedure, and 
society’s willingness to pay for such therapy.
1164-271 Minimally Invasive Bilateral Epicardial Pulmonary Vein 
Isolation And Left Atrial Appendage Exclusion
Eric W. Schneeberger, Randall K. Wolf, John B. Flege, Jr., Walter H. Merrill, University of 
Cincinnati College of Medicine, Cincinnati, OH
BACKGROUND. The Cox Maze procedure, was seldom performed because of its 
complexity and invasiveness despite it’s effectiveness. Pulmonary vein isolation has 
been shown to be curative in a number of patients with AF. Catheter techniques have 
demonstrated mixed results due to the variations in endocardial topography and the 
propensity for delivery of non-transmural lesions. A number of complications have also 
been reported. A new approach that results in electrical isolation of the pulmonary veins 
has been achieved at surgery by placing a bi-polar radio frequency device on the atrium 
just medial to the pulmonary veins (on the atrial cuff).
METHODS. Twenty-ﬁve patients (4 female) (20 paroxysmal, 3 persistent, 2 permanent 
with signed consent who agreed to 6 months of follow up) were treated using a minimally 
invasive bilateral surgical procedure. The indications for operation were: symptomatic AF 
despite maximal drug therapy, antiarrhythmic drug side effects, intolerance to warfarin and 
history of TIA or stroke. After encircling the veins, a bi-polar clamp was passed through a 
port site and around both sets of pulmonary veins. Isolation of the atrial cuff was achieved 
in less than 15 seconds. The left atrial appendage was removed by a stapling device fed 
through a port site with TEE control.
RESULTS. 25 symptomatic AF were treated and there were no perioperative 
complications or blood product usage. The average time for the procedure was: 186mins 
(Rt Side 83 mins, Turning16mins, Lt Side 87 mins). Pain was graded by the patients as: 
3.5/10 at 24 hours. All patients left hospital on their preoperative medications and were 
weaned from them at follow up visits. To date all patients are in sinus rhythm (by 1 week 
monitoring) and are asymptomatic with an average follow up of 124 days.
CONCLUSIONS. Minimally invasive bilateral epicardial pulmonary vein isolation (in which 
encircling transmural atrial lesions are created and in which the left atrial appendage is 
excluded) may have a role as a stand alone procedure to cure atrial ﬁbrillation. A clinical 
trial is being designed to conﬁrm its efﬁcacy. Longer term follow up is warranted.
1164-272 Inferior Right Atrial Wall as a Predilection Site of Atrial 
Arrhythmias in Patients with Tricuspid Atresia.
Natasja M. de Groot, Wing King Chan, Nico Blom, Ernst E. van der Wall, Martin J. 
Schalij, Leiden University Medical Center, Leiden, The Netherlands
Atrial tachycardias (AT) frequently occur in patients with tricuspid atresia (TA) late after 
corrective or palliative cardiac surgery. Mapping prior to ablation has proven to be 
mandatory for identiﬁcation of crucial pathways of conduction during ART and to select the 
most optimal ablation strategy. In this study, we analysed the relation between the location of 
crucial pathways of conduction and spatial distribution of right atrial bipolar voltages.
Method: Patients (n=12, 28±12 yrs, 5 male) with TA and AT were studied. 3D electro-
anatomical bipolar mapping was performed during AT. Ablation was targeted at crucial 
pathways of conduction. Spatial distribution of peak-to-peak voltages of bipolar electrograms 
were off-line analysed in antero-posterior (A-P) and postero-anterior (P-A) view of the 
reconstructed right atrium. The X, Y and Z-axis were in both views used to subdivide the right 
atrium in a high lateral (HL), low lateral (LL), high septal (HS) and low septal quadrant (LS).
Results: Eighteen different AT’s (CL 309±76 ms) were mapped and ablated. The 
underlying mechanism was reentry (n=17) or a focus (n=1). Crucial pathways of 
conduction were located in the P-A view between 1) areas of scar tissue (n=17) and 2) 
the inferior caval vein and scar tissue in the lower lateral area (n=1). Bipolar voltages of 
these quadrants were signiﬁcant lower than in the remainder of the atria (table).
Conclusion: In TA patients, most post-operative AT originate from low voltage areas in 
the inferior right atrial wall. 
N median V (mV) P5 P95
AP-HL 434 0,56 0,06 3,56
AP-LL 513 0,58 0,06 4,33
AP-HS 448 1,1 0,07 4,73
AP-LS 363 0,43 0,07 4,77
PA-HL 349 0,46 0,05 5,05
PA-LL 340 0,21* 0,04 1,83
PA-HS 407 0,30 0,04 1,90
PA-LS 575 0,17* 0,03 1,51
*p<0,01
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882FO  Featured Oral Session...Noninvasive 
Markers of Arrhythmia Vulnerability
Wednesday, March 09, 2005, 10:30 a.m.-Noon
Orange County Convention Center, Room 231A
10:45 a.m.
882-4 A New Technique for the Quantitative Assessment of 
Repolarization Variability in Holter ECGs: Evaluation on 
the ICD Population of Madit II
Jean-Philippe Y. Couderc, Wojciech Zareba, Scott McNitt, Arthur J. Moss, University of 
Rochester Medical Center, Rochester, NY
T-wave variability (TWV) is associated with electrical instability of the myocardium leading 
to malignant arrhythmias and sudden cardiac death. In this study, we present a novel 
approach for the measurement of T-wave variability. We investigated the prognostic 
signiﬁcance of TWV in patients (pts) from the Multicenter Automatic Deﬁbrillator 
Implantation Trial II (MADIT II) population with and without appropriate ICD therapy 
(AIT).
Method: the exclusion criteria of pts in the ICD arm were: abnormal conduction, right 
or left bundle branch block or QRS duration >120 ms. TWV was measured based on 
amplitude variance of T-wave amplitude.
Results: a group of 202 pts were analyzed, 39 pts had AIT. No signiﬁcant differences 
were found between the 2 groups for age, QRS duration, BUN, gender and BMI. After 
adjustment for heart rate, ejection fraction, a Cox proportional-hazards regression model 
revealed that TWV values were predictive for AIT (HR: 3.3, CI:1.3-7.6, p=0.0049). Based 
on the higher quartile values (HRQ) of TWV in the no AIT group, an increased TWV value 
was associated with a signiﬁcant increased probability of AIT (see ﬁgure, p=0.046).
Conclusion: we designed a method for the assessment of repolarization instability in 
ambulatory Holter recordings. The method is able to detect transient variability of T-wave 
amplitude. In the ICD arm of the MADIT II population, the method revealed an increased 
variability of repolarization predicting the occurrence of VT/VF events (documented by 
ICD interrogation). 
11:00 a.m.
882-5 Heart Rate Turbulence: An Useful Non Invasive Risk 
Predictor In Patients With Myotonic Dystrophy Type 1.
Michela Casella, Antonio Dello Russo, Loredana Messano, Sergio Valsecchi, Alfonso 
Sestito, Gemma Pelargonio, Giuseppe De Martino, Manuela Pace, Tommaso Sanna, 
Maria Lucia Narducci, Gianluigi Bencardino, Fortunato Mangiola, Gaetano Antonio 
Lanza, Paolo Zecchi, Fulvio Bellocci, Cardiovascular Department Catholic University, 
Rome, Italy, Centre for Neuromuscular Diseases, Rome, Italy
Background. Myotonic Dystrophy type 1 (DM1) is a multisystemic disorder with 
cardiac complications and life-threatening arrhythmias. Heart rate turbulence (HRT) is a 
noninvasive tool for risk stratiﬁcation. Aim of our study is to assess HRT in DM1 patients 
in comparison to patients with frequent ventricular arrhythmias and structurally normal 
heart (VANH). We also evaluated the correlation between HRT and sustained ventricular 
arrhythmias induced at electrophysiological study in DM1 patients.
Methods. We performed HRT analysis, by 24 hours Holter recording, in 15 DM1 (mean 
age 52±10 yrs) and in 15 VANH patients (mean age 54±9 yrs). We calculated: turbulence 
onset (TO), a percentage difference between the mean of ﬁrst 2 RR intervals after and 
the last 2 RR intervals before a premature ventricular contraction, and turbulence slope 
(TS), a maximum positive slope of a regression line assessed over any 5 consecutive 
RR intervals within the ﬁrst 20 RR intervals after a premature ventricular contraction. 
An electrophysiological study was performed in all DM1 patients to evaluate ventricular 
arrhythmias inducibility.
Results. No differences were observed in TS between DM1 and VANH patients (12.3±4.2 
and 9.2±3.9 ms/RR, respectively); TO were signiﬁcantly different between DM1 and VANH 
(-0.44±2 and -2.9±1.8 % respectively; p 0.02). At electrophysiological study, sustained 
ventricular arrhythmias were induced in 6 (40%) DM1 patients. We observed a correlation 
between TO and inducibility of sustained ventricular arrhythmias in DM1 patients: 
TO -2.29±1.5 in not inducible and 2.32±1.3 % in inducible DM1 patients (p 0.008). No 
difference between no inducible DM1 (TO -2.28±1.57) and VANH (TO -2.91±1.8 %) was 
found, while a difference was observed between inducible DM1 and VANH (2.32±4 and 
-2.9±1.8% respectively; p<0.001).
Conclusions. Our data suggest a dysfunction of the nervous autonomic system, 
assessed by HRT analysis, in DM1 patients respect to VANH . The difference is more 
evident in inducible DM1 patients with the most pathological TO values (>0%). Therefore 
TO seems an useful non invasive risk predictor of sustained ventricular arrhythmias 
induced at electrophysiological study in DM1 patients.
11:15 a.m.
882-6 Atrial Turbulence Slope, Beta-Blocker Treatment, and 
Age Identify Postinfarction Patients Who Might Beneﬁt 
From Prophylactic Treatment With Amiodarone
Dan Wichterle, John Camm, Marek Malik, General University Hospital, Prague, Czech 
Republic, St. George’s Hospital Medical School, London, United Kingdom
Background: A subgroup analysis of EMIAT trial showed that high-risk patients with 
depressed heart rate variability (HRV) beneﬁt from treatment with amiodarone. In the 
same population, we investigated whether low-risk patients might also beneﬁt from the 
treatment.
Methods: All-cause mortality was compared in the placebo and amiodarone arms (n = 
1255) in several subgroups of low-risk patients selected according to clinical and Holter-
based predictors with previously established dichotomies (age < 65 yrs, ﬁrst myocardial 
infarction (MI), left ventricular ejection fraction > 30%, beta-blocker (BB) treatment, absent 
diabetes mellitus, thrombolysis for index MI, QRS duration <= 100 ms, HRV index > 20, 
low-frequency HRV spectral power > 130 ms2, high-frequency HRV spectral power > 30 
ms2, ventricular and atrial turbulence slope (VTS and ATS) > 2.5 ms/RR).
Results: Highly signiﬁcant beneﬁt from amiodarone treatment with 91% reduction of all-
cause mortality was observed in patients who were < 65 yrs of age and who had ATS 
> 2.5 ms/RR (23% of total population). Normal ATS in younger patients on amiodarone 
has negative predictive value of 99.3 and 100% for all-cause and arrhythmic mortality, 
respectively. 
Cox regression analysis - association of amiodarone  
treatment with all-cause mortality reduction 
Subgroup n relative risk 95% CI p
Age < 65 yrs 764 0.77 0.49 - 1.21 0.26
BB treatment 559 0.72 0.41 - 1.27 0.25
ATS > 2.5 ms/RR 404 0.46 0.19 - 1.11 0.075
Age < 65 yrs and BB treatment 359 0.34 0.12 - 0.93 0.028
Age < 65 yrs and ATS > 2.5 ms/RR 286 0.09 0.01 - 0.73 0.005
BB treatment and ATS > 2.5 ms/RR 211 0.12 0.02 - 0.94 0.015
Conclusion: Stratiﬁcation using ATS, BB treatment, and age served to ﬁnd the low-risk 
subgroups of postinfarction patients with left ventricular dysfunction who signiﬁcantly 
beneﬁt from treatment with amiodarone.
11:30 a.m.
882-7 Abnormal Heart Rate Variability is Signiﬁcantly 
Associated With Sudden Cardiac Death Among the 
Community-Dwelling Elderly
Phyllis K. Stein, Nona Sotooadehnia, Peter P. Domitrovich, David Siscovick, Emily 
Larsen, John Gottdiener, Pentti Rautaharju, Washington University School of Medicine, 
St. Louis, MO, University of Washington, Seattle, WA
Background: Associations between decreased heart rate variability (HRV) and risk of 
sudden cardiac death (SCD) have been found in patient populations. It is not known if 
HRV is associated with SCD in the community-dwelling elderly.
Methods: Of 1649 subjects with eligible Holter recordings in the Cardiovascular Health 
Study, N=49 died suddenly during up to 14 yrs of follow up. Time to SCD was 4.7±0.4 
(range 0.15-10.4) yrs. They were age/gender matched 2:1 with controls, alive at the time 
of death of the case, who did not die suddenly on follow up. Subjects were 74±5 yrs, 99M, 
47F. Traditional 24-hr time and frequency-domain HRV as well as non-linear indices and 
ventricular premature complex (VPC) counts were determined and compared between 
groups via t-tests.
Results: No signiﬁcant differences were seen between groups in heart rate, or in 
most time domain HRV indices. Among short-term HRV indices, reﬂecting beat-by-beat 
changes, rMSSD and pNN50 tended to be higher (p<0.06) and pNN6.25% (8.8±12.3 
vs. 4.7±6.3, p=0.032) was higher for SCD, as was the VPC count (1466 ± 2778 vs. 
451±1506, p=0.005). In the frequency domain, also consistent with increased short-term 
variability, both the LF(low frequency power)/HF(high frequency power) ratio (3.4 ± 2.1 
vs. 4.6±2.7, p=0.017) and normalized LF (42 ±9% vs. 47± 9%, p=0.003) were lower, 
and normalized HF power (18±8% SCD vs. 22±10%, p=0.020) was signiﬁcantly higher 
among SCD. Among non-linear HRV indices, which measure the degree of randomness 
or correlatedness of HR patterns, DFA1 was signiﬁcantly lower (0.95±0.19 vs. 1.07±0.18, 
p=0.001) and SD12 was signiﬁcantly higher (0.32 ±0.16 vs. 0.25 ±0.09) consistent with 
increased randomness of HR, i.e., increased non-respiratory sinus arrhythmia.
Conclusions: In contrast to clinical population studies, decreased long-term HRV was not 
associated with SCD among community-based elderly. However, increases in time domain 
and frequency domain indices reﬂecting relatively increased short-term HRV, together with 
non-linear results, are consistent with an increase in beat-to-beat randomness of heart rate 
patterns among elderly persons at increased risk of sudden death.
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882-8 Prevalence and Clinical Relevance of Short QT Interval 
in 12,012 Apparenthly Healthy Individuals.
Giovanni B. Forleo, Lucia De Luca, Luca Santini, Claudia Postorino, Maurizio Aracri, 
Valeria Morgia, Giulia Magliano, Fabio Di Liberato, Ruggero Mango, Clarissa Cola, 
Fabrizio Clementi, Roberto Leo, Francesco Romeo, University of Tor Vergata, Rome, Italy
BACKGROUND: Short QT interval (QTI) was recently associated with increased risk 
of life-threatening arrhythmias and may allow identifying a subset of high-risk patients 
by ECG observation. To our knowledge no epidemiological short QTI surveys have ever 
been reported and whether short QTI is associated with clinical events in a non hospital-
based population is uncertain. We sought to study prevalence and prognosis of short QTI 
recognized by chance in subjects without demonstrable structural heart disease.
METHODS: We analyzed ECGs and clinical data of 12,012 apparently healthy European 
adults undergoing routine medical examinations for occupational reasons. All subjects 
underwent a medical examination, blood sampling testing and 12-lead ECG. Enrollment 
was conﬁned to persons without evidence of heart disease or electrolytic imbalance. 
All subjects ECG records (91% male, age 29.9 ± 10 years) were reviewed by two 
investigators. QRS duration, QTI and RR interval were measured and predicted QTI 
(QTp) was calculated by means of QTp formula: 656/(1+Heart Rate/100).
RESULTS: Prevalence of patients with QTI shorter than 80% of predicted value was 
0.12% (CI: 0.07-0.21%; 15 of 12,012 subjects), all male (P:NS). In 13 cases (87%), we 
had clinical information available. No sudden death or signiﬁcant cardiac arrhythmias 
were recorded among these patients in a follow-up of 11.56±5.2 years (range 3-18).
CONCLUSIONS: A substantial number of subjects with short QTI were observed in a non 
hospital-based population. An incidental ﬁnding of this ECG pattern in otherwise healthy 
subjects may have a benign clinical course.
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883-3 Renal Insufﬁciency: A Potent and Previously 
Unrecognized Risk for Infection After Device 
Implantation
Heather L. Bloom, Brian Heeke, Angel Leon, David Delurgio, Fernando Mera, John 
Beshai, Jonathan J. Langberg, Emory University, Atlanta, GA
Background: As indications for devices expand, more patients with comorbidities undergo 
implantation. Medicare data shows increasing rates of infection between 1990 and 1999. The 
introduction of cardiac resynchronization therapy (CRT) has exposed a sicker patient population 
to longer procedures, making it likely that infection rates have continued to rise. We reviewed our 
device experience from 1999 to the present to determine risk factors for infection. 
Methods: A case-control study design was used. Of the 4111 device procedures, 65 
(1.6%) subsequently underwent lead extraction for infection. An additional 76 patients 
were referred to us for extraction of infected systems. These 141 patients were compared 
to 158 consecutive patients whose device implants were not complicated by infection. 
Results: Infection was more common in men (77% vs. 61%, p= <.002 ). Diabetes and 
warfarin use also increased risk of infection (OR 2.3, 2.8, p<.002,<.001). Neither obesity 
(BMI>30) or underweight (BMI<18) were associated with infection. The type of procedure 
(new implant vs replacement) did not predispose to infection. Renal insufﬁciency (Cr>1.7) 
was much more common in patients with infection than controls (25.2% vs. 5.8 %, 
p<.001). Patients with infection were also more likely to be on hemodialysis (6.5% vs. 
1.3%, p<.001). Renal insufﬁciency and hemodialysis were associated with a 5.5 and a 
5.4 fold increase in the incidence of infection. The OR for a CrCl<50ml/min was 11.9 
(46% vs. 6.6%). 
Conclusions: As has been shown in previous studies, diabetes and anticoagulation 
increase the risk of infection following device implantation or replacement. In the current 
study, renal insufﬁciency was the most potent risk factor for infection, with odds ratios 
more than twice that of any other parameter. Awareness of this previously unrecognized 
association may facilitate patient selection for device therapy and postoperative 
management as well.
10:45 a.m.
883-4 Radiographic LV-RV Inter-Lead Distance Predicts The 
Hemodynamic Response To Cardiac Resynchronization.
E. Kevin Heist, Dali Fan, Daniel Arzola-Castaner, Theofanie Mela, Michael H. Picard, 
Vivek Y. Reddy, Moussa Mansour, Jeremy N. Ruskin, Jagmeet P. Singh, Massachusetts 
General Hospital, Boston, MA
Background: Maximal separation between right and left ventricular leads is commonly 
sought during cardiac resynchronization therapy (CRT), but there is little data to support 
this practice. This study examines the relationship between relative LV and RV lead 
position and effects of CRT on contractility.
Methods: 101 consecutive patients undergoing CRT for standard indications were 
screened for this single center study. Of these, 51 ( age 69+10 y, LVEF 20+8) with 
transvenous LV lead placement and sufﬁcient mitral regurgitation for non-invasive 
hemodynamic analysis were included. Echocardiographic assessment of contractility was 
measured by Doppler analysis of mitral regurgitation as a percentage change in dP/dt 
(�dP/dt) with CRT on and off. The horizontal and vertical coordinates of the LV and RV 
leads was determined on post-procedural PA and lateral radiographs, with correction for 
the cardio-thoracic ratio.
Results: The corrected LV to RV inter-lead distance on the lateral radiograph (15.8+3.9 
cm) correlates well with �dP/dt (36.5+47.1%) (n=51, r=0.43, p=0.002). Further analyses 
show that the inter-lead distance in the horizontal plane (r=0.58, p<0.0001) and not 
the vertical plane (r=-0.28, p=NS) is associated with �dP/dt. A signiﬁcant correlation 
between the horizontal inter-lead distance on the lateral ﬁlm and �dP/dt was observed 
only in subjects with ischemic cardiomyopathy (n=34, r=0.69, p<0.0001), and not those 
with non-ischemic cardiomyopathy (n=17, r=0.21, p=NS). In the ischemic subgroup, the 
corrected horizontal inter-lead distance is greater in acute responders (�dP/dt>25%) (n= 
15; 16.8+3.3 cm) compared to non-responders (n= 19; 9.5+6.2 cm) (p=0.0002). Other 
radiographic measures, including the inter-lead distance (direct as well as horizontal and 
vertical components) on the PA ﬁlm and the distance of the LV lead tip from base to apex 
did not correlate with �dP/dt.
Conclusion: The horizontal LV to RV inter-lead distance on the lateral chest radiograph 
is a useful predictor of the acute hemodynamic response to CRT in patients with ischemic 
cardiomyopathy. Use of these ﬁndings with a lateral ﬂuoroscopic view during lead 
placement may improve the beneﬁt derived from CRT.
11:00 a.m.
883-5 Left Ventricular Remodeling after Cardiac 
Resynchronization Therapy Reduces Inducibility of 
Ventricular Tachy-Arrhythmias
Philippine Kiès, Jeroen J. Bax, Sander G. Molhoek, Gabe B. Bleeker, Katja Zeppenfeld, 
Marianne Bootsma, Lieselot van Erven, Paul Steendijk, Ernst E. van der Wall, Martin J. 
Schalij, Leiden University Medical Center, Leiden, The Netherlands
Introduction: Severe heart failure patients are at high risk of cardiac death due to 
ventricular arrhythmias or progressive heart failure. Therefore these patients may beneﬁt 
from implantable cardioverter deﬁbrillator (ICD) therapy and/or cardiac resynchronization 
therapy (CRT). Several reports have suggested that CRT may decrease the frequency of 
ventricular arrhythmias. We evaluated by electrophysiological study the effect of CRT on 
the inducibility of ventricular arrhythmias in relation to reverse remodeling after 6 months 
of CRT.
Methods: Eighteen patients (15 men, mean age 62±11 yrs), eligible for treatment with 
a combined CRT-ICD device, have been evaluated by electrophysiological study before 
implantation of the device and after 6 months of therapy. In addition left ventricular 
(LV) end-diastolic (EDV) and end-systolic volumes (ESV) were echocardiographically 
measured before and after 6 months of CRT.
Results: Before CRT, in 15 (83%) patients a sustained ventricular tachycardia was 
inducible during electrophysiological study. After 6 months of CRT, in only 6 (33%) 
patients a sustained ventricular tachycardia was inducible (P<0.01). None of the patients 
showed increased inducibility. Anti-arrhythmic drug usage did not differ between both 
electrophysiological studies. The patients who showed loss of inducibility showed 
signiﬁcant reverse remodeling (LVEDV from 293±67 to 258±69 ml and LVESV from 
244±69 to198±69 ml, both p<0.01) as opposed to the patients who remained inducible 
(LVEDV from 258±30 to 252±41; LVESV from 208±27 to 199±35 ml, both ns).
Conclusion: In patients with severe heart failure, six months of CRT resulted in a 
signiﬁcant reduction of inducible ventricular arrhythmias, in patients showing signiﬁcant 
reverse remodeling as a result of CRT.
11:15 a.m.
883-6 Pro-arrhythmic State Following the Initiation of Cardiac 
Resynchronization Therapy in Patients With Heart 
Failure
Frieder Braunschweig, Hannes Pﬁzenmayer, Aigars Rubulis, Cecilia Linde, Lennart 
Bergfeldt, Karolinska University Hospital, Stockholm, Sweden
Cardiac Resynchronisation Therapy (CRT) is increasingly used in patients with heart 
failure. Occasionally, ventricular arrhythmia and sudden cardiac death has been reported 
in association with the initiation of biventricular stimulation (BiV).
Methods: In 15 pts (61±12 yr, EF 22±8 %, QRS 168±25 ms), BiV was suspended for 14 
d by programming the pacemaker to atrial-inhibited mode (AAI). The QT interval was 
assessed on 9 occasions: day 0 (BiV); day 0, 1, 7, and 14 (AAI); day 14, 15, 16, and 
21 (BiV). Twelve-lead ECG recordings were obtained at 50 mm/s with the pacemaker 
programmed to 60, 70 and 80 bpm, all preceded by 5 min of supine rest. The QT interval, 
average of 3 cycles, was assessed as the mean of all measurable leads.
Results: BiV was associated with a signiﬁcant QT prolongation (p<0.05). Immediately 
after re-initiation of BiV (day 14), the QT interval increased on average by 5% (p<0.01). 
The ﬁgure shows a signiﬁcant rate dependence (p<0.01), and suggests a time dependent 
shortening of the QT interval after BiV reactivation. Conclusion: BiV was associated with 
a signiﬁcant prolongation of the QT-interval, suggesting the induction of a pro-arrhythmic 
state. This is in agreement with occasional reports on malignant arrhythmia and sudden 
cardiac death occuring in close relation to the initiation of CRT. Pacing at higher heart rates 
resulted in a shortened repolarization and may be considered for arrhythmia prevention, 
at least during the initial phase of CRT. 
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883-7 Improvements in Left Ventricular Diastolic Function 
After Cardiac Resynchronization Therapy: Results at 
Four-Month and 12-Month Follow-up
Alan D. Waggoner, Mitchell N. Faddis, Lisa de las Fuentes, Marye J. Gleva, Sharon 
Heuerman, Victor G. Davila-Roman, Washinton University, St. Louis, MO
Introduction: Cardiac resynchronization therapy (CRT) decreases left ventricular (LV) 
volumes and increases ejection fraction (EF) in patients with heart failure. The CRT-
related improvements in LV diastolic function have not been evaluated by relative load-
independent, non-invasive measurements.
Methods: 34 patients (age 61±10 years, 65% male, 26% ischemic etiology) were studied 
with two-dimensional and pulsed-wave Doppler (PWD) echocardiography, tissue Doppler 
imaging (TDI) and color M-Mode ﬂow propagation (FP), prior to CRT, 4±2 months (mo), 
and 12±2 mo after CRT. Measurements included LV volumes, LVEF, PWD mitral E/A ratio, 
deceleration time (DT), diastolic ﬁlling time (DFT) and isovolumic relaxation time (IVRT). 
TDI early diastolic (Em at septal annulus) and FP velocities were obtained in apical 4 
chamber view; PWD mitral E wave/FP was used to estimate LV ﬁlling pressure.
Results: 
EDV (ml) ESV (ml) LVEF (%) E/A DT (ms) DFT (ms) E/FP
Pre CRT 233±90 176±78 26±5 1.5±1.1 181±46 351±84 2.2±0.6
4 mo 194±81 132±74 35±11 1.2±0.9 209±60 446±126 1.8±0.7
12 mo 190±82 131±77 35±13 1.2±0.7 232±79 447±110 1.9±0.8
ANOVA .07 .02 .0003 .29 .005 .0003 .06
Mean ± SD; ANOVA with post-hoc analysis by Fisher’s least-signiﬁcant-difference.
After 4 mo of CRT, end-systolic volume (ESV) decreased, LVEF and DFT both increased, 
but without further interval changes at 12 mo. LV ﬁlling pressures (E/FP) also decrease at 
4 mo (p=.03). DT increased signiﬁcantly at 12 mo after CRT. The mitral E/A ratio and LV 
relaxation indices (IVRT, Em, and FP) were unchanged after CRT.
Conclusions: CRT improves LV diastolic ﬁlling in patients with severe heart failure and 
modestly decreases ﬁlling pressure. The ﬁndings are associated with reduction in LV 
volumes and improvement in LVEF. The beneﬁts of CRT observed at short term follow-up 
are sustained at 1 year.
11:45 a.m.
883-8 Gender-related Long-Term Outcome in Heart Failure 
Patients Treated With Cardiac Resynchronisation 
Therapy
Cecilia Fantoni, Santi Raffa, Francois Regoli, Mihoko Kawabata, Helmut U Klein, Angelo 
Auricchio, University Hospital, Magdeburg, Germany, University of Insubria, Varese, Italy
Background: Gender-related difference in long-term outcome after CRT has not been 
investigated so far.
Methods: We compared improvement of functional capacity and echo-parameters 
at 1 year follow-up and long term event free survival rate in 139 male and 35 female 
heart failure patients consecutively implanted with a CRT device, using a transvenous 
lead. Events considered for survival rate analysis were death for any cause, heart 
transplantation and left ventricular (LV) assist device implantation.
Results: At baseline men were younger than women (62±9 vs 66±7 yrs, p<0,04). Mean 
capillary wedge pressure was higher in male (16,2±9,8 vs 11,9±7,7 mmHg, p<0,03). 
All the other clinical, echocardiographic and hemodynamic variables were not different 
between the 2 groups. Rate of a deﬁbrillator back-up was higher in male (p<0,02). At 1 
year follow-up NYHA class, LV ejection fraction, LV diameters, mitral regurgitation and 
peak oxygen consumption signiﬁcantly improved in both groups compared to baseline. 
During a mean follow-up of 683±444 days 20 events occurred among men (14%) and 
only 1 among women (3%). Male patients demonstrated a signiﬁcant worse outcome 
after CRT compared to female as shown by the Kaplan-Meyer event-free survival curves 
(p<0,05).
Conclusions: Male patients show a signiﬁcant worse outcome after CRT compared to 
female, in spite of similar baseline clinical proﬁle and equal functional improvement at 1 
year follow-up. These results need to be conﬁrmed by prospective randomised trials.
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